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Abstract
The recent technology of single-cell RNA sequencing can be used to in-
vestigate molecular and transcriptional changes in cells as they develop. I
reviewed the literature on the technology andmade a large scale quantitative
comparison of the different implementations of single cell RNA sequencing
to identify their technical limitations.
I investigated how to model transcriptional changes during cellular de-
velopment. The patterns that gene expression levels can show over de-
velopment have unknown shape. This leads to the use of non-parametric
regression, using Gaussian process models. I used Gaussian process models to
investigate expression patterns in early embryonic development, and com-
pared the development of mice and humans. When using in vivo systems,
ground truth developmental stage or time for each cell cannot be known.
Only a snapshot of cells, all being in different stages of development, can be
obtained. In an experiment measuring the transcriptome of zebrafish blood
precursor cells, undergoing development from hematopoietic stem cells to
thrombocytes, I used a Gaussian process latent variable model (GPLVM) to
align the cells according to the developmental trajectory. This way I could
investigate which genes were driving the development and characterise the
different patterns of expression.
With the latent variable strategy in mind, I designed an experiment to
study the rare event of murine embryonic stem cells entering a state similar
to very early embryos. The GPLVM can take advantage of the nonlinear
expression patterns involved in this process. The results showed multiple
activation events of genes as cells progress towards the rare state.
viii
An essential feature of developmental biology is the ability of precursor
cells to give rise to multiple types of differentiated (daughter) cells. In the
immune system, naive T-helper cells differentiate to different sub-types
depending on the infection. In an experiment where mice were infected by
malaria, T-helper cells develop into two cell types, Th1 and Tfh. I model
this branching development using an Overlapping Mixture of Gaussian
Processes, which allowed me to identify which cells belong to which branch,
and learn which genes are involved with the different branches.
Researchers have recently started to perform high-throughput exper-
iments where spatial context of gene expression is recorded. Similar to
the methods I have developed to identify temporal expression patterns,
spatial expression patterns can be identified nonparametrically. To enable
researchers to make use of this technique, I developed a very fast method to
perform a statistical test for spatial dependence and applied the resulting
method on multiple data sets.
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Chapter1
The rise of single cell RNA-seq experiments
The measurement of the transcriptome of single-cells has only become pos-
sible over the last few years, but is becoming an extremely popular assay.
While many types of analysis and questions can be answered using single
cell RNA-sequencing, of prime interest is the ability to investigate what
cell types occur in nature. Unbiased and reproducible cataloging of dis-
tinct cell types require large numbers of cells to be sampled. Technological
development and improvement of protocols has exponentially scaled the
size of single cell RNA-seq studies, much faster than Moore’s Law. In this
perspective we will illustrate the steps that facilitated this growth, and will
discuss the implications for our ability to define cell types.
1.1 Introduction
Cells are the fundamental units of life and cell differentiation allows the
generation of complex multicellular organisms. This variety of cells is made
possible because cells exhibit different identities that are determined in-
trinsically (as a consequence of development) and extrinsically by their
environment. The molecular mechanisms that regulate cell state and func-
tion are of fundamental interest, as key determinants of the cell phenotype,
inform on developmental origin and tissue context.
Regulation of cell state and function occurs significantly at the mRNA
level, with transcription factors defining a cell’s transcriptional “programme”.
In light of this, the abundances of different RNAs within cells are represen-
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Fig. 1.1 Scaling single cell transcriptomics. Since the advent of single cell RNA se-
quencing, key technologies (top) have advanced the scale of single cell RNA-seq studies.
Representative studies over the years are illustrated with their publication dates compared
to their sample sizes (bottom). Key technological advances are named and annotated in
the figure close to the corresponding study.
tative of functionally relevant cellular states. The ability to measure RNA in
cells ties together cell biology, in terms of cellular phenotypes, with molecu-
lar biology, in terms of regulation of function. Shortly after the advent of
RNA sequencing as a biological tool (Mortazavi et al., 2008), researchers
started working on adapting the technology to single cells. Imaging-based
assays such as in situ hybridization for RNA, or immunostaining for proteins
had long revealed that population level averages were not representative of
individual cell states (Raj and van Oudenaarden, 2008).
Over the last few years, many sensitive and accurate single-cell RNA-
sequencing (scRNA-Seq) protocols have been developed (Svensson et al.,
2017).
In this chapter, we show that single cell transcriptome experiments have
grown exponentially, up to hundreds of thousands cells per study, in less
than a decade (Figure 1.1). We also highlight what this has meant for the
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investigation of cell states1, cell types2 and other sources of cell-to-cell varia-
tion.
1.2 From tens to hundreds of cells
The increase inmultiplexing of samples is driven by two factors: (i) reduction
in the volume of reagents per sample and (ii) parallel processing of samples.
In the first single-cell RNA-seq study published eight years ago by Tang
et al. (2009), a single 4-cell stage blastomere was manually isolated using a
glass capillary. The entire RNA-sequencing procedure was performed on
the cell individually. The motivation was to make the most of precious em-
bryonic samples compared to microarray techniques. The original method
by Tang et al requires multiple PCR tubes for each cell, and a gel purification
step (Sasagawa et al., 2013; Tang et al., 2010).
Since it was known that intrinsic transcriptional variation might cause
measurement issues, a technique called STRT-Seq was developed and pre-
sented in a study by Islam et al. (2011). Up to 85 samples were multiplexed to
characterize the transcriptional landscape of MEFs and mESCs. At the time,
the value of multiplexing strategies started to be recognized as a means to
allow higher throughput of sequencing experiments in general (Kozarewa
and Turner, 2011). In this technique, the 96 cells are added to individual
wells, and cell specific barcodes are added using the template-switching
mechanism of reverse transcriptase during cDNA generation independently
for each sample. The material from each well is then pooled before it is
amplified by PCR. From the results of Islam et al. (2011), it was clear that
while there was a great degree of intrinsic variation between cells of the
same type, embryonic stem cells (mESC) could be distinguished from MEF
cells based on the transcriptome, illustrating the notion of a transcriptional
cell state. This served as a pilot for future studies where cells would be
1Cell state refer to cases where cells are transiently distinct, by expressing genes or carry
some other phenotype.
2Cell type on the other hand refer to cases when cells are terminally differentiated and
locked to a phenotype, e.g. by epigenetic marks. The exact dilenation between these two
notions can however often be hard to dinstinguish.
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randomly sampled, and not have a priori annotated cell types and de novo
annotated.
The ability to distinguish cell types by single cell transcriptomics was
also demonstrated by (Hashimshony et al., 2012), who introduced the CEL-
seq technique. As with STRT-seq, cells in individual wells are barcoded
during cDNA synthesis and pooled, but rather than using PCR, the material
is amplified by in vitro transcription (IVT).
Illumina, Inc. introduced highly multiplexed procedures for Illumina
sequencing using dual-index barcoding in the form of the transposase-based
‘tagmentation’ with the Nextera XT kits (Illumina, Inc, 2012). This meant
that multiplexing cells could be simplified by commercially available kits,
allowing up to 192 samples per Illumina sequencing lane. The SMART-
seq technique was introduced as a single-cell sequencing technology by
Ramskold et al (Ramsköld et al., 2012), giving full length coverage of tran-
scripts using the SMART template switching technology. The data generated
was more familiar to users of traditional RNA-sequencing, making bioin-
formatics processing easier. This method made use of the Nextera kit for
multiplexing and library generation. The Smart-seq technique made scRNA-
seq experiments widely accessible by becoming readily available as the
SMARTer kit from Clontech (Clontech Laboratories, Inc., 2013). A drawback
compared to STRT- and CEL-seq is that amplification and library generation
must be carried out for all the cells individually, increasing the processing
time.
While readily available and easy to use (Smart-seq has a smaller number
of experimental steps than STRT-Seq or CEL-Seq), the cost per sample using
the SMARTer kit was prohibitive when scaling up to the numbers in the
STRT-seq and CEL-seq applications. Indeed, none of the published studies
using this technique in microwells processed more than 20 cells (Marinov
et al., 2014; Ramsköld et al., 2012; Shalek et al., 2013). While it was noted
that discrete cell states could be identified (Shalek et al., 2013), it became
clear that more statistical power through increased sample numbers would
be helpful. Two parallel strategies emerged to tackle this: reducing the
reaction volume per cell and the use of cheaper reagents for similar goals.
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The introduction of the Fluidigm C1 system improved the reagent cost, by
letting the reaction occur in nanoliter chambers of an integrated fluidic
circuit (IFC) (Fluidigm Corporation, 2013). The system also simplified cell
isolation, as users were simply able to load a cell suspension into the system.
Cells were automatically captured in 96 chambers of the IFC and processed
material could later be transferred to microwell plates (Brennecke et al., 2013;
Wu et al., 2014). Recently, a higher throughput version of the IFC allowing
up to 800 cells to be captured was announced (Fluidigm Corporation, 2016).
The use of ∼ 100 samples allowed researchers to estimate variance and
decompose it into biological and technical noise (Brennecke et al., 2013; Kim
et al., 2015).
The Linnarsson group also modified their STRT-Seq protocol to be com-
patible with the C1 IFCs. In addition to reducing the reagent volume per cell,
this reduced the labour of manually isolating cells (Islam et al., 2014). After
the addition of robotic automation for library preparation this eventually
enabled the group to survey and catalogue neuronal subtypes in mouse
cortex by investigating 3,005 cells from 67 individual mice (Zeisel et al., 2015).
The large number of cells frommultiple mice allowed the authors to develop
BackSPIN, a stable algorithm to cluster cells into neuronal cell types.
The group of Rickard Sandberg released the Smart-seq2 protocol, a
refined version of Smart-seq which used less expensive off the shelf reagents
(Picelli et al., 2013, 2014b), and also used smaller volumes in individual
wells. The microwell based Smart-seq2 protocol was more appropriate
when cells could not be provided in a dense suspension, as is the case e.g.
when studying early embryonic cells (Deng et al., 2014).
Researchers also noted that some cell types were difficult to capture
on the C1 IFC chips (for example, in the study by Zeisel et al. (2015) the
average successful cell capture rate was 41%). With the lower reagent price
per volume, the Smart-seq2 protocol gave an alternative with greater control,
though at the cost of increased labour. The strategy of relying on off-the-
shelf reagents and not needing the expensive IFC reduced the price per
cell. The dominant cost factor for Smart-seq2 at this point was the reliance
on the Nextera kit for barcoding. The cost per cell was further reduced by
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in-house production of the transposase Tn5, a variant of the active enzyme
in Illumina’s Nextera XT tagmentation kit (Picelli et al., 2014a). The same
Tn5 transposase was used by the Linnarsson lab to reduce the cost of the
STRT-seq technology (Islam et al., 2014).
1.3 Surpassing thousands of cells
With well-calibrated flow cytometers, cells can quickly be isolated in indi-
vidual wells of 96 or 384 microwell plates. Once cells are available as a single
cell suspension, researchers can use this strategy to populate large numbers
of plates with their cells of interest, the bottleneck becoming the processing
of the plates. With this in mind, Jaitin et al modified the CEL-seq protocol
to be compatible with robotic automation in massively parallel single-cell
RNA-sequencing (MARS-Seq, Jaitin et al. (2014)). This allowed the Amit
team to decrease the labour of processing plates filled with isolated cells and
scale up massively, investigating 4,000 cells in one study (Jaitin et al., 2014).
Several laboratories have set up automation procedures for their standard
protocol of choice (Soumillon et al., 2014; Zeisel et al., 2015). The refined
CEL-seq2 method (Hashimshony et al., 2016) was automated in form of
the SORT-seq method (Muraro et al., 2016). The large number of samples
allowed researchers to develop a probabilistic mixture model that allowed
them to assign cells to immune cell types without known markers (Jaitin
et al., 2014).
In CEL-seq and derivative protocols (Hashimshony et al., 2016, 2012;
Jaitin et al., 2014; Velten et al., 2015), it had been demonstrated that as
long as you had isolated and barcoded the cDNA material, the following
steps of amplification and library preparation could be done in a single
unit. The bottleneck to improving throughput was pinpointed to two major
factors: isolation of cells and the ability to generate enough multiplexing
barcodes to investigate large numbers of cells in parallel. Methods had
emerged to randomly capture and manipulate individual cells in nanoliter
droplet emulsions (Mazutis et al., 2013). The challenge of creating cDNA
and barcode the material in the individual droplets was solved by Klein
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et al. (2015) and Macosko et al. (2015) by delivering beads coated with
barcoded sequences into the droplets in the inDrop and Drop-seq methods,
respectively.
The reverse droplets have miniscule volumes of about 1 nL per cell,
further reducing the reagent cost per cell. However, to avoid capturing two
cells in a single droplet, the random isolation must be rate limited. This
means the efficiency of capturing any given cell by a unique bead is low (in
the order of 5-10% (Klein et al., 2015; Macosko et al., 2015)) and therefore
the barcode space must be sufficiently large to allow for a great number of
unused sequences. This is a challenge considering the molecular properties
of the barcodes need to be accounted for during the barcode design (Costea
et al., 2013).
A benefit of the droplet microfluidics is that it is simple to manufac-
ture the components. The plans and details for the Drop-seq system was
made public online at http://mccarrolllab.com/dropseq/. This spread the
use of the technology, and has enabled researchers to customize it to their
needs. Still, optimization and experience with microfluidics is needed for
optimal results. The company 10x Genomics commercialised the material
required (device and reagents) to perform the inDropmethod, spreading the
technology worldwide (10x Genomics, Inc, 2016). In their implementation,
up to 8 independent cell pools can be processed simultaneously, allowing
the parallelisation of several experiments in a single run. The technology
was demonstrated in a massive study of 250,000 cells (Zheng et al., 2017).
Recently, Illumina and Bio-Rad also announced a nanodroplet based single
cell isolation system (Illumina, Inc., 2017a).
An alternative strategy for massively parallel cell isolation is to deposit
beads into picoliter wells, and randomly load them with cells at limiting
dilution (Bose et al., 2015; Fan et al., 2015; Gierahn et al., 2017). Beside
decreasing the reaction volume, the picowell systems are easier to control,
and more portable. This allows for more rapid collection of fresh cells
in e.g. clinical settings, further improving the ability to make single cell
observations.
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A related strategy by Vickovic et al. (2016) consists of FACS sorting cells
onto the surface of an array with attached barcoded Poly(dT) capture probes.
The throughput is estimated to be 10,000 cells over two days. Since cells
are not randomly isolated but actively placed, the capture efficiency per cell
should be better depending on the flow sorter.
1.4 On the horizon: hundreds of thousands to millions of cells
Rate limiting the number of cells in random capture system to avoid captur-
ing multiple cells at once prohibits further scaling of these methods. Two
new methods have been developed to overcome these issues, making use of
sequential in situ barcoding (Cao et al., 2017; Rosenberg et al., 2017).
In the in situ barcoding approaches, cells are permeabilized and fixed
with formaldehyde (Rosenberg et al., 2017) or methanol (Cao et al., 2017).
The fixed cells are then divided into small fractions of reactions where in
the first round cDNA is generated from RNA and all cells in a fraction are
marked with a unique barcode. In subsequent steps, fractions are pooled
together, and re-divided into fractions. In the new fractions a second barcode
is appended to the cDNA. The low probability of cells going together into the
sequential fractions means each cell will get a unique sequence of barcodes,
while the cells have actually never been isolated. In the study of Cao et
al, this technique was applied to C. elegans and the researchers were able
to obtain sequencing data for about 50 copies of each known cell type in
the worm, providing a single-cell atlas of a whole animal (Cao et al., 2017).
Cell types could be identified in an unbiased manner by first creating a
low-dimensional representation through t-distributed stochastic neighbour
embedding (t-SNE, Van der Maaten and Hinton (2008)), then applying the
Density Peak clustering algorithm (Rodriguez and Laio, 2014). The high copy
number of the cell types allowed the low-dimensional representation to be
well represented with distinct groups.
Currently, the major cost limitation is library preparation and cDNA
sequencing. To identify cell types and regulatory networks, relatively shal-
low sequencing suffices (Heimberg et al., 2016; Pollen et al., 2014), but the
1.4 9
sequencing cost is still prohibitive, even at shallow depths, when wishing
to analyse hundreds of thousands of cells. Recent announcements promise
slightly cheaper sequencing from higher throughput (Illumina, Inc., 2017b),
albeit some radical change in sequencing technology might be needed to
further drive down sequencing cost.
Beyond sequencing, the limitation is obtaining cells. In some cases, cells
might not be easy to isolate and in many interesting cases, it is difficult to
obtain a single cell suspension as cell viability is comprimised by the tissue
disaggregation. In line with this, two laboratories in parallel adapted single-
cell transcriptomics to isolated nuclei, allowing work with tissues where
harsh dissociation protocols will damage RNA integrity (Habib et al., 2017,
2016; Lake et al., 2016). Moreover, stored material can be used in nuclear
single-cell RNA analysis, as it is compatible with cell fixation. Recent work
has shown that cells can be preserved prior to preparation for single cell
RNA-sequencing, increasing the ability to gather usable material without
reducing the complexity of the transcriptome (Alles et al., 2017; Guillaumet-
Adkins et al., 2017) and potentially use archived material.
A particularly telling example of the improvements in scalingwhich have
happened over the years is from the Regev lab. This lab initially used 18 cells
(Shalek et al., 2014) (microwell plates), scaled to 2,000 cells (Shalek et al., 2014)
(microfluidics) and then to 200,000 cells (Dixit et al., 2016) (nanodroplets) of
the same cell type over the last 4 years. The field of transcriptomics has long
been cursed by the so called “large P small N problem”, where the number
of observations (cells, N) is much smaller than the number of variables
(genes, P). With hundreds of thousands of cells, each expressing up to 10,000
genes, this is no longer the case, and in the coming years we will see a lot of
interesting results from this.
Recently, single cell studies have started including artificial perturbations
of the system, fromwhich direct regulatory information can be gained using
relatively simple linear models (Adamson et al., 2016; Datlinger et al., 2017;
Dixit et al., 2016; Jaitin et al., 2016). It has been widely accepted that simple
analysis methods with a lot of data perform better than complex methods
with small amounts of data (Halevy et al., 2009). A good recent illustration
10 The rise of single cell RNA-seq experiments
MERFISH, 2016
SeqFISH, 2016
IMC, 2014
Padlock Probes, 2013
MIBI, 2014
MERFISH, 2015
Spatial Transcriptomics*, 2016
FISSEQ, 2014
TIVA, 2013
Fig. 1.2 Expression in spatial context. Many recent studies not only quantify gene
expression in single cells, but also retain information about the spatial origin of the cells.
Size of symbols correspond to area of tissue investigated, ranging from 20 µm × 20
µm (TIVA) to 6.2 mm × 6.6 mm (ST). Squares indicate methods that measure proteins,
while circles indicate RNA measurement. Spatial Transcriptomics is a special case, as it
measures expression in circular regions of 50 µm radius rather than single cells.
is the work of Esteva et al, where a gold standard data set of 1,000 images
was increased to one with 100,000, images, allowing the researchers to train
a neural network which performed better than trained dermatologists in
clinical classification of skin lesions (Esteva et al., 2017). When studies reach
millions of cells, even rare cell types will be identifiable without issue, and
we will have an unbiased view of transcriptional diversity.
1.5 Retaining spatial context
The increasingly large sample sizes of single cells is one aspect of technolog-
ical improvement. In addition to this, many new experimental technologoes
allow the spatial information of cells in tissues to be preserved. This will al-
low researchers to investigate how cell communication affects transcriptional
regulation. Technologies are still emerging (Figure 1.2) and are starting to
achieve enough scale to be useful. This will be a very promising field in the
future.
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1.6 Biological insights gained and structure of this thesis
Studies of single-cell transcriptomes allow us to directly investigate prop-
erties of individual cells, i.e. mRNA abundance. Thus gene regulation is
analyzed at the single cell level and, unlike traditional traditional RNA-
sequencing, cell-to-cell heterogeneity can be considered.
There can be multiple possible sources of cellular heterogeneity in a pop-
ulation. 1) Expression can be intrinsically heterogenouos. 2) A population
can consist of multiple distinct cell types, expressing different genes. 3) An
underlying process modulates expression of many genes, in a continuous
fashion.
The latter point is the focus of this thesis. By measuring gene expression
in development, differentiation, or other responses, we can start to under-
stand cellular phenotypes as well as the regulatory processes that determine
these phenotypes. In many experiments cells are sampled at many time
points and gene expression is assessed. To analyse general gene expression
patterns, we need to use a non-parametric analysis framework. In Chapter 3
we discuss this.
Actively collecting cells requires large experimental resources, and ig-
nores heterogeneity in development or response to stimuli. Since transcrip-
tome data is extremely rich, the continuous differences between measured
cells can be identified from the data alone. The task of identifying the pro-
cess or trajectory has been codified in the field as Pseudotime. In Chapter 3
we describe how non-parametric models can also be used for this task, and
applied to study blood development.
In Chapter 4, we consider the problem of studying expression changes
over time when cells are sampled from multiple unlabeled cell populations
which act differently over time. We present a method to identify and decon-
volve multiple simulatneuous expression patterns using the same model
framework as in Chapter 3.
Finally, in Chapter 5 we consider genes which depend on spatial coordi-
nates, rather than a time value. We then conclude the thesis by disscusing
our conclusions and give an outlook towards future work.
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We start however, in Chapter 2 by assessing the technical performance
of various methods mentioned in this chapter. If we wish to gain biological
insights from these data, we need to know how quantitative and sensitive the
different techniques are. This also guides us in our choices of experimental
design in the following chapters.
Chapter2
Technical performance of Single Cell RNA-Seq experi-
ments
Single-cell RNA sequencing (scRNA-seq) has become an established and
powerful method to investigate transcriptomic cell-to-cell variation, thereby
revealing new cell types and providing insights into developmental pro-
cesses and transcriptional stochasticity. A key question is how the vari-
ety of available protocols compare in terms of their ability to detect and
accurately quantify gene expression. Here, we assessed the protocol sen-
sitivity and accuracy of many published data sets on the basis of spike-
in standards and uniform data processing. For our workflow, we devel-
oped a flexible tool for counting the number of unique molecular identifiers
(https://github.com/vals/umis/). We compared 5 protocols computation-
ally and 4 protocols experimentally for batch-matched cell populations. In
addition we investigated the effects of molecular spike-in degradation on
measurements. Our analysis provides an integrated framework for compar-
ing scRNA-seq protocols.
The work presented in this chapter was published in Nature Methods as
Power-analysis of Single Cell RNA-seq experiments (Svensson et al., 2017).
Individual contributions The work in this chapter includes experiments
performed by Kedar Natarajan, who was joint first author of the manuscript.
For detailed experimental methods see Section A.1.
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2.1 Introduction
The recent explosion in the development of protocols for sequencing the
RNA of individual cells (Macaulay and Voet, 2014; Stegle et al., 2015) has
generated different approaches to capture cells, amplify cDNA, minimize
biases and use liquid-handling platforms. Owing to the tiny amount of
starting material, considerable amplification is an integral step in all of
these protocols. Consequently, it is important to assess the sensitivity and
accuracy of the protocols in terms of the number of RNAmolecules detected.
Previous studies have experimentally compared the performance of a limited
number of protocols (Wu et al., 2014; Ziegenhain et al., 2016). In this study,
we assessed the performance of a large number of published scRNA-seq
protocols on the basis of their ability to quantify the expression of spike-in
RNAs of known concentration.
We defined the sensitivity of a method as the minimum number of input
RNA molecules required for a spike-in control to be confidently detected
(also known as the lower molecular-detection limit, for a given sequencing
depth) and we defined the accuracy as how close the estimated relative
abundance levels were to the known abundance levels of input molecules
(or in other words, the correlation between input and measurement). High
sensitivity permits the detection of very weakly expressed genes, whereas
high accuracy suggests that detected variations in expression reflect true
biological differences in mRNA abundance across cells, rather than technical
factors.
The External RNAControls Consortium (ERCC) (External RNAControls
Consortium, 2005) spike-in standards consist of a mixture of 92 RNA species
of varying length and GC content, which are present at 22 abundance levels
spaced one fold change apart from one another (Figure A.1). Such spike-ins
have been used to assess the reproducibility of standard RNA-seq protocols
(Jiang et al., 2011) and to assess the performance of differential expression
tests on RNA-seq data (Munro et al., 2014). In the context of scRNA-seq,
ERCC spike-ins were first used in a multiplexed linear amplification (CEL-
seq) protocol (Hashimshony et al., 2012). Here, we exploited spike-ins as
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Fig. 2.1 Strategy for scRNA-seq protocol comparison. (a) Endogenous mRNA levels
vary by cell type and condition and cannot be used to compare protocols applied to
different cell types. By contrast, protocols can be compared, regardless of cell type,
by measuring the same spike-in RNA standards added at known concentrations to all
experiments. (b,c) We define two global technical performance metrics for spike-ins:
sensitivity, the number of input spike-in molecules at the point at which the probability
of detection reaches 50% (b), and accuracy, the Pearson product-moment correlation
(R) between estimated expression levels and actual input RNA-molecule concentration
(ground truth) (c). TPM, transcripts per million.
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a unified framework to compare the technical sensitivity and accuracy of
different scRNA-seq protocols across various platforms, independently of
the biological cell type investigated (Figure 2.1).
Our analysis was subject to limitations (described in depth in the Dis-
cussion). We relied on accurate reporting of spike-in volumes and dilutions
by the original authors, which we reconfirmed by personal communica-
tion in several cases. In addition, spike-in molecules may not truly reflect
endogenous mRNA capture efficiency in scRNA-seq, owing to deviation
from natural mRNA sequence features such as shorter poly(A) tails and the
absence of mRNA-binding proteins. Nevertheless, our approach allows for
comparison across the large number of protocols and platforms with pub-
lished spike-in data, most of which have been replicated across at least two
different cell types and different laboratories. This methodology decreases
potential bias due to a specific cell type or study.
2.2 Results
Our analysis spanned 15 distinct experimental protocols encompassing
28 single-cell studies, including 17 studies that measured expression with
full-length transcript coverage and 11 that used unique molecular identi-
fiers (UMIs) for digital quantification. We also carried out three different
scRNA-seq protocols on the Fluidigm C1 platform by using batch-matched
mouse embryonic stem cells (mESCs) with both ERCC and Spike-in RNA
Variant (SIRV) spike-ins (Methods). SMARTer and Smart-seq2 were per-
formed in duplicate and single-cell tagged reverse transcription (STRT)-seq
was performed once. We also generated a high-throughput droplet-based
10× Genomics Chromium data set on ERCC spike-ins and human brain
total RNA. In total, our analysis covered 18,123 publicly available samples
comprising 30 billion sequencing reads.
Using reported spike-in dilutions and volumes, we calculated the abso-
lute number of spike-in RNA molecules at different abundance levels across
individual cell samples, thus permitting all data sets to be compared on the
same scale.
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2.3 scRNA-seq quantification accuracy
To assess the quantification accuracy of different protocols, we computed the
Pearson product-moment correlation coefficient R between log-transformed
values of estimated ERCC RNA expression and input concentration for each
individual cell or sample (Figure 2.2a).
Conventional bulk-RNA sequencing is more accurate than scRNA-seq
protocols. Remarkably, the accuracy of scRNA-seq protocols is still high, and
individual samples rarely have a Pearson correlation less than 0.6. The lower
accuracy and variable Pearson correlations for individual cells within some
protocols (genome and transcriptome sequencing (G&T-seq), CEL-seq, and
massively parallel single-cell RNA-seq (MARS-seq)) may indicate variable
success rates for these protocols.
2.4 scRNA-seq sensitivity
To investigate the technical sensitivity achieved for each sample and to
quantify the inter-sample variability for each protocol, we devised a logistic
regression model with detection of expression as the dependent variable.
Our measure of sensitivity was the spike-in input level at which the proba-
bility of detection reached 50% (Figure 2.1B). Measuring the sensitivity of
each sample individually avoided biases due to uneven batch sizes. This
approach also avoided the need to use detected spike-in ratios at each abun-
dance level, which would have resulted in poor resolution, because no more
than seven spike-ins share one abundance level.
scRNA-seq protocols are more sensitive than bulk-RNA sequencing and
can detect very low numbers of inputmolecules (Figure 2.2b). The sensitivity
of scRNA-seq protocols varied over four orders of magnitude, and several
protocols (SMARTer (C1), CEL-seq2 (C1), STRT-seq, and inDrop) have the
potential to detect as little as single-digit input spike-in molecules. We
observed high within-protocol variability in sensitivity, which may have
been attributable to sequencing depth; as described below, we quantified
this variability to rank the protocols.
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Fig. 2.2 Performance metrics for scRNA-seq protocols. (a) Accuracy. Distributions of
Pearson correlations (R) for all samples, stratified by protocol (without accounting for
sequencing depth). BAT-seq, barcoded 3’-specific sequencing. (b) Sensitivity. Distributions
of molecular-detection limits for all samples, stratified by protocol (without accounting
for sequencing depth). n, number of samples. The implementation platforms and
quantification strategies are indicated below the protocols. (c) UMI efficiency. Distributions
of UMI counting efficiencies in samples, based on UMI-tag counting, stratified by protocol.
Boxes, quartiles; whiskers, full range of values; white dots, median.
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2.5 UMI efficiency in tag-counting protocols
The majority of scRNA-seq protocols use an UMI-tag-counting strategy, in
which a single unique random identifier sequence is added to each reverse-
transcribed mRNA molecule to achieve digital transcript quantification.
This strategy has largely been applied to protocols that sequence short 5´
or 3´ RNA sequence tags and create cDNA libraries with extremely low
complexity, thus potentially leading to strong amplification biases. The UMI
on each tag should allow for removal of these biases, because the UMI is
added before amplification (Islam et al., 2014). The question then remains
as to how efficient the entire scRNA-seq process is.
If E is the UMI (counting) efficiency, the underlying assumption is that
the number of UMIs of a gene (U ) is equal to E × M , where 0 < E <
1 (Figure A.2a), and M is the number of RNA molecules of a gene. We
fitted this model for every UMI-tag sample and compared the results across
protocols (Figure A.2c). The results recapitulated the logistic-regression-
based measure for sensitivity, because samples with high efficiency had a
low molecular-detection limit (with the exception of MARS-seq data; Figure
A.2b).
However, this measure might not be as appropriate as it appears. If we
extend the model to U = E ×M c, the best fit should yield values of the
molecular exponent c close to 1, if the underlying UMI counting assumption
is correct. Instead, we found that the best fit was systematically lower than
1, with a mode of approximately 0.8 (Figure A.2c). This finding suggested
a saturation of UMI counts as a function of input molecules and may be
partially (but not fully) explained by differences in UMI length among the
different protocols (Figure A.2d). For example, UMIs with a length of 4
bp are able to count up to only 256 unique molecules and had a molecular
exponent of 0.6, on average. However, even in protocols with UMIs of 10
bp (which are able to count over 1 million unique molecules), the molecular
exponentwas 0.8 per sample, on average, and rarely reached 1. In conclusion,
whereas UMIs should provide a way of removing amplification biases, the
assumed absolute quantification does not appear to hold true perfectly.
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2.6 Endogenous transcripts are more efficiently captured than ERCC spike-
ins
It is unclear to what extent sensitivity and accuracy calculations apply to
endogenous mRNA when exogenous spike-ins are used. On the one hand,
ERCC spike-ins have shorter poly(A) tails than those of typical mRNAs from
mammalian cells (Viphakone et al., 2008), thus making them more difficult
to capture by poly(T) priming. On the other hand, endogenous mRNAs
may have intricate secondary structure and may be bound to proteins, thus
potentially decreasing the efficiency of reverse transcription.
To investigate the relationship between endogenous and spike-in mea-
surements, we analyzed single-molecule fluorescence in situ hybridization
(smFISH) data and CEL-seq data from the same mESC line and culture
conditions (Grün et al., 2014) (molecule counts from D. Grun, Max Planck
Institute of Immunobiology and Epigenetics, personal communication). On
the basis of data for nine endogenous genes, CEL-seq UMI counts corre-
sponded to 5-10% of smFISH counts, whereas the average UMI counts for
ERCC transcripts corresponded to only 0.5–1% of input-molecule counts
(Figure A.2e).
Although the number of transcripts was not large, these data suggested
that endogenous RNA is much more efficiently captured and amplified than
ERCC spike-in molecules and that our sensitivity measures are likely to be
underestimates. The accuracy metric was based on relative abundance and
was not affected by underestimated capture. This difference in efficiency is
important to consider if absolute molecule counts are to be inferred on the
basis of ERCC spike-ins.
2.7 Sensitivity is more dependent on sequencing depth than accuracy is
The results of the per-sample accuracy and sensitivity analysis showed a
large amount of within-protocol heterogeneity (Figure 2.2a,b). Seeking to
explain performance by technical factors, we identified a relationship with
sequencing depth per sample, a parameter that researchers can control to fit
their budgets and needs. We used a linear model considering a global effect
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of sequencing depth, including diminishing returns. The model includes an
individual corrected performance parameter for each protocol, thus allowing
protocols to be ranked while accounting for the substantial technical factor
of sequencing depth.
We found that accuracy does not strongly depend on sequencing depth
(Figure 2.3a). The best-performing protocols in terms of accuracy were
single-cell universal poly(A)-independent RNA-seq (SUPeR-seq) (R = 0.95),
a total-RNA protocol for single cells, and CEL-seq2 (R = 0.94), which uses in
vitro transcription rather than PCR to amplify cDNA.
Because the model considers diminishing returns on the sequencing
depth, we found from the model parameters that accuracy becomes sat-
urated at as few as 250,000 reads and thus is not strongly dependent on
sequencing depth. This finding also suggested that the expression levels
of detected RNAs are generally accurate and quantitatively meaningful in
scRNA-seq data.
By contrast, we found that technical sensitivity is critically dependent
on sequencing depth, and sensitivity comparisons that do not account for
differences in depth would be misleading (Figure 2.3b). The sensitivity
parameter of the model accounts for sequencing depth to allow for fair com-
parison and we used this parameter to rank protocols. The three protocols
implemented in a C1 microfluidics system (CEL-seq2 (C1), STRT-seq (C1),
and SMARTer (C1); number of molecules at one million reads (#M) of 2, 3,
and 4, respectively) were the top-performing protocols in terms of molecular
detection. The matched microwell-plate implementation of CEL-seq2 had
poorer sensitivity than the C1 implementation (#M = 13).
On the basis of the model, we found that the sensitivity saturates at
approximately 4.5 million reads per sample. The increase in read depth from
1million reads to 4.5million reads per sample results inmarginally increased
sensitivity, of less than one fold change. However, the increase from 100,000
reads to 1 million reads per sample results in increased sensitivity of an
order of magnitude. Thus, we recommend considering 1 million reads per
sample as a good target for saturated gene detection.
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A
B
Read depth controlled accuracy
Read depth controlled sensitivity
Fig. 2.3 Performance metrics after accounting for sequencing depth. (a,b) Models
of accuracy and sensitivity with a global dependency on sequencing depth, considering
diminishing returns, with a distinct corrected performance parameter for each protocol.
Each model has 26 parameters and is fitted to n = 20,717 samples. Bulk data (pink
triangles) are displayed only for context. Solid curves show the predicted dependence
on sequencing depth. (a) Accuracy is only marginally dependent on sequencing depth.
Saturation occurs at 270,000 reads per cell in the model (dashed red line). Protocol
names are ordered by performance on the basis of predicted correlation (R) at 1 million
reads. (b) Sensitivity is critically dependent on sequencing depth. Saturation occurs at
4.6 million reads per cell (dashed red line). The gain from 1 to 4 million reads per sample
is marginal, whereas moving from 100,000 reads to 1 million reads corresponds to an
order-of-magnitude gain in sensitivity (dashed black lines). Protocols are ordered by
performance on the basis of predicted detection limit (#M, number of molecules at 1
million reads).
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Notably, not all studies need to saturate detection, especially in cases in
which the genes of interest are highly expressed. It is equally important to
note that sequencing depth is a technical feature, and the number of genes
detected depends on the depth. Therefore, sequencing depth must be taken
into account when performing and computationally analysing scRNA-seq
data, even for compositional expression units such as transcripts per million
(TPM).
2.8 Degradation of spike-ins does not explain performance variation among
experiments
Our performance analysis inherently assumed the gold-standard annotation
of the spike-ins to be correct. However, owing to its labile nature, RNA can
be degraded during the course of normal reagent handling. To quantify the
effects of such degradation, we subjected spike-in molecules (both ERCCs
and SIRVs) to repeated freeze–thaw cycles (Methods). Additionally, as a
measure of complete or full degradation, we left the spike-ins either at room
temperature or at 37°C overnight. The freeze–thaw cycles emulated normal
handling, and by comparing samples at different degradation levels, we
observed a small overall effect on accuracy and sensitivity, which was similar
to the variation within a protocol (Figure 2.4a).
Spike-in degradation directly impinges on the effective spike-in dilution
in a sample and is a central factor for calculating the technical sensitivity.
We observed that normal handling accounted for molecule-limit differences
within an order of magnitude, even when spike-ins were subjected to as
many as six freeze–thaw cycles. The sensitivity metric for samples subjected
to conditions as extreme as overnight degradation (either in room temper-
ature or at 37°C), compared with other samples, had a difference of two
orders of magnitude, which was similar to the difference between protocols
(Figure 2.4a).
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2.9 SIRV spike-ins recapitulate the accuracy results from ERCC spike-ins
All the studies described above used ERCC spike-ins, which have bacterial
sequence composition. To ensure the general applicability of our conclusions,
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Fig. 2.4 Effects of various factors on performance metrics. (a) Batch effects and
RNA degradation. Performance distributions for three protocols, implemented as a
single batch, on the Fluidigm C1 (left) and 10× Chromium (far left; different batch)
platforms. Performance distributions of spike-ins measured after freeze–thaw cycles,
with normal (two or three cycles) to critical degradation (six cycles, left overnight at room
temperature). Temp, temperature. (b) Accuracy estimates across both ERCC and SIRV
spike-ins are similar. Accuracy (Pearson correlation) of both ERCC and SIRV spike-ins
inferred across two replicates, under multiple protocols. (c) Endogenous mRNA amount
does not affect performance metrics. Comparison of performance metrics between
empty (lacking endogenous mRNA) and nonempty samples from three published data
sets shows similar performance and no bias due to the presence of endogenous mRNA.
Red dot, median; red bar, 95% CI of median, estimated with bootstraps. (d) Model of
relative spike-in abundance degradation during normal handling. Posterior predictions
from Bayesian exponential-decay model, for both ERCCs and SIRVs (decay parameter,
19% and 18.5%, respectively). Confidence bands correspond to 95% CI from posterior
parameter distribution.
we also analysed the SIRV spike-in mix, consisting of 69 artificial transcripts
that mimic the splicing patterns of seven human genes and allow for RNA-
isoform assessment. The SIRV mix E2 contains these isoforms across four
abundance levels. Because SIRVs span only four abundance levels, they are
not compatible with sensitivity analysis; hence, we focused on accuracy. To
compare accuracy by using ERCC and SIRV standards, we performed two
matched scRNA-seq comparisons (Smart-seq2, SMARTer, and STRT-seq on
a C1 system), using mESCs with both spike-ins (Figure 2.4b).
We observed that the accuracy was systematically lower when SIRVs
were used. This result was expected, because the ambiguous read assign-
ment to the isoforms introduced a noise element. Overall, when using SIRVs
and ERCCs, we observed a similar pattern of relative accuracy between our
SMARTer and Smart-seq2 experiments. The STRT-seq samples had very
poor accuracy, as was expected, because the 5´ transcript tags alone cannot
distinguish among different mRNA isoforms.
This experiment provided quantitative evidence that mRNA splice-form
variation can be inferred at the single-cell level when the appropriate proto-
col is used. Comparing the protocols, we found that the accuracy calculated
when SIRVs were used recapitulated the accuracy when ERCCs were used,
thus indicating that spike-in batch variability does not generally explain
differences among protocols.
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2.10 The amount of endogenous mRNA does not affect performance metrics
based on spike-ins
cDNA is generated from both endogenous mRNA and spike-in RNA during
library preparation; thus, spike-ins are less likely to be sampled if the amount
of mRNA is high. To verify that discrepancies in endogenous mRNA levels
(due to, for example, cell-type differences) do not affect performance metrics,
we investigated published data in which information on empty (spike-in
RNA alone) and nonempty (mRNA and spike-ins present) samples were
reported for the same batch of cells. We compared accuracy and sensitiv-
ity between empty and nonempty samples from three studies and found
equivalent results, thus confirming that endogenous mRNA content does
not affect performance metrics (Figure 2.4c). We quantified the equivalence
through 95% confidence interval (CI)-based equivalence analysis (Walker
and Nowacki, 2011). We found that the empty median CI was 100% con-
tained within the nonempty median CI for accuracy and was 84% contained
for sensitivity.
2.11 Effects of freeze–thaw cycles on spike-in abundance
To quantify RNA-degradation rates in our freeze–thaw experiment, we
added single mESCs to individual wells and performed the Smart-seq2
protocol. We compared the spike-in content to the endogenous mRNA
contentwithin eachwell and related the results to the number of freeze–thaw
cycles.
We made a predictive Bayesian model of mRNA degradation with a
degradation-rate parameter p. Sampling from the posterior distribution of p
when applying the model to ERCC spike-ins, we found a degradation rate
of 19 ± 0.7% per freeze–thaw cycle (mean ± 95% CI, Figure A.3; posterior
predictions in Figure 2.4d). We also applied the mRNA degradation model
to SIRVs and found a similar degradation rate of 18.5 ± 0.1%. However,
the SIRV measurements were more noisy, probably because of mapping
uncertainty (described in Discussion). Overall, our data approximated a
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20% degradation rate of spike-ins in each freeze–thaw cycle during normal
sample handling.
Although we did not observe a large variation in molecular detection
limit or accuracy due to normal handling, the relative abundance of spike-ins
in a samplewas strongly affected by freeze–thaw cycles. Hence, the inference
of total mRNA in cells when spike-ins are used might prove problematic.
Because we also found that the degradation rate was conserved between
ERCC and SIRV spike-ins, the approximately 20% degradation rate per
freeze–thaw cycle may hold true for RNA in general.
2.12 Discussion
A previous study has shown (SEQC/MAQC-III Consortium, 2014) that
ERCC read alignment varies widely across libraries and platforms, and
some spike-ins have reproducible poor behaviour, thus raising the question
of whether spike-ins are suitable for the calibration of absolute expression
values. The ERCC spike-ins have short poly(A) tails ranging from 20 to 26
bases long (the majority are 24 bases), in comparison to eukaryotic mRNAs,
which have 250-base-long poly(A) tails (Viphakone et al., 2008). Hence,
poly(T) priming of ERCC spike-ins might be less efficient than priming for
endogenous mRNA. Furthermore, ERCC spike-ins are not capped at the 5´
end, thus possibly leading to decreased template-switching efficiency (used
in several protocols) when compared to endogenous mRNAs (Kapteyn et al.,
2010). Finally, unlike endogenous mRNAs, spike-in RNAs are not naturally
bound by mRNA-binding proteins, nor do they have secondary structures.
Our comparison of spike-in values and smFISH values, a gold stan-
dard for absolute mRNA quantification, suggested that endogenous RNA is
detected more efficiently than spike-ins by approximately one order of mag-
nitude. Therefore, it is important to highlight that the ‘spike-in molecular-
detection limit’ may underestimate the detection limit for endogenous RNA
and should be used only as a relative sensitivity measure to rank protocols.
The global ranking of protocol sensitivity remains relevant and accuracy is
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unaffected by these issues, because all ERCC spike-ins within a sample are
equally affected.
A perfect comparison would implement each protocol in multiple labo-
ratories by using a single stock of reagents and mRNA dilution ladders as
standards. Having multiple scientists carry out each protocol would allow
for the effects of skill to be excluded. A control ladder of mRNA would
eliminate issues arising from differences between synthetic spike-ins and
mRNA.Whereas the majority of the protocols that we investigated here have
been reproduced by at least two different laboratories, we cannot completely
rule out the effects of technical proficiency on protocol performance.
We showed that handling and batch variation in ERCC dilutions led to
smaller variations in performance than those observed among protocols
(Figure 2.4a). Nevertheless, in certain published experiments, spike-ins
may have been greatly degraded and consequently may have affected our
performance metrics. In addition to these caveats, it is important to note
that our assessment was performed on currently available data and does
not necessarily reflect the full potential or suitability of a given protocol.
The scRNA-seq protocols that analysed provide tremendously powerful
and high-resolution techniques for unbiased genome-wide dissection of cell
populations and their transcriptional regulation. We show that, whereas
these protocols vary widely in their detection sensitivity, with lower limits
between 1 and 1,000 molecules per cell, their accuracy in quantification
of gene expression is generally high. Sensitivity depends on sequencing
depth, but sequencing depth is less critical for accuracy. However, both
sensitivity and accuracy are closely dependent on the scRNA-seq protocol
used to generate the data. Protocols with high sensitivity are more suitable
for analysing weakly expressed genes, or for gaining additional insights into
subtle gene expression differences affecting individual cell states, but may
be less suitable for other scenarios.
Our comparison also suggests that miniaturised scRNA-seq reaction
volumes increase sensitivity and provide a good return on investment when
approximately 1 million reads per sample are sequenced. Future improve-
ments in protocols and decreases in the price of sequencing should further
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boost the ability to answer new questions in biology by using single-cell
transcriptomics.
2.13 Methods
Before moving on to the next chapter, we list keymethodological notes about
analysis in this study. More minute details and experimental methods are
covered in Section A.1.
2.14 Fast and flexible UMI counting
While analysis of coverage-based data has been optimised in general purpose
computational tools (see Section A.2.2), tag counting protocols are usually
processed ad-hoc in different laboratories. To process all UMI-based data
in a coherent manner, we developed a quantification strategy based on
pseudomapping and counting evidence for transcript–UMI pairs.
The principle was to transfer information from a UMI–tag pair to a tran-
script–UMI pair according to which transcript the tag mapped to. Because
UMI-based methods use only 3´- or 5´-end tags of cDNA, which may be as
short as 25 bp, mapping of these tags is commonly ambiguous. Our strat-
egy was to weight a UMI–tag pair according to the number of transcripts
to which the tag mapped. After UMI–tag pairs were mapped with either
RapMap (Srivastava et al., 2016) or Kallisto (Bray et al., 2016) in pseudobam
mode, only transcript–UMI pairs with a user-specified minimum amount
of evidence were counted (default 1) at either the gene or the transcript
level. In the 10× Genomics Chromium data, we detected 70, 000 and 45,000
droplets with respect to the samples. For the sake of computational memory
efficiency, we uniformly sampled 2,000 droplets out of all detected droplets
to count the UMI tags per droplet.
2.14.1 Code avai labi l i ty We implemented the UMI counting strategy in
a publicly available command-line tool, which we call “umis”. The tool
is available at https://github.com/vals/umis/ as well as in the Python
Package Index and in Bioconda.
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2.15 Statistical analysis
An ERCC spike-in was considered to be detected when the estimated TPM
was greater than zero. For UMI-based data, a spike-in was detected when
at least one copy of an ERCC molecule was inferred.
The amount of input spike-in molecules for each spike, for each sample,
in each experiment was calculated from the final concentration of ERCC
spike-in mix in the sample.
The calculation of the accuracy of an individual sample was determined
with the Pearson correlation between input concentration of the spike-ins
and the measured expression values. If fewer than eight spike-ins were
observed, the accuracy was set to infinity, because we considered this level
to be insufficient evidence to estimate the accuracy.
2.15.1 Model for sensit iv ity For the logistic regression model of each sam-
ple’s detection limit, the probability of detecting a spike-in at a given input
level was modelled by the logistic function:
logit(p(detectedi)) = −(a · log(Mi) + b)
We used the LogisticRegression class from the linear_model module
of the machine-learning package scikit-learn. The fit was performed with
the liblinear solver and the optional argument fit_intercept = True. The
logistic regression analysis was limited to samples with at least eight spike-
ins detected. The detection limit was chosen as the molecular abundance at
which the logistic regression model passes 50% detection probability:
Detection limit = − b
a
To investigate the UMI efficiency of UMI-based protocols, we used a
linear model in which the only parameter was the efficiency:
UMIi = E ·Mi + ε,
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with ε ∼ N (0, σ2). However, as mentioned in the main text, the data fit
the model much better when there is a non-one exponent parameter on the
number of input molecules:
UMIi = E ·M ci + ε
2.15.2 Protocol comparison model accounting for sequencing depth
When we modelled the relationship between the read depth and perfor-
mance metrics for individual protocols, we used a linear model with a
quadratic term for read depth to capture diminishing returns on investment.
The model considers the read-depth effect to be global and has a categorical
performance parameter for each protocol:
metrici = a2 × log10(readsi) + b× log10(readsi) + performanceprotocol + ε.
Here, the performance metric plateaus and saturates when
log10(reads) = −
b
2a
.
The linear models were fitted and analyzed with the OLS regression
function in the statsmodels Python package.
2.15.3 Model l ing of spike-in degradation In the spike-in degradationmodel,
the degradation rate p and the cellular fraction F were inferred by a Bayesian
approach with Stan (Carpenter et al., 2016) (R package rstan v 2.10.1). The
model was specified as the following: the prior for p was the uniform distri-
bution between 0 and 1, and F for each spike-in i had their priors defined
as the normal distribution with a mean of 0.5 and an s.d. of 1. Fi,j was
modeled by a normal distribution with mean Fi · (1 − p)j , where j is the
j-th freeze–thaw cycle, and s.d. σ had the uniform distribution between 0
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and 20 as a prior.
Fi,j ∼ Fi,0 · (1− p)j +N (0, σ2)
Fi,j , Fi,0 ∼ N (0.5, 1.)
p ∼ U(0, 1)
σ ∼ U(0, 20)
The model posterior was sampled with 5,000 iteration steps, 1,000 warm-up
steps and four chains.
Chapter3
Pseudotime analysis reveals a continuous spectrum of
differentiation in haematopoietic cells
The transcriptional programs that govern hematopoiesis have been inves-
tigated primarily by population level analysis of hematopoietic stem and
progenitor cells, which cannot reveal the continuous nature of the differenti-
ation process. Here we applied single-cell RNA-sequencing to a population
of hematopoietic cells in zebrafish as they undergo thrombocyte lineage
commitment. By reconstructing their developmental chronology computa-
tionally, we were able to place each cell along a continuum from stem cell
to mature cell, refining the traditional lineage tree. The progression of cells
along this continuum is characterised by a highly coordinated transcriptional
program, displaying simultaneous suppression of genes involved in cell
proliferation and ribosomal biogenesis as the expression of lineage specific
genes increases. Within this program, there is substantial heterogeneity in
the expression of the key lineage regulators. Overall, the total number of
genes expressed, as well as the total mRNA content of the cell, decreases as
the cells undergo lineage commitment.
The work in this chapter was published in Cell Reports as Single cell RNA-
sequencing reveals a continuous spectrum of differentiation in haematopoietic cells
(Macaulay et al., 2016). The same analysis procedure was also applied to
studymESC development in a studywhichwas published asMERVL/Zscan4
Network Activation Results in Transient Genome-wide DNA Demethylation of
mESCs in Cell Reports (Eckersley-Maslin et al., 2016).
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Individual contributions The study in this chapter was designed by Ana
Cvejic, who interpreted the results andwas the senior author of themanuscript.
The zebrafish experiments were performed by Charlotte Labalette, and sin-
gle cell RNA-seq experiments were performed by Iain Macaulay; both of
whom are co-first authors of the manuscript. For detailed experimental
procedures, see Section B.1.
The first part of the chapter describes the experimental study which
motivated making a model for Pseudotime. After the experimental results,
we give an in depth description of the models we are using, in the context
of single cell gene expression.
3.1 Introduction
Hematopoietic stem cells (HSCs) have the ability to self-renew and give rise
to all different blood cell types (Orkin and Zon, 2008). Our understanding
of the functional properties of different hematopoietic cell types has been
advanced mainly by population level analysis. Current methods of purify-
ing hematopoietic cells to relative homogeneity are based on the expression
of specific combinations of cell surface markers. However, a homogeneous
population of cells, as determined by a well-defined set of cell surface mark-
ers, may include many functionally distinct populations. This was nicely
illustrated in studies showing that within the HSC compartment, individ-
ual HSCs may differ in their ability to reconstitute the blood cell lineages
(e.g., balanced production of myeloid and lymphoid cells or deficiency in
lymphoid potential) (Muller-Sieburg et al., 2012). More recently, it was
demonstrated that common myeloid progenitors (CMP) are a mixed popu-
lation of cells with distinct lineage potentials (Notta et al., 2015). The lack
of CMPs as a separate cell entity with broad myeloid potential brings into
question the traditional model of hematopoietic lineage development and
further underscores the importance of revising the current view of lineage
development in hematopoiesis. Therefore, there is a need to address the
exact composition of the stem and progenitor populations in vivo, as well as
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the relationships between them. Single cell transcriptome analysis might
provide answers to these outstanding questions (Cvejic, 2015).
Among vertebrate models, the zebrafish provides a unique combination
of advantages for the study of blood development at the single cell level.
Zebrafish blood contains cells of all hematopoietic lineages and orthologs of
most transcription factors involved in mammalian hematopoiesis have been
defined (Hsia and Zon, 2005; Song et al., 2004). Importantly, transcriptional
mechanisms and signaling pathways in hematopoiesis are well conserved
between zebrafish and mammals, making them a clinically relevant model
system (Jagannathan-Bogdan and Zon, 2013).
Over the past few years, a number of transgenic zebrafish lines have been
generated in which promotors specific to hematopoietic subpopulations
drive expression of fluorescent molecules (Carradice and Lieschke, 2008).
These reporter lines provide a valuable resource of labelled cells ranging
fromHSCs to a wide range of mature blood cell types. As inmammals, adult
hematopoiesis in zebrafish is both continuous and asynchronous. Thus,
a single sample of kidney marrow (the analogous tissue to mammalian
bone marrow) contains the full spectrum of hematopoietic cell types at
various stages of differentiation at any one time. As this is the single site of
hematopoiesis in zebrafish, and is easily accessible, the cells are minimally
perturbed when sorted ex vivo, making this an ideal system to study basic
principles of regulation of differentiation, both at the molecular and cellular
levels.
Here we used high-throughput single-cell RNA sequencing combined
with fluorescence-activated cell sorting (FACS) index sorting1 of adult ze-
brafish marrow-derived hematopoietic cells. We ordered cells by their pro-
gression through differentiation based on gene expression profiles using
no prior knowledge of which cell population they belong to. Our analysis
revealed the continuous nature of thrombocyte development and the coordi-
nated transcriptional programs that govern cell differentiation. Interestingly,
1Index sorting refers to maintaining flow cytometric analysis values for the individual
cells sorted into wells.
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thrombocytes in zebrafish remain transcriptionally active even after leaving
the kidney marrow and entering the circulation.
3.2 Profiling individual hematopoietic cells ex vivo
Here, we used single-cell RNA-sequencing (RNA-seq) of zebrafish kidney
cells to resolve the cellular hierarchy of lineage development in the myeloid
branch of hematopoiesis. To focus on this lineage, we used expression
of CD41 as a marker of HSCs and the megakaryocyte equivalent in fish
(“thrombocytes”). CD41 in human is highly regulated during hematopoi-
etic development (Debili et al., 2001; Robin et al., 2011), with CD41 being
switched on. In zebrafish the Tg(cd41:EGFP) reporter line labels two dis-
tinct populations of cells that express the cd41-EGFP transgene. The weakly
fluorescent (EGFPlow) subset marks HSCs and progenitor cells (Ma et al.,
2011) and the brightly fluorescent (EGFPhigh) subset includes mature and
differentiated thrombocytes (Ma et al., 2011).
Using flow cytometry, we identified EGFPlow and EGFPhigh cells and
sorted 188 cells from each population from a single kidney from a
Tg(cd41:EGFP) reporter fish (Figure 3.1A; Figures B.1A-B.1I). Each EGFP+
cell was collected in a single well of a 96-well plate, and for each cell, its
size (forward scatter, FSC), granularity (side scatter, SSC), and EGFP fluores-
cence level were recorded. Single-cell mRNA-seq libraries were constructed
and sequenced to a depth of around 2.5 million reads per library. Of 376
cells, 13 cells failed our quality control (QC) and were removed from further
analysis (Section B.1; Figures B.2A and B.2B). For the remaining 363 cells,
we accurately quantified between 1, 000 and 6, 000 genes per cell.
3.3 Ordering hematopoietic cells from a single kidney across lineage devel-
opment
To identify groups of cells and order them in terms of their develop-
mental progression, we initially used a multi-step approach. First, we
used independent component analysis (ICA) to identify distinct factors
that describe the variability of EGFP cells. ICA revealed four latent fac-
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Fig. 3.1 cd41 cells transition through five transcriptional states during thrombocyte
differentiation in zebrafish. (A) A single kidney, from a heterozygote Tg(cd41:EGFP)
reporter fish, was dissected and carefully passed through a strainer. Using flow cytometry,
EGFPlow and EGFPhigh cells were identified and 188 cells from each population were index
sorted. Two wells (in red) per plate were left without cells. RNA from each cell was isolated
and used to construct a single mRNA-seq library per cell, which was then sequenced
using Hi-seq. (B) t-SNE plot of the RNA-seq data from 363 EGFPlow and EGFPhigh cells.
(C) The same t-SNE plot (as shown in B) but with points colored based on the cluster the
cells belong to. Clusters are labeled as 1a, 1b, 2, 3, 4, and outlier cells. See also Figures
B.1, B.2, and B.3.
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tors (hidden variables) that explain (1) a progression among EGFPlow
cells (“within_small_component”), (2) a switch from EGFPlow cells toward
EGFPhigh cells (“difference_component”), and (3) progression among the
EGFPhigh cells (“within_large_component”). Finally, the fourth factor iden-
tified three outlier cells (“outlier_component”) (Figure B.3A).
To facilitate data depiction, we used non-linear dimensionality reduction
(t-distributed stochastic neighbour embedding [t-SNE]; (Van derMaaten and
Hinton, 2008)) to represent the four latent factors in two dimensions (Figure
3.1B). ICA revealed a clear distinction between EGFPlow and EGFPhigh cells,
implying sharp divergence at the transcriptional level (Figure B.3A; Figure
3.1B).
In addition, EGFPlow cells are a more heterogeneous group compared to
EGFPhigh cells. To explore this further, we used hierarchical clustering to
partition EGFP cells based on their independent components (Figure B.3B).
Interestingly, whereas EGFPlow cells were split into four distinct clusters
(here named 1a, 1b, 2, and 3), EGFPhigh cells were all grouped into a single
cluster (here named 4), confirming the substantial heterogeneity of the
EGFPlow population of cells (Figure 3.1C).
Differentiation of hematopoietic cells involves the acquisition of spe-
cific phenotypes that depend on the repression of genes characteristic of a
multipotent cell state and expression of lineage-restricted genes (Seita and
Weissman, 2010). Thus, the whole process can be conceptualized as a tempo-
ral ordering of a highly coordinated transcriptional program through which
each cell progresses. To examine the transcriptional transitions undergone
by cd41-EGFP cells during differentiation, we ordered cells based on the
cluster they belonged to, the latent factor that explains the variability of the
cells within the cluster, and the level of EGFP fluorescence (details provided
in the Experimental Procedures). Our model assumes gradual changes in
gene expression during developmental progression of thrombocytes along
a one-dimensional (i.e., non-branching) path. (We could not detect any
apparent branch point in the data.) This ranking of cells through the entire
process was treated as “pseudotime.”
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Fig. 3.2 Ordering of cells through the developmental trajectory. (A) We inferred a
smooth progression over the developmental lineage, represented as pseudotime, using
two different methods. Here we demonstrate the path of both pseudotimes by regressing
them into a t-SNE plot of the data. Points are colored based on the cluster the cells
belong to. (B) The pseudotime inferred with two different methods correlate very strongly
(Spearman correlation 0.97). (C) Expression of cd41 mRNA (top), GFP mRNA (middle), and
GFP fluorescence (bottom) shown in pseudotime. Each point represents an individual
cell; points are colored based on the cluster the cells belong to. See also Figure B.3.
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To ensure our pseudotime ordering was stable, we also ordered the
cells using a more principled method, a Bayesian Gaussian Process Latent
Variable Model (BGPLVM) (Titsias and Lawrence, 2010) (see Section B.1).
Comparing the paths these orderings take when regressed into the t-SNE
depiction, one can appreciate the similarity between them (Figure 3.2A).
The two pseudotime orderings agreed very strongly (Spearman correlation
0.97; Figure 3.2B), giving us confidence in our ordering.
When presented in pseudotime, the expression of endogenous cd41 (also
known as itga2b) and EGFP, as well as EGFP fluorescence, recorded during
sorting, were highly correlated and showed an expected increase through
pseudotime (Spearman rho 0.85, 0.80, and 0.82, respectively) (Figure 3.2C).
This supports our pseudotime ordering of the cells from the HSC to the
differentiated thrombocyte extracted from a single kidney.
3.4 Inferring cell states in the myeloid lineage
To define the identity of cell types within the five clusters, we evaluated
the expression of orthologs of transcription factors and other genes known
to be relevant in mammalian hematopoiesis, including the expression of
early (cd61, also known as itgb3a/b) and late (cd42b, also known as gp1bb)
markers of megakaryocyte differentiation (Figure 3.3). The panel of genes
analyzedwas representative of HSCs (Tal1, Lmo2, Lyl1, Gata2, Runx1, Meis1,
C-myb, and Erg) (Capron et al., 2006; Greig et al., 2008; Loughran et al., 2008;
Orkin and Zon, 2008; Pineault et al., 2002), megakaryocyte/erythroid (Fli1,
Gfi1b, Gata1, Cd61, Cd42b, Vwf, and Selp) (Clay et al., 2001; Orkin and Zon,
2008; Poirault-Chassac et al., 2010; Schick et al., 1993), and myeloid- (Gfi1,
Pu.1 also known as spi1a/b, and Cebp1) (Tenen et al., 1997; Zeng et al., 2004)
lineage-affiliated genes.
For each gene, we assessed the level of its expression in pseudotime, as
well as the fraction of cells that expressed the gene of interest in each of the
clusters (Figure 3.3). For example, c-myb was highly expressed in cluster
1a, as well as in clusters 1b, 2, and 3, but was downregulated in cluster 4.
This is in line with previous reports that C-myb is expressed in immature
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Fig. 3.3 Expression of key regulators of hematopoiesis over pseudotime. Expression
(in TPM) of genes, relevant in hematopoiesis, over pseudotime. Points are colored based
on the cluster the cells belong to. For each cluster, we show the proportion of cells within
the given cluster expressing the gene at TPM > 1. HSC, hematopoietic stem cells-affiliated
genes; Meg-Erythroid, megakaryocyteerythroid progenitors-affiliated genes; Myeloid,
myeloid lineage-affiliated genes.
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hematopoietic cells and is downregulated during differentiation (Greig et al.,
2008). Cells in cluster 1a had relatively high expression of lmo2, tal1, and
meis1. These genes, together with fli1, showed a similar distribution of
expression across pseudotime, whereas gata2 was more restricted to cluster
1a. The mammalian HSC genes runx1 and erg were expressed at a relatively
low level overall, and in a small fraction of cells within all clusters. Overall,
most of themammalianHSCmarker genes examined are expressed in cluster
1a, and to a lesser degree in 1b, 2, and 3.
In contrast, Gata1 and Gfi1b are known to be expressed at high levels
in the erythroid and megakaryocyte lineages (Orkin and Zon, 2008; Vassen
et al., 2007) but not in HSCs. In our dataset, gata1a and gfi1b were ex-
pressed in all clusters except cluster 1a. Furthermore, expression of both
early (itgb3a/b) and late (gp1bb) markers of megakaryocyte differentiation
started very early and peaked late in pseudotime, confirming that more
mature thrombocytes are largely confined to cluster 4.
We also assessed the expression of two well-known platelet genes, vWf
(von Willebrand factor) and selp (P-selectin), through pseudotime (Fig-
ure 3.3). Our analysis revealed that, contrary to previous reports (Carrillo
et al., 2010), thrombocytes in zebrafish do not express von Willebrand fac-
tor and P-selectin. This was confirmed by qPCR analysis of cd41 EGFPhigh
thrombocytes from zebrafish kidney. We found, however, that vWf was
expressed in the whole kidney sample and in fli1:GFP positive cells sorted
from Tg(fli:EGFP) fish, suggesting that the vWf expression pattern differs
somewhat between zebrafish and mammals.
Surprisingly, myeloid lineage-affiliated genes (e.g., spi1, gfi1, and cebp1)
were largely absent across all cells (Figure 3.3). This suggests that there is
no common myeloid progenitor population in this dataset, which charts a
continuous HSC to thrombocyte pathway. Altogether, our data are consis-
tent with the notion that cells from cluster 1a belong to HSCs that transition
directly to erythroid-thrombocyte progenitor cells, possibly circumventing
the CMP step. Although this is surprising, there are other reports of direct,
unconventional, HSC to megakaryocyte-erythroid progenitor transitions,
such as a recent report in mouse (Guo et al., 2013).
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Identification of these intermediate progenitor and differentiated cell
types prompted us to carry out additional analyses of the sets of genes that
strongly correlate with individual cell types. We trained a random forest
classifier for each cluster. Using feature importance for each gene (the Gini
gain when including the gene in the model) we found genes which “mark”
distinct clusters of cells. The unique sets of genes expressed in each of the
cell types provide an opportunity to reveal novel markers of the identified
cell types, and at the same time, provide more insight into their biological
function.
Among the numerous newly identified cell-type markers, we found
several of particular interest (Figure 3.4A). Ccr9a is a member of the beta
chemokine receptor family and is known to be expressed in HSCs (Wright
et al., 2002); our data show that ccr9a expression is highly correlated with
cluster 1a (Figure 3.4B). Transcription elongation factor A (SII), tcea3, was
specifically expressed in cluster 1b (Figure 3.4B). Cells from cluster 1b can
also be sorted by combining expression of plasminogen receptor gene (plgrkt)
and ascc1 (Figure 3.4B). Good marker genes for cluster 2 included e2f8,
which encodes a protein involved in progression through the cell cycle
(Deng et al., 2010) and top2a, a DNA topoisomerase involved in processes
such as chromosome condensation and chromatid separation (Downes et al.,
1994) (Figure 3.4B). Interestingly, the enriched gene ontology (GO) terms for
cluster 2 included cell division and cell cycle (Figure 3.4A), suggesting that an
expansion phase precedes lineage commitment and terminal differentiation
of thrombocytes.
To experimentally validate the prediction of greater proliferation in this
progenitor population, we sorted cells from clusters 1a/1b/2 versus 3 and
4, based on EGFP fluorescence, and SSC and FSC (Figures B.4A–B.4G).
We compared the cell cycle distributions of the sorted populations using
propidium iodide (PI) staining. The combined cells from clusters 1a/1b/2
had a significantly higher proportion of cells in S andG2/Mphase compared
to clusters 3 and 4 (Figure 3.4C), validating our finding that these cells
proliferate faster.
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Fig. 3.4 Identification of new cell-type markers. (A) t-SNE plot of the RNA-seq data
from 363 EGFP cells. Points are colored based on the cluster the cells belong to. Selected
genes, whose expression is highly correlated with individual clusters, are shown next
to each cluster. Selected gene ontology terms associated with genes that are highly
correlated with cluster 2 and the outlier cells are included. (B) Expression of marker
genes over pseudotime (left). Points are colored based on the cluster the cells belong
to. For each cluster, we show the proportion of cells expressing the gene at TPM > 1.
Expression of pairs of genes is shown on the right. Points are colored based on the
cluster the cells belong to. The side diagrams show the proportion of cells within the
cluster expressing the gene at the given level of expression. (C) Cell cycle analysis of
three different populations of EGFP cells. The GFPlowSSChigh cells are enriched for cells
from clusters 1a/1b/2, GFPlowSSChigh and GFPhigh cells are enriched for cells from clusters
3 and 4, respectively. An average of two experiments is shown as a percentage of cells
in G0 and G1 (G0/1) and S and G2 phase (S/G2) ± SEM. (D) Distribution of FSC (top) and
SSC (bottom) values in the different clusters. In particular, one can see that the small
population of outliers (cluster x, shaded gray) has higher FSC and SSC values than cells
from other clusters. See also Figures B.4 and B.5.
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These results show that expression of EGFP together with SSC and FSC
values could be used to efficiently separate cells from clusters 3 and 4 from
the early progenitor populations (1a/1b/2) in the cd41 reporter line (Figures
B.4 and B.5). Additional markers for cluster 3 included combined high
expression of fzd8b and no expression of mibp (Figure 3.4B). For cluster 4, a
high level of cd41 uniquely marks this population.
Finally, we also assessed a unique set of genes expressed by the three out-
lier cells. GO enrichment analysis of their marker genes yielded only three
statistically significant GO terms, all linked with immunity (Figure 3.4A).
One plausible explanation is that these outlier cells represent macrophages
that have engulfed or are attached to thrombocytes and hence retained a
high level of EGFP fluorescence. Indeed, the outlier cells expressed an ar-
ray of macrophage/monocyte affiliated genes such as mpeg (macrophage
expressed gene 1), csf1r (colony-stimulating factor 1 receptor), csf3r (colony-
stimulating factor 3 receptor) etc. Furthermore, compared to all other cells,
the outlier cells had remarkably high FSC and SSC values, characteristic of
macrophages (Figure 3.4D).
3.5 Validation of developmental progression from the kidney and circulation
Having identified the developmental progression in our initial experiment,
we set out to validate our findings in a second fish, examining both kid-
ney and circulating cells. We sorted an additional 92 cells from cluster
1a/1b/2 (named here EarlyEnriched), 46 EGFPlow cells and 46 EGFPhigh
cells from the kidney of another Tg(cd41:EGFP) fish. We also sorted 24
EGFPlow and 68 EGFPhigh circulating cells from the same fish (Figure B.6A).
Our analysis confirmed that the pattern of ICA follows the same structure as
observed in the previous experiment (Figure B.6B). This means that the cell
populations and their relative relationships are conserved in this biological
replicate. Similarly, the pseudotime ordering of EarlyEnriched, EGFPlow,
and EGFPhigh cells in the kidney recapitulated patterns we identified in the
initial experiment (Figures 3.5A–3.5F).
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In addition, we discovered that EGFPhigh cells in circulation are tran-
scriptionally identical to EGFPhigh cells in the kidney, with no significant
change in the number of expressed genes (Figure 3.5B), RNA content (Fig-
ure 3.5C), or any gene’s expression pattern (likelihood ratio test, corrected
for multiple testing with Holm-Sidak). We concluded, therefore, that the
thrombocytes exit the kidney in a fully mature state and are maintained in
a transcriptionally active state in circulation.
In both datasets, the total number of genes and total mRNA content
expressed per cell were correlated with its differentiation state (Figure B.7).
This was not due to a difference in the sequencing depth or cell size (Figure
B.7). Instead, it represents a biological difference between cells during
development. This supports the idea that more differentiated, post-mitotic
cells (clusters 3 and 4) have a specialized transcriptional program with
expression of a small, focused set of genes (Figure B.7).
3.6 Transcriptional modules related to growth and proliferation in the throm-
bocyte developmental gene expression program
To find genes with similar trends in expression across pseudotime, we used a
mixtures of hierarchical Gaussian processes model to cluster the pseudotime
series (Hensman et al., 2015). We identified 130 genes that are dynamically
expressed through pseudotime. Clustering of these genes revealed three
distinct patterns of progression during differentiation (Figure 3.6A). Genes
upregulated early in pseudotime and then downregulated later (group I)
were significantly enriched with the GO term “nucleic acid binding” and
“chromosome maintenance” (Figures 3.6B and 3.6C), possibly reflecting
the increased proliferation of cells earlier in pseudotime. Genes gradually
downregulated through pseudotime (group II) were highly enriched with
the GO terms “eukaryotic translation elongation”, “ribosomes” etc. (Figures
3.6B and 3.6C). Expression of these genes was highly correlated with the
general trend of decreased RNA content over pseudotime (Spearman rho =
0.85), therefore suggesting a regulatory loop between the total RNA content
in the cell and expression of genes that encode proteins relevant for ribosome
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Fig. 3.6 Identification of genes that are dynamically regulated over pseudotime. (A)
Pseudotime expression patterns of genes (rows) that significantly vary over pseudotime
progression (X axis). Every row is the Z score scaled Gaussian process regression
prediction representing the expression pattern. (B) The gene expression pattern for
the underlying function explaining the expression pattern in each group is shown as a
black line (95% confidence interval in the gray area). Below, selected gene ontology
terms associated with the genes in each group are shown. (C) Expression (in TPM) of an
example gene from each group through pseudotime. Points are colored based on the
cluster the cells belong to.
synthesis. Finally, genes upregulated early and then maintained at a high
level (group III) were highly enriched with the GO terms “ECM-receptor
interaction,” “platelet aggregation,” and “hemostasis,” pointing to genes
important for thrombocyte function (Figures 3.6B and 3.6C). Taken together,
our analysis suggests that differentiation of thrombocytes is governed by
coordinated transcriptional programs that limit the proliferation of cells and
their translational capacity while simultaneously promoting expression of
genes relevant to thrombocyte function.
3.7 Single cell gene expression patterns of whole-genome duplicated genes
Gene duplication is a common event in eukaryotic genomes (Meyer and
Schartl, 1999) and due to the teleost-specific genome duplication around
26% (i.e., 3, 440) (Howe et al., 2013) of zebrafish genes are duplicated. Gene
duplicates that originate from genome duplication are called ohnologs. To
assess the use of duplicated genes during thrombopoiesis in zebrafish, we
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Fig. 3.7 Single cell analysis reveals three main patterns of usage of duplicated
genes during thrombopoiesis in zebrafish. (A) Ohnolog gene pairs were divided into
four classes based on thresholds in a decision tree. (B) Expression (in TPM) of example
ohnologs, randomly selected from each class, in individual cells. Points are colored based
on the cluster the cells belong to. XOR ohnolog: both ohnologs are expressed but never
in the same cell. Single ohnolog: just one ohnolog is expressed. Mixed ohnologs: both
ohnologs are expressed in individual cells.
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examined the expression of ohnologs in each of the 363 cd41:EGFP cells. Of
∼ 8, 000 ohnolog categories (Howe et al., 2013), we looked at 3, 034 ohnolog
categories that have only been duplicated once (ohnolog gene pairs). Of these
3, 034 ohnologs (Howe et al., 2013), 2, 107 were not expressed in our dataset.
However the remaining 927 pairs can be divided into the following three
major groups: (1) expression of ohnologs is mutually exclusive in individual
cells (n = 177) (Figures 3.7A and 3.7B). In this group, the expression of any one
ohnolog appeared to be an independent event with an equal probability of
happening. This suggests selective activation or silencing of these ohnologs
in individual cells; (2) only one of the ohnologs is expressed in all cells (n =
430), Figures 3.7A and 3.7B, and (3) both ohnologs are equally expressed in
all cells (n = 218), (Figures 3.7A and 3.7B). No patterns of ohnolog use over
pseudotime were observed.
3.8 Discussion
Here we show the power of single cell transcriptome analysis to decipher
the kinetics of hematopoietic lineage development. We ordered cd41 cells by
their progression through differentiation based on gene expression profiles.
Our analysis illustrates the continual nature of this process, where cells
progressively transit through five transcriptional states that result in the
generation of mature thrombocytes.
Interestingly, myeloid lineage-affiliated genes were largely absent across
all cells, suggesting direct HSC to thrombocyte-erythroid progenitor transi-
tion. The model of hematopoiesis generated recently, using single cells from
over ten hematopoietic populations inmouse, implies that themegakaryocyte-
erythroid lineage is closely linked to long-term repopulating HSCs and
separates early from the lympho-myeloid lineage (Guo et al., 2013). The
identification of platelet-primed stem cells within vWf-expressing long-term
HSCs further confirmed that commitment to the megakaryocyte lineage
starts in the most primitive stem cell compartment (Sanjuan-Pla et al., 2013).
Although in our dataset vWf was not expressed in any of the identified cell
populations, the low expression of some of the thrombocyte lineage-affiliated
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genes in cluster 1a suggests that using our sorting strategy we are possibly
capturing thrombocyte-primed stem cells. Therefore, HSCs in cluster 1amay
represent a biased subpopulation within the wider pool of hematopoietic
stem/progenitor cells present in the zebrafish kidney. Nevertheless, the
gradual transition of cells during thrombocyte lineage development that we
see in our dataset (e.g., gradual changes in the total number of genes as well
as the total mRNA content) suggest that we do capture a continuous spectra
of cells and that the common myeloid stage is not an obligatory step during
thrombopoiesis.
We also show that although each of the identified transcriptional states
was characterized by substantial heterogeneity in the expression of the key
lineage regulators, the underlying transcriptional program was highly coor-
dinated. It included the simultaneous increase in the expression of genes
important for thrombocyte function and suppression of genes relevant in
cell proliferation and ribosomal biogenesis. Interestingly, although the mat-
uration of thrombocytes was completed in the kidney, they maintained a
transcriptionally active state in circulation. We did not, however, detect
any qualitative or quantitative difference in the gene expression between
circulating and kidney-based EGFPhigh thrombocytes. Surprisingly, unlike
mammalian platelets, which have abundant expression of vWf, thrombo-
cytes in zebrafish do not express vWf. Instead, our analysis suggests that
other cells within the kidney marrow, such as endothelial cells (fli1:GFP
positive cells), express vWf in zebrafish. Finally, we assessed use of dupli-
cated genes during thrombopoiesis in zebrafish and identified patterns of
their expression that would not be possible using a bulk transcriptomics
approach.
We used single-cell RNA-seq of zebrafish kidney cells to resolve the cellu-
lar hierarchy of lineage development in the myeloid branch of hematopoiesis
and propose a refinedmodel of developmental progression of hematopoietic
cells.
Our study addresses some of the basic questions of regulation of differ-
entiation, both at the molecular and cellular levels. In this study, we focused
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on zebrafish thrombocyte development; however, a similar approach could
be used in other systems and cell types.
3.9 Experimental procedures and methods
Before describing the computational methods related to this study, we de-
scribe the experimental procedures.
3.10 Marker gene discovery
To discover marker genes for the clusters of cells, we trained a random forest
model for each cluster versus the rest of the cells. We used the Gini feature
importance scores for each gene to order genes by how well they can distin-
guish a cluster from the rest of the cells. We used the ExtraTreesClassifier
(Geurts et al., 2006) implementation in the Python machine learning pack-
age scikit-learn (Pedregosa et al., 2011), with the parameter n_estimators =
100,000.
3.11 Classification of Ohnolog gene pairs
We obtained the list of duplicated genes arising from the teleost-specific
genome duplication event from Howe et al., 2013 (Howe et al., 2013). We
filtered the list to only retain pairs of genes whose IDs were present in
version 77 of Ensembl. For these genes, we binarized the expression to
“expressed” or “not expressed” in each cell based on whether the TPM
was greater than 1. Using these binary values, for each Ohnolog pair we
counted cells expressing either member of the pair, both members of the
pair, or none of the members in the pair. Ohnolog pairs in which none of
the members were expressed in more than 300 cells were annotated as “Not
expressed.” We defined a value “both_min_diff” as the difference between
the smallest number of cells expressing only one of the members in a pair,
and the number of cells expressing both members of the pair. Ohnolog
pairs with a “both_min_diff”-value larger than 15 were annotated as “XOR
Ohnologs.” To identify Ohnolog pairs in which only one member was used,
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we looked at the difference between the largest number of cells using one
member compared to the largest number of cells using the other member. If
this difference was larger than 60 cells, the Ohnolog pair was considered
a “Single Ohnolog.” The remaining cells were dubbed “Mixed Ohnologs,”
meaning cells with a mixture of both members of a pair.
3.12 The Pseudotime model
3.12.1 Gaussian Process Regression Themain goal of this study is tomodel
temporal transitions. We use the Gaussian process (GP) framework, thereby
casting this problem as non-parametric regression. Let us begin by assuming
that the developmental time t for each cell we observe is known. Then, the
output yg (i.e. expression of gene g) is modelled as a continuous function of
the input t (i.e. developmental progression)
yg = f(t) + ε, (3.1)
where
p(ε) = N (0, σ2)
is Gaussian distributed residual noise and f(t) denotes the unknown regres-
sion function. In this work yg is considered to be an N -dimensional vector
ofN cells with observed expression of the gene g. We denote the expression
of g in an individual cell n as [yg]n.
A GP can be interpreted as a function-valued prior on the elements of f ,
which is defined by a covariance function that in turn is parameterized by
the input (developmental time) t:
cov(f(tn1), f(tn2)) = k(tn, tn2).
The covariance function k(tn1 , tn2) encodes prior assumptions on the smooth-
ness and lengthscales of the function f(t). The most widely used covariance
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function is the Squared Exponential (SE) covariance function,
k(tn1 , tn2) = σ
2
SE exp
(
−|tn1 − tn2 |
2
2l2SE
)
, (3.2)
and this is the covariance function that will generally be used in this work.
This covariance has the hyperparameters θ = (σ2SE, l2SE), which parameterize
the amplitude ( σ2SE) and the lengthscale (l2SE) of functions under the prior.
Throughout the remainder of the textwewill omit the hyperparameters from
equations for the sake of brevity. Note that there is a whole compendium
of valid covariance functions, which can also be combined using sum or
multiplication; see (Williams and Rasmussen, 2006) for an overview.
We write that a function f is Gaussian Process distributed by
f(t) ∼ GP(0, k(tn1 , tn2)).
This prior on the function f can be linked to the finite observed data
using a Gaussian likelihood:
p(yg|f) =
N∏
n=1
N ([yg]n|fn, σ2).
Together with the prior on the corresponding (finite) elements of f ,
p(f) = N (f |0,Kt),
this results in the marginal likelihood
p(yg|t) = N (yg|0,Kt + σ2 · I).
Here Kt is an N × N matrix of pairwise evaluations of the covariance
functions at the observed times t. I.e.
[Kt]n,m = k(tn, tm). (3.3)
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By considering the joint distribution of the observed data yg and an
unseen function value f(t⋆), it is possible to derive the predictive distribution
for f(t⋆):
p(f(t⋆)|t, yg, t⋆) = N
(
f(t⋆), k(t⋆)
)
,
where
f(t⋆) = k(t⋆, t)[Kt + σ
2 · I]−1yg, and
k(t⋆) = k(t⋆, t⋆)− k(t⋆, t)[Kt + σ2 · I]−1k(t, t⋆).
For a full review on Gaussian Processes, see (Williams and Rasmussen,
2006).
So far, we have only described Gaussian Process Regression for expres-
sion yg of a single gene g. If we consider a collection of G genes {1, . . . , G},
their expression can be modelled together by
(y1, . . . , yG) = (f
1(t), . . . , fG(t)) + (ε, . . . , ε). (3.4)
We use Y to compactly denote theN ×G expression matrix of cells × genes,
where
Yn,g = [yg]n.
The assumption that all genes are governed by similar functional relation-
ships with t means we place the same GP prior (with shared covariance
function):
p(Y |t) =
G∏
g=1
p(yg|t) =
G∏
g=1
N (yg|0,Kt + σ2 · I). (3.5)
In the next section we will see the usefulness of considering multiple genes
at once.
3.12.2 Pseudotime inference by Bayesian GPLVM The Gaussian Process
regression framework described above assumes we know the time t of each
cell. While many scRNAseq experiments record data over some time course,
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here we take snapshots of sample cells from a population where responses
are asynchronous. Each cell has reached a certain stage in the differentiation
process under investigation, which we do not observe directly. The progress
in this process is referred to as pseudotime. Whilst we cannot observe this
directly, we can infer this from the data. In the Gaussian Process Latent
Variable Model (GPLVM) (Lawrence, 2006), we use the multiple output
case of Gaussian Process regression (equation 3.4),but unlike the regression
model described above, we consider the values of t to be parameters which
we wish to infer.
The joint probability of the GPLVM is
p(Y, t) = p(Y |t) · p(t),
where p(Y |t) is defined in equation 3.5, and the prior p(t) is such that for
cell n,
p(tn) = N (0, 1).
The objective of Bayesian GPLVM (Titsias and Lawrence, 2010), is to find
the posterior probability distribution p(t|Y ) ∝ p(Y |t) · p(t). This is due to
the t values appearing non-linearly in the matrix inverse [Kt + σ2 · I]−1. In
(Titsias and Lawrence, 2010), a lower bound of the marginal likelihood is
calculated by estimating the posterior p(t|Y ) by a variational distribution
q(t). The distribution
q(t) =
N∏
n=1
N (tn|µn, Sn)
is described in that paper and Bayesian training of the model is used to
maximise this lower bound. This is the method we use to fit the model.
3.12.3 Downstream pseudotime analysis After a pseudotimehas been found,
data can be processed in the same way as time-course data.
3.12.4 Identi fying dynamic genes First, we used pseudotime to rank order
the cells as a time series. Then, we trained two Gaussian processes (GPs)
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for each gene: The first with a radial basis function (RBF) kernel (which
can model change over time) and the second with a constant kernel (which
assumes that the expression of a gene does not change over time). After
optimizing parameters for both models, we filtered the genes by the ratios of
the likelihoods of the models. If the RBF kernel GP has a higher likelihood
than the constant kernel GP, we can conclude that expression of the gene in
question is dynamic in pseudotime.
3.12.5 Clustering genes into expression trends Once we identified genes
that were pseudotime-dependent, we applied a mixtures of hierarchical
Gaussian processes (MoHGP)model to identify groups of genes with similar
pseudotime expression patterns as described in (Hensman et al., 2015). In
this setting, we assume the data is generated by
yg = fc,g(gc(t)) + ε,
where all fc,g and gc are Gaussian process distributed:
gc(t) ∼ GP(0, kg(t1, t2)),
fc,g(t) ∼ GP(gc(t), kf (t1, t2)).
This model uses the structure of the data which can be expressed in terms
of the covariance function
k((t1, c1), (t2, c2)) = kf (t1, t2) + [c1 = c2] · kc(t1, t2),
(using the Iverson bracket notation for indicators). The cluster assignments
c are not known and need to be learned. We use the implementation from
(Hensman et al., 2015) for this.
All functional enrichment analysis was performed with the gProfiler
(Reimand et al., 2011) web service with the standard gene list as background.

Chapter4
Temporal mixture modeling of TH1 and TFH bifurcation
in malaria
Differentiation of naïve CD4+ T cells into functionally distinct T helper (TH)
subsets is crucial for the orchestration of immune responses. Because of
extensive heterogeneity and multiple overlapping transcriptional programs
in differentiating T cell populations of this process in vivo has remained
a challenge for systematic dissection. By using single-cell transcriptomics
and computational analysis with a temporal mixture of Gaussian processes
model, termed GPfates, we reconstructed the developmental trajectories
of TH1 and TFH (T follicular helper) cells during blood-stage Plasmodium
infection in mice. By tracking clonality using endogenous T cell receptor
sequences, we first demonstrated that TH1/TFH bifurcation occurred at both
population and single-clone level. Next, we identified genes whose expres-
sionwas associatedwith TH1 or TFH fates and demonstrated a T cell–intrinsic
role for Galectin-1 in supporting TH1 differentiation. We also revealed the
close molecular relationship between TH1 and interleukin-10–producing Tr1
cells in this infection. TH1 and TFH fates emerged from a highly proliferative
precursor that up-regulated aerobic glycolysis and accelerated cell cycling
as cytokine expression began. Dynamic gene expression of chemokine re-
ceptors at the time of bifurcation allowed us to predict the role of cell-cell
interaction in driving TH1/TFH fates. In particular, we found that precursor
TH cells were coached toward a TH1 but not a TFH fate by inflammatory
monocytes. By integrating genomic and computational approaches, our
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study has generated two unique resources: a database1, which facilitates
discovery of novel factors controlling TH1/TFH fate commitment, and, more
generally, a modeling framework (GPfates) for characterizing cell differentia-
tion toward multiple fates.
The work in this chapter was published in Science Immunology with
the title Single-cell RNA-seq and computational analysis using temporal mixture
modeling resolves TH1/TFH fate bifurcation in malaria (Lönnberg et al., 2017).
Individual contributions The study in this chapterwas designed by Tapio
Lönnberg and Kylie James together with Ashraful Haque. Lönnberg and
James performed the experiments described in this chapter. Tapio Lönnberg
performed the initial exploratory analysis and Kylie James analysed the
monocyte and dendritic cell data.
First I will present the study that has generated the data, and full results.
Then I describe the modelling strategies we used, detailing additional com-
putational experiments to characterize limitations and comparatively assess
the methods.
4.1 Introduction
CD4+ T cells are key instructors of the immune system. They can display
extensive phenotypic and functional diversity by differentiating into a range
of T helper (TH) subsets, including TH1, TH2, TH17, TFH (T follicular helper),
TH22, Treg (T regulatory), and TH9 cells, that are distinguished mainly by
cytokine and transcription factor expression profiles. As TH cells can control
infections and drive immune-mediated diseases, there remains tremendous
interest in the molecular mechanisms that mediate their in vivo differentia-
tion.
Malaria, caused by the protozoan parasite Plasmodium, affected 212 mil-
lion people in 2015 (Organization and Others, 2016). TH1 responses (Pinzon-
Charry et al., 2010) and TFH-dependent antibody responses (Boyle et al.,
2015) can independently protect against malaria and both are elicited si-
1www.PlasmoTH.org
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multaneously in malaria-infected individuals (Obeng-Adjei et al., 2015), as
well as in mice challenged with rodent-infective strains, such as Plasmod-
ium chabaudi chabaudi AS (PcAS) (Perez-Mazliah and Langhorne, 2014).
However, the molecular relationships between TH1 and TFH cells remain
unclear during Plasmodium infection and, more generally, during any im-
mune challenge. A recent study has demonstrated that the unique T cell
receptor (TCR) -specificity of a naïve CD4+ T cell imparted a strong prefer-
ence for either a TH1 or a TFH fate (Tubo et al., 2013). Nevertheless, for many
clones, both fates could still emerge, implying that other mechanisms, such
as internal stochasticity and cell-extrinsic factors, also govern fate choices
in vivo. Transcription factors including T-bet, Gata3, RORγT, and Bcl6 have
been reported to drive and stabilise distinct TH fates, leading to their charac-
terisation as “lineage defining” molecules. This has led TH differentiation
to be presented as a choice between mutually exclusive linear pathways.
However, transient co-expression of these transcription factors (for example,
of Bcl6/T-bet and Foxp3/RORγT) suggests that overlapping intermediate
TH states also exist in vivo. Moreover, substantial heterogeneity occurs in
the kinetics of CD4+ T cell responses, resulting in a complex mixture of
intermediate states during differentiation, which are not easily resolved via
assessment of a small number of molecules.
Conventional dendritic cells (cDCs) are the dominant initial source of
antigenic signaling to naive CD4 T cells in secondary lymphoid tissues, for
example, in the spleens of Plasmodium-infected mice (deWalick et al., 2007).
In other models, it was shown that cDCs made long-lasting stable contacts
with naive CD4+ T cells to initiate priming (Celli et al., 2007). Once activated,
CD4+ T cells regained motility, permitting further cellular interactions. Con-
sistent with this observation, activated CD4 T cells required further antigenic
stimulation to optimise clonal expansion and TH differentiation (Bajénoff
et al., 2002); cDCs were considered the most likely candidates as the source
of this signal (Celli et al., 2007; Groom et al., 2012), with other cell types
remaining less explored. Studies of mice with altered monocytic responses
suggested roles for these cells in CD4+ T cell priming, specifically in tissues
with few cDCs (Hohl et al., 2009). Other reports used cDC deficiency to illus-
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trate that monocytes could activate naive CD4+ T cells (Nakano et al., 2009).
However, few in vivo studies have explored potential roles for monocytes in
TH differentiation, in systems where cDC responses remain intact.
Here, we used single-cell RNA sequencing (scRNA-seq) to study Plas-
modium-specific TCR transgenic CD4+ T (PbTII) cells during blood-stage
PcAS infection in mice. We then used a computational modelling strategy
to reconstruct the molecular trajectories of TH1 and TFH cells. Last, we in-
vestigated cell-cell interactions based on dynamic expression of chemokines
and their receptors and examined the roles of inflammatory monocytes in
driving activated CD4+ T cells toward a TH fate.
4.2 scRNA-seq resolves TH1 and TFH cell fates during Plasmodium infection
in mice
We used scRNA-seq to elucidate the development and heterogeneity of TH1
and TFH cells during PcAS infection (Fig. 4.1A and fig. C.1). We transferred
naive, proliferative dye-labeled PbTII cells into congenic wild-type mice and
recovered them at days 2, 3, 4, and 7 after infection by cell-sorting those
cells expressing the early activation marker CD69 or displaying dilution
of the proliferative dye (fig. C.2). Flow cytometric measurements of the
canonical TH1 markers T-bet (coded by Tbx21) and interferon-γ (IFNγ) and
TFHmarkers CXCR5 andBcl6 indicated that these subsets emerged in parallel
by day 7 after infection (Fig. 4.1, B to D, and fig. C.3) (Johnston et al., 2009;
Szabo et al., 2000). Notably, markers of TH2, TH17, or Treg subsets were not
up-regulated by PbTII cells (fig. C.4).
Initially, we used Principal Components Analysis (PCA) to explore the
overall transcriptomic landscape of the PbTII cells (fig. C.5A). The top
principal components were strongly associated with the number of detected
unique transcripts [reflective of mRNA content and proliferative status (fig.
C.5B)] and differentiation (figs. C.5C to C.7). As expected, the variability
related to previously established TH1 and TFH gene expression signatures
became more prominent with time, separating two subpopulations at day
7 (Fig. 4.1, E and F) (Hale et al., 2013). Together, these results suggested a
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Fig. 4.1 Single-cell mRNA sequencing of PbTII cells. (A) PbTII cells were transferred
from a single donor to multiple recipients. The numbers denote single cells from which
mRNA-sequencing data were successfully recorded. Numbers in parentheses refer to
the replicate experiment presented in fig. C.12. (B and C) Representative fluorescence-
activated cell sorting (FACS) plots showing bifurcation of splenic TH1 (T-bet+IFNγ+) and
TFH (Bcl6+CXCR5+) PbTII CD4+ T cells at day 7 post-infection (p.i.) with PcAS. (D) Flow
cytometry data indicate concurrent differentiation of TH1 (IFNγ+) and TFH (CXCR5+)
PbTII CD4+ T cells within the spleen of PcAS-infected mice (n = 4). Index expression is
the product of mean fluorescence intensity and proportion IFNγ+ or CXCR5+. Data are
representative of two independent experiments. (E) PCA of single PbTII cells at day 7
after infection with PcAS. The arrows represent Pearson correlation with PC1 and PC2.
Cell size refers to the number of detected genes. “TH1 signature” and “TFH signature”
refer to cumulative expression of genes associated with TH1 or TFH phenotypes [total
transcripts per million (TPM) of all genes in the set] (Hale et al., 2013). (F) Expression
levels of the leading 50 genes with the largest PC2 loadings at day 7 (D). Genes were
annotated as either TH1- or TFH-associated on the basis of public data sets (Hale et al.,
2013; Liu et al., 2012; Marshall et al., 2011; Stubbington et al., 2015). *Cdk2ap2 appears
twice because two alternative genomic annotations exist.
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progressive commitment to TH1 and TFH fates and indicated that single-cell
transcriptomes could be used for estimating both proliferative states and
degrees of differentiation of individual cells.
4.3 Delineation of TH1 and TFH trajectories using a Mixture of Gaussian
Processes model
The results from the PCA suggested that variation in PbTII transcriptomes
could be used to reconstruct the transcriptional programs that are underlying
the TH1 and TFH differentiation. To more explicitly model the temporal
dynamics of this differentiation process, we developed GPfates, a temporal
mixture model that builds on the Gaussian Process Latent Variable Model
(GPLVM) (Lawrence, 2006) and OverlappingMixtures of Gaussian Processes
(OMGP) (Lázaro-Gredilla et al., 2012). Briefly, this approach is based on
first reconstructing the differentiation trajectory from the observed data
(“pseudotime,” Fig. 4.2, A and B), thereby establishing an order for the cells.
Although our model uses the sample time as prior information, the inferred
orderings did not strictly adhere to the experimental time points (fig. C.8).
For example, cells from day 4 after infection were mixed with some of the
cells from days 3 and 7 at either end of the day 4 pseudotime distribution.
This result is consistent with the idea that bulk assessments of cells at specific
time points fail to account for the heterogeneity and differential kinetics of
responses made by single cells. To assess the robustness of the established
ordering, we repeated this analysis without supplying the experimental
sampling times to the model, finding overall consistent results (4.13).
In a second step, GPfates uses the inferred temporal orders as input for a
nonparametric time series mixture model [OMGP (Lázaro-Gredilla et al.,
2012)]. This approach revealed two simultaneous trends emerging during
pseudotime (Fig. 4.2, C and D), which separated from each other, indicating
that a developmental bifurcation occurred.
In a third step, GPfates uses a change point model (section 4.14.2), thereby
facilitating the annotation of pseudotime after bifurcation. The cell fate split
appeared to initiate among early day 4 post-infection cells (in pseudotime;
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Fig. 4.2, C and D), an inference that was robust when using bootstrapped
subsets of cells (section 4.17.1).
Fig. 4.2 (Caption on next page)
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Fig. 4.2 GPfates modeling of bifurcation processes using scRNA-seq data. (A)
Overview of the analysis workflow that underlies GPfates, consisting of dimensionality
reduction of high-dimensional single-cell transcriptomes (left), inference of a pseudotem-
poral ordering of the cells (middle), and the reconstruction of trajectories using temporal
mixture modeling (right). These individual steps build on models derived using the Gaus-
sian process framework. Once fitted, GPfates enables different downstream analyses,
including cell orderings, bifurcation time point estimates, and inference of the genes that
drive bifurcation events. (B) Illustration of intermediate results obtained from GPfates.
Left: A low-dimensional representation, as well as a pseudotemporal ordering of the
cells, is inferred using a nonlinear dimensionality reduction (Gaussian Process Latent
Variable Model). Temporal trajectories and bifurcations are then reconstructed using a
temporal mixture model (Overlapping Mixture of Gaussian Processes), with data-trend
assignments per cell. B-GPLVM, Bayesian Gaussian Process Latent Variable Model; 3D,
three-dimensional. (C) Low-dimensional representation (2D) of the complete data sets
(408 single-cell transcriptomes). The blue line depicts the inferred progression of pseu-
dotime. Text labels illustrate features typical of cells in the corresponding pseudotime
region. (D) Inference of two simultaneous trends based on the pseudotime using the
temporal mixture model.
We found that genes differentially expressed between the identified
trajectories agreed with known TH1/TFH signature genes (Fig. 4.3, A and B,
and fig. C.9) (Hale et al., 2013), strongly suggesting that the fitted mixture
components corresponded to cells with TH1 and TFH phenotypes. Notably,
these bifurcation trends could not be identified by other published methods
for reconstructing bifurcating single-cell trajectories (Comp. Supp. Fig. 14)
(Chen et al., 2016; Haghverdi et al., 2016; Marco et al., 2014; Setty et al.,
2016; Trapnell et al., 2014). We also successfully applied GPfates to resolve
bifurcation events in other published data sets (Comp. Supp. Figs. 11 and 12)
(Guo et al., 2015; Treutlein et al., 2014), suggesting that our approach is more
generally applicable for studying cellular differentiation using scRNA-seq
data.
4.4 Lineage barcoding using endogenous TCR sequences reveals TH1/TFH
bifurcation from single CD4+ T cells
Although the TCR transgenic approach used in this study minimised the
influence of TCR sequence variability on cell fate determination (Tubo et al.,
2013), the strain was Rag-sufficient, thus retaining potential for expression
of diverse endogenous TCR chains, in addition to the transgenic TCR. Se-
4.4 67
Fig. 4.3 The relationship of known TH1 and TFH transcriptomic signatures and the
GPfates trajectories. (A) TH1 and TFH assignment probabilities of individual cells. For
differential expression analysis (B), TH1 and TFH were defined as cells with assignment
probability of ≥ 0.8 for the respective trend. (B) Differential expression patterns between
cells assigned to TH1 and TFH states. Fold differences (x axis) and the corresponding
adjusted P value (y axis) of differential expression for expressed genes (in at least 20%
of cells) are shown. Statistical significance was determined using Wilcoxon rank sum
test, with Benjamini and Hochberg correction for multiple testing. The horizontal and
vertical dashed lines denote adjusted P value of 0.05 and twofold change, respectively.
(C) Parallel TH1 and TFH differentiation within cells of a single CD4+ T cell clone. Colors
correspond to individual clones determined by sequence analysis of endogenous TCR
genes. (D) Identification of genes associated with TH1 and TFH trajectories. For each
gene, the expression correlation with pseudotime (x axis) versus the correlation with
the TFH trend assignment (y axis) is shown. Gene relevance was determined using the
bifurcation statistic (fig. C.9C). The top 248 bifurcating genes, with bifurcation statistic
>49, are represented in colors according to the functional classification of the genes). (E)
Genes with the strongest association with TH1 or TFH differentiation, filtered using the
bifurcation score as in (D). The genes are ranked in descending order of association with
the respective trend. Cdk2ap2 appears twice because of alternative genomic annotations.
(F) Web address for GPfates database, where the expression kinetics of genes of interest
can be visualized. Examples illustrate the top-ranking bifurcating genes from (E).
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quence analysis of TCR transcripts in single PbTII cells confirmed universal
expression of the PbTII Vγ2 and Vγ12 chains, as well as highly diverse,
though lower, levels of expression of endogenous TCRγ chains in many
cells (fig. C.10). Rag-sufficient PbTII cells differentiated as effectively as
Rag1-/- PbTII cells into both TH1 and TFH cells (fig. C.11), indicating that
endogenous TCR sequences had not influenced TH fate bifurcation.
Given the vast combinatorial diversity of the endogenous TCR sequences,
we used these as unique molecular barcodes to identify ancestrally related
PbTII clones. We identified six clones comprising multiple sibling cells. Of
these, two consisted of sibling cells thatmapped close to the bifurcation point.
For the remaining four clones, siblings exhibited highly diverging patterns
of differentiation, with three sibling pairs mapping to the extremities of
the TH1-TFH phenotype spectrum (Fig. 4.3C). These results demonstrated
that TH1/TFH bifurcation had occurred at both population and single-clone
levels in our system, with the progeny of a single cell populating both TH1
and TFH compartments.
4.5 Transcriptional signatures associated with bifurcation of TH1 and TFH
fates
Next, we sought to identify genes whose expression differed between the
TH1 and TFH branches. We derived a bifurcation statistic to estimate the
concordance with bifurcation for individual genes (Fig. 4.3D). Among the
highest-ranking genes, the most common pattern was up-regulation along
the TH1 branch (Fig. 4.3D). This suggested that TFH cells were developmen-
tally closer to the shared progenitor state than TH1 cells, because the TH1
fate involved up-regulation of numerous genes not expressed in either the
progenitor or TFH states.
To validate the robustness of these gene signatures and the timing of the
bifurcation, we repeated the infection and, at days 0, 4, and 7, sequenced
additional PbTII cells using the Smart-seq2 protocol (Fig. 4.1A and fig.
C.12A). A nonlinear dimensionality reduction indicated that the single
cells from both experiments populated similar transcriptional landscapes
4.5 69
(fig. C.12B) and that the subset characteristic co-expression patterns of
the bifurcating genes identified by GPfates emerged by day 7 (fig. C.12C).
Notably, the day 7 cells from eachmouse could be separated into distinct TH1
and TFH subpopulations using the top bifurcating genes (fig. C.12D). These
results indicated that the bifurcation-associated gene expression patterns
were reproducible across experiments and sequencing platforms.
The highest-ranking transcription factors for the bifurcation included
Tcf7 for the TFH fate and Id2 for the TH1 fate (Fig. 4.3, D and E). Tcf7 is
required for T cell development and has been recently shown to be instru-
mental for TFH differentiation (Choi et al., 2015; Xu et al., 2015). It also
represented one of the rare genes defined by a decrease in expression when
moving toward the TH1 fate. Id2 is an antagonist of Tcf7 and was recently
identified as a key driver of TH1 responses (Shaw et al., 2016). As expected,
the hallmark TFH transcription factor Bcl6 was also strongly associated with
the TFH fate. In TH1 cells, many bifurcating genes encoded immune-related
receptors (Fig. 4.3, D and E), such as Cxcr6 (fig. C.13, A and B), Ifngr1, and
S1pr1, which mediate egress from secondary lymphoid organs. This was
consistent with the notion that TH1 cells can migrate to peripheral tissues
and remain receptive to external signals. In contrast, the only bifurcating
chemokine receptor associatedwith a TFH fate was Cxcr5, which is important
for trafficking into B cell follicles (Hardtke et al., 2005).
Many of the bifurcating genes had no known role in TH differentiation.
For example, lgals1 (encoding Galectin-1), a molecule generally implicated
in cDC (Poncini et al., 2015) and Treg function (Garín et al., 2007), was unex-
pectedly upregulated in PbTII cells around bifurcation and maintained at
high levels along the TH1 but not the TFH trajectory (fig. C.14A). This obser-
vation was confirmed at the protein level (fig. C.14B). Next, comparison of
TH1/TFH fates in cotransferred wild-type and lgals1-/- PbTII cells during
PcAS infection (fig. C.14C) revealed a specific role for Galectin-1 in sup-
porting TH1 but not TFH fate (fig. C.14D). Together, these data illustrate the
potential for the GPfatesmodel to enable identification of factors controlling
TH1 and TFH fates. Further examination of bifurcating genes is facilitated
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by an online database (www.PlasmoTH.org) accompanying this study (Fig.
4.3F).
Coinciding with TH1/TFH differentiation, we also noted up-regulation of
Il10 particularly in the TH1 branch (fig. C.15A). Most of the Il10-expressing
cells also expressed Ifng at equal or higher levels when observed in those
cells expressing Ifng alone (fig. C.15, B and C). These data revealed the de-
velopment of Tr1 cells, defined as interleukin-10 (IL-10)/IFNγ–coexpressing
CD4+ T cells. Given that Il10 expression was associated with the TH1 branch,
this suggested that Tr1 cells were developmentally related to TH1 cells. Unex-
pectedly, we found that aside from Il10, only two genes, Trib2 and BC017643,
were differentially expressed between Il10/Ifng-coexpressing Tr1 cells and
Ifng-expressing TH1 cells (fig. C.15D). Furthermore, a comparison of gene
expression frequencies between Tr1 and TH1 cells revealed a substantial
degree of similarity across the transcriptome (fig. C.15E). Together, these
data strongly suggest that Tr1 cells derive directly from TH1 cells during
blood-stage Plasmodium infection.
4.6 Pseudotemporal relationships between cell cycling, aerobic glycolysis,
and cytokine expression
Clonal expansion, increased aerobic glycolysis, and cytokine expression are
hallmarks of TH cell development whose temporal relationships with each
other remain to be fully resolved in vivo. We noted that PbTII cells became
highly proliferative around bifurcation, as shown by the up-regulation of
Mki67 (Fig. 4.4, A and B, and fig. C.16A) and other known proliferation
marker genes (fig. C.16B) (Whitfield et al., 2006). This correlated with cell
cycle activity, as inferred from the scRNA-seq data using the Cyclone tool,
and confirmed by flow cytometric measurements of DNA content and cell
size (Fig. 4.4, C and D, and fig. C.16C). On day 4 after infection, the cells
also increased expression of genes associated with aerobic glycolysis but not
oxidative phosphorylation (Fig. 4.4F), an indication of increased metabolic
requirements being met by glucose metabolism and increased mammalian
target of rapamycin complex 1 (mTORC1) activity. Consistent with this was
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Fig. 4.4 The bifurcation of T cell fates is accompanied by changes in transcrip-
tion, proliferation, and metabolism. (A) Expression kinetics of Mki67, encoding the
proliferative marker Ki-67, as a function of pseudotime. (B) Representative FACS plots
showing kinetics of CellTrace Violet (CTV) dilution and Ki-67, IFNγ, or CXCR5 expression,
with summary graphs showing % of PbTII cells expressing these (after 106 PbTII cells
transferred) in uninfected (day 0) and PcAS-infected mice at indicated days after infection
(n = 4 mice per time point, with data from individual mice shown in summary graphs;
solid line in summary graphs indicates temporal trends fit using a third-order polynominal
regression). Data are representative of two independent experiments. (C) Relative cell
cycle speed of PbTII cells, determined by measuring the fraction of cells in S, G2, or M
phase. Results when allocating cells to cell cycle phases using flow cytometry (fig. C.16C)
or computational assignments on the basis of the scRNA-seq data are shown. (D) Cell size
estimation using forward scatter (FSC) measurements of PbTII cells. (E) Cellular metabolic
activity of PbTII cells in naive mice (n = 3) and at days 4 and 7 after infection (n = 6),
as determined by flow cytometric assessment of ribosomal protein S6 phosphorylation
(p-S6). Histogram and proportions are representative of two independent experiments.
***P < 0.001, one-way analysis of variance (ANOVA) and Tukey’s multiple comparisons
tests. (F) Expression kinetics of genes associated with the cell cycle [251 genes derived
from Cyclebase (48)], glycolysis (41 genes, GO:0006096), and oxidative phosphorylation
(30 genes, GO:0006119) during PcAS infection. Cumulative expression levels of genes in
the respective categories per single cell are shown. Data from all cells and mice (Fig. 4.1A)
were pooled. (G) Differential expression analysis comparing the experiment-corrected
expression of genes associated with cell cycle (P < 10−103, glycolysis (P < 10−4, and
oxidative phosphorylation (P < 10−5 (F) in Ifng-positive (≥ 10 TPM) and Ifng-negative
cells (<10 TPM) at day 4 after infection with PcAS from both experiments combined.
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the observed elevated level of ribosomal protein S6 phosphorylation on day
4 after infection (Fig. 4.4E).
By day 4 after infection, PbTII cells had gone through several rounds of
cell division with differing kinetics and with some cells expressing IFNγ.
By comparing Ifng-expressing and nonexpressing cells on day 4 after infec-
tion, we noted that early Ifng-expressing cells cycled faster and expressed
aerobic glycolysis genes more highly than their non-cytokine-expressing
counterparts (Fig. 4.4G). Together, our data suggest that around bifurcation,
PbTII cells exhibited a highly proliferative and metabolically active state,
with those cells cycling fastest and exhibiting most glycolytic activity being
the first to acquire the capacity to secrete IFNγ.
4.7 Gene dynamics identifies potential decision-making molecules
To elucidate how PbTII cells transitioned from the proliferative precursor
state to TH1 and TFH fates, we sought to resolve the hierarchy of gene expres-
sion before and during cell fate bifurcation. In addition to genes directly
following the bifurcation trend, we reasoned that expression of genes encod-
ing key decision-making molecules is likely to be dynamic and peak before
the bifurcation. First, to identify these, we selected those genes displaying
interesting nonlinear trends in their expression patterns over pseudotime
by Gaussian Process regression. This was achieved via a D statistic (model
likelihood ratio), where each gene’s expression pattern over pseudotime was
tested for variation unexplained by random noise (Macaulay et al., 2016).
On the basis of the D statistic (> 50.0, Fig. 4.5C), we identified 2061 dy-
namic genes (Fig. 4.5A). Second, we ordered these genes according to their
peak expression time to provide a temporal overview (Fig. 4.5A) and noted
that a substantial fraction peaked around bifurcation. These included the
TH1-driving genes Tbx21, Il2ra, and Il2rb, supporting our initial hypothesis.
Moreover, cells around bifurcation also transcribed the highest number of
genes compared with cells at all other points in pseudotime (Fig. 4.5B).
This model also infers the length-scale of the dynamic model, namely,
the degree of fast-acting behavior over pseudotime (Fig. 4.5C). Using this
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Fig. 4.5 Temporal gene expression dynamics during PcAS infection. (A) Expression
patterns over pseudotime shown for top 2061 dynamic genes (defined by D statistic >50).
Genes are ordered per peak expression time. TH1 and TFH probability trajectories from
the GPfates OMGP model presented at the bottom to depict bifurcation and provide
temporal context between the gene expressions and cellular fates. Various dynamically
expressed immune receptors, transcription factors, and secreted molecules are annotated.
(B) Relationship of transcriptional activity and divergence of TH1 and TFH fates. The
number of detected genes per cell is shown across pseudotime. The color of the data
points represents trend assignment probability (Fig. 4.2). TH1 and TFH trajectories from the
GPfates OMGP model presented to depict relation to the bifurcating behavior. (C) Gene
expression dynamics assessed using D statistic and optimal squared exponential kernel
length-scales. Genes with a D statistic of >50 selected as displaying nonlinear expression
patterns over pseudotime. The optimal length-scales of the squared exponential kernels
of the Gaussian Processes plotted on x axis, where small values indicate that some rapid
changes in expression over pseudotime occur. (D) Model summarizing the expression
patterns of key chemokine receptors and the transcription factors Id2 and Tcf7 during
TH1-TFH cell fate determination. The size of the cell represents proliferative capacity (Fig.
4.4, A to F).
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additional feature, we noted roughly equivalent dynamics for Tbx21, Il2ra,
and Il2rb. Furthermore, we noted similar dynamics, though with slightly
later peak times, for the chemokine receptors Cxcr5 and Cxcr3. Closer ex-
amination of all chemokine receptor genes also revealed peak expression
around bifurcation for Ccr4 but not others (fig. C.17). Given that Cxcr5
and Cxcr3 have been associated with TFH and TH1 cells, respectively (Breit-
feld et al., 2000; Groom et al., 2012; Schaerli et al., 2000), and because they
exhibited similar dynamics, we hypothesised that these were competing
receptors that directly influenced TH1/TFH fate (Fig. 4.5D). Assessment of
Cxcr3/Cxcr5 coexpression around bifurcation revealed a substantial portion
of cells expressing both receptors (fig. C.18). Thus, our examination of gene
expression dynamics revealed large numbers of genes being expressed and
peaking around bifurcation, including not only those associated with clonal
expansion but also numerous sequentially expressed transcription factors
and receptors with potential to influence TH fate.
4.8 Monocytes support activated PbTII cells toward a TH1 but not a TFH fate
Given similar dynamics and peak expression times for Cxcr3 and Cxcr5, and
peak expression around bifurcation for Ccr4 (fig. C.17), we reasoned that
cell-cell interactions via these receptors controlled TH1/ TFH fate. Hence,
we considered cell types that could control TH fate, specifically around
bifurcation. Because B cells supported a TFH fate (fig. C.19), we hypothesized
that coordinated action by myeloid cells provided competing signals to
support a TH1 fate.
To study this, we examined splenic cDCs and inflammatory monocytes
before PbTII bifurcation. We sorted CD8+ and CD11b+ cDCs and Ly6Chi
monocytes from naive and infected mice (fig. C.20) and performed scRNA-
seq. PCA of cDCs distinguished the two naive cell types along PC2 (Fig.
4.6A and fig. C.21) with an efficiency consistent with recent data (Jaitin
et al., 2014) and further highlighted a number of expected and previously
unknown cDC subset-specific genes (fig. C.22). We next compared naive
cDCs with those from infection (Fig. 4.6A and fig. C.21) and separated
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these along PC6 (Fig. 4.6A). Analysis of differential gene expression in cDCs
due to infection identified 30 genes, 29 of which were up-regulated (Fig.
4.6B), including transcription factors Stat1 and Irf1 and CXCR3-attractant
chemokines Cxcl9 and Cxcl10.
Notably, gene expression patterns among individual cDCs varied accord-
ing to the gene. For example, Stat1 and Irf1 were expressed by several naive
Fig. 4.6 (Caption on next page)
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Fig. 4.6 Myeloid cells influence TH bifurcation in uncommitted PbTII cells. (A to
C) Splenic CD8α+ and CD11b+ CD8α- cDCs from a naive mouse, mixed cDCs from
an infected mouse, and (D to F) Ly6Chi monocytes from naïve and infected mice were
analyzed by scRNA-seq, with mRNA reads filtered by minimum expression of 100 TPM
in at least two cells. (A and D) PCA showing clustering of (A) cDCs or (D) monocytes.
(B and E) Fold change and confidence for differentially expressed genes (19) between
infected and naive (B) cDCs or (E) monocytes; genes were filtered on expression in >10
cells; genes satisfying q < 0.05 are colored per function. (C and F) Differentially expressed
genes (q < 0.05) in (C) cDCs and (F) monocytes, between naive and infected mice:
Cells and genes are ordered according to PC score and loading, respectively. Common
genes between heat maps are annotated in (F). (G) Representative FACS histograms and
proportions of splenic CD8α+ cDCs, CD8α- cDCs, and Ly6Chi monocytes expressing
CXCL9 in naive and infected mice; data show individual mice with line at mean and
are representative of two independent experiments (n = 4 mice per time point per
experiment). (H) PbTII cells were transferred into LysMCre × iDTR mice 1 day before
infection. At 3 days after infection, mice were treated with diphtheria toxin (DT) or saline.
Proportions of TH1 (T-bethi IFNγ+) and TFH (CXCR5+) PbTII cells at 7 days after infection;
data pooled from three independent experiments (n = 5 to 6 per experiment). ****P
< 0.0001, Mann-Whitney U test; NS, not significant. (I) Summary model proposes that
chemokine interactions between nonbifurcated PbTII cells and myeloid cells support a
TH1 fate, whereas B cells support a TFH fate.
cDCs and further up-regulated during infection (Fig. 4.6C). This was simi-
lar for Cxcl9, which was expressed by CD8+ cDCs in naive mice, whereas
Cxcl10 was induced only upon infection (Fig. 4.6C). These data suggested
interactions between cDCs and uncommitted CXCR3+ PbTII cells, consistent
with a recent study (Groom et al., 2012).
Next, PCA of Ly6Chi monocytes from naive and infected mice distin-
guished these two populations them from each other along PC2 (Fig. 4.6D
and fig. C.24). Differential gene expression analysis between naive and in-
fected groups uncovered 100 genes, both up-regulated and down-regulated
during infection (Fig. 4.6E). A high proportion ( 40%) of genes up-regulated
in cDCs were also induced in Ly6Chi monocytes, including Stat1, Irf1, and
Cxcl10 (Fig. 4.6, E and F), suggesting possible overlapping functionality. In
addition, monocytes expressed other chemokines, including Cxcl2, Ccl2, and
Ccl3 (Fig. 4.6, E and F). Furthermore, specific examination of all immune cel-
lular interaction genes revealed emerging variable expression of Tnf, Cd40,
Pdl1, Ccl4, Ccl5, Cxcl16, Cxcl9, and Cxcl11 in monocytes, thus suggesting
complex cell-cell interactions for Ly6Chi monocytes during infection.
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As Cxcl9, Cxcl10, Cxcl11, Ccl2, Ccl3, and Ccl5 signal through Cxcr3 or
Ccr4, which were expressed by activated PbTII cells, we next hypothesised
that Ly6Chi monocytes, in addition to cDCs (Groom et al., 2012), interacted
with PbTII cells and influenced TH1/TFH fate. To test this, we first assessed
chemokine expression at the protein level by Ly6Chi monocytes (Fig. 4.6G).
Kinetics of CXCL9 production was similar in cDCs and Ly6Chi monocytes.
Next, we used LysMCre × iDTR mice, in which Ly6Chi monocytes were
depleted after PbTII cell activation but before bifurcation (Fig. 4.6H and fig.
C.25). We noted a modest reduction in CD68+ splenic macrophages using
this approach (fig. C.25B). This way, we found thatmonocytes/macrophages
supported a TH1 but not a TFH fate (Fig. 4.6H). Together, our data support a
model in which activated PbTII cells are supported toward either a TFH fate
by B cells (fig. C.19) or a TH1 fate by chemokine-expressing myeloid cells,
including Ly6Chi inflammatory monocytes.
4.9 Discussion
By capturing single CD4 T cell transcriptomes during an experimental
malaria infection and computationally reconstructing the course of events,
we have resolved the bifurcation of naive CD4+ T cells into TH1 and TFH
cells at a molecular level. GPfatesmodeling of scRNA-seq data is not lim-
ited to immune cells or single bifurcation events. This model can also be
combined with existing computational workflows, including alternative
methods to estimate pseudotemporal dynamics (see section 4.16.1) (Bendall
et al., 2014; Trapnell et al., 2014). The GPfates approach permits analysis
of cellular differentiation toward two fates (Comp. Supp. Fig. 11) and, in
principle, toward multiple fates (Comp. Supp. Fig. 12). However, GPfates
exhibits some limitations. Most notably, the ability to identify and pinpoint
bifurcation events is linked to changes in the transcriptome that reflect these
cellular decisions. In particular, because scRNA-seq profiles are subject to
high levels of noise, this means that changes will only be detectable with
some lag time (Supplementary Computational Methods). The processed ex-
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pression data and the GPfatesmodel presented in this study can be accessed
at www.plasmoTH.org, where users can visualise their genes of interest.
Our data provide a framework for revealing molecular insights into the
early stages of TH cell differentiation and describe the sequence of tran-
scriptional events before and after the bifurcation of TH1 and TFH fates.
Transcriptomic profiling previously suggested developmental similarities
between TFH and TH1 cells (Liu et al., 2012). However, highly immunogenic
viral or bacterial infections induced CD4+ T cells to segregate into Bcl6+
(TFH) or Blimp-1+ (TH1) subpopulations within 2 days (Choi et al., 2011;
Pepper et al., 2011). In our parasitic model, single CD4+ T cell transcrip-
tomes remained remarkably similar until 4 days of infection. Although it
is difficult to directly compare infection models, we speculate that Plasmod-
ium infection in mice may not drive TH bifurcation as early as observed
with highly immunogenic viruses or bacteria, particularly given evidence of
immunosuppression (Haque et al., 2014).
IL-10–producing Tr1 cells can suppress immune responses, which could
aid the treatment of immune-mediated disorders (Clemente-Casares et al.,
2016) or be detrimental for chronic infections (Couper et al., 2008). Despite
this, the relationship of Tr1 cells to TH1 cells is not clear (Apetoh et al., 2010).
In our model, Tr1 cells emerged from the TH1 trajectory. This observation,
coupledwith similar transcriptomes for TH1 and Tr1 cells, provides evidence
that Tr1 cells are highly related to, and derive directly from, TH1 cells in
this model. Thus, our modelling of scRNA-seq data revealed molecular
relationships between TH1, Tr1, and TFH cells and showed that a single naive
CD4+ T cell can simultaneously give rise to more than one cell fate during
experimental malaria.
Activated CD4+ T cells may experience different microenvironments
within secondary lymphoid tissue. The observation that bifurcation toward
TH1 and TFH fates was preceded by up-regulation of chemokine receptors
prompted us to investigate possible cell-cell interactions with chemokine-
expressing myeloid cells. Previous studies have highlighted the potential for
cDCs in lymph nodes to produce TH1-associated chemokines (Groom et al.,
2012). Our study, which focused on the spleen, further implicated inflam-
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matory monocytes in supporting TH1 differentiation. However, because our
transgenic approach for depleting monocytes also removed a small portion
of splenic red pulp macrophages, we cannot fully discount the possibility
that they may partly contribute to a TH1 fate. Nevertheless, we propose that
splenic monocytes/macrophages influence bifurcation by supporting a TH1
fate during Plasmodium infection. Our studies emphasise that although cDCs
are key for initiating CD4+ T cell activation in the spleen, other myeloid cells
can also promote a TH1 fate in the presence of cDCs. In contrast, given that
CXCR5was the only chemokine receptor notably associated with bifurcation
toward a TFH fate, cellular interaction with B cell follicles may be the primary
mechanism for supporting a TFH fate. Our model proposes that activated,
uncommitted CD4+ T cells become receptive to competing chemoattractant
signals from different zones of the spleen, and suggests intercellular com-
munication as a major driver of bifurcation. However, upstream of these
processes, internal stochasticity in uncommitted CD4+ T cells may control
the balance of chemokine receptor expression. Future experiments combin-
ing our integrated single-cell genomics and computational modelling with
in vivo positional and trafficking data may reveal molecular relationships
between internal stochasticity, migratory behavior, and TH cell fate.
4.10 Material and methods
The goal of this study was to use scRNA-seq to capture the transcriptomes
of individual splenic PbTII cells at various time points during the first week
of a blood-stage PcAS infection. Multiple mice were used for most time
points to test for possible batch effects, with an independent experimental
repeat performed on a different scRNA-seq platform. scRNA-seq data were
modelled using Gaussian processes, with statistical testing for significance
of both genes and cells associated with the Gaussian processes.
In depth details on the experimental design and methods are covered
in C.1. In the following section, we cover in depth the models used to infer
pseudotime and study the cellular bifurcation.
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4.11 The GPfates model
GPfates is based on a three-stage approach that first i) infers a low-dimensional
representation of single-cell RNA-seq data, then ii) infers pseudotime to iii)
model the temporal dynamics of gene expression profiles with a mixture
model. These steps build on existing modeling components: The Gaussian
Process Latent Variable Model (GPLVM) (Lawrence, 2006), and the Overlap-
ping Mixture of Gaussian Processes (OMGP) (Lázaro-Gredilla et al., 2012).
For a graphical illustration of the major steps involved in this analysis, see
Figure 4.2. In Sections 4.12 and 4.13 I describe the statistical models that
underlie the components of GPfates. In Section 4.14 I describe downstream
analysis methods for interpreting the fitted model followed by the inte-
grated implementation and combination with existing workflows in Section
4.16. Section 4.17 and 4.18 include additional validation experiments using
simulations, robustness analyses and analyses on multiple existing data
sets. Finally, in Section 4.19, we compare the outcome of other published
methods inferring pseudotime and branching events on the same data with
the results obtained by GPfates.
4.12 Pseudotime inference
Description of pseudotimemethodology as it relates to the Gaussian process
framework is described in detail in Section 3.12. Here, we extend this further.
4.12.1 Pseudotime inference by Bayesian GPLVM with per -cel l prior In
the notation of Section 3.12 The joint probability of the GPLVM is
p(Y, t) = p(Y |t) · p(t),
where p(Y |t) is defined in equation 3.5, and the prior p(t) is such that for
cell n,
p(tn) = N (0, 1).
Following (Reid and Wernisch, 2016), we can also consider the prior p(t) to
be informed about the experimental ordering of collection times of the cells,
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putting the mean of tn to correspond to the time point of cell n. When we
use our Malaria time course as an example, we can put the prior on t so that
p(tn) = N (dayn, σ2prior),
where dayn ∈ {1, 2, 3, 4, 5} correspond to the collection order of those cells.
The parameter σ2prior alters the strength of the prior.
For a simple and fast implementation of per-cell priors, in practice we use
a prior on the variational parameterisation. When performing variational
inference we have
q(tn) = N (µn, σn)
and the goal is to minimise the Kullback-Leibler divergence between p(t|Y )
and q(t). We put a prior on the variational parameters µn. Rather than a
lower bound of themarginal likelihood of the BayesianGPLVMwill optimize
the lower bound marginal maximum a posteriori probability (MAP).
4.12.2 Dimensional ity reduction In many cases it is useful to work on a
reduced representation of cellular expression profiles. For example, when
modelling transcriptomic data, fitting a model to a low-dimensional repre-
sentation can be preferable to fitting it to expression profiles of thousands of
genes. Formally, the objective of dimensionality reduction is to find someM -
dimensional representation of theG-dimensional expression measurements,
whereM << G. TypicallyM is 2 or 3, which aides visual interpretation.
Analogous to the pseudotime inference, these latent cell states can also be
inferred using the GPLVM. Say X is anM × N matrix so that each cell n
corresponds to anM -dimensional vector,
Xn = (x
1
n, . . . , x
M
n ).
We want to model the expression matrix Y so that
[yg]n = f
g(x1n, . . . , x
M
n ) + ε = f
g(Xn) + ε.
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Note that now the covariance function is evaluated as k(Xn1 , Xn2),where,
in the squared exponential (SE) covariance function in equation 3.2, the
operator | · | is evaluated as the Euclidean norm for vectors, rather than
absolute value.
Just as the tn values are inferred from data above, so can the Xn vectors
be inferred from the data.
4.13 Bifurcation inference using overlapping mixtures of Gaussian processes
In a continuous setting, a bifurcating process can be seen as one function,
splitting apart into two functions over time. One approach to model this
could be to consider two functions throughout time, which are identical
before the point of bifurcation. With this in mind, we can use a mixture
model to tease apart the shared and bifurcated functions.
4.13.1 Mixture model Mixture models are hierarchical models where an
observation is assumed to be generated from one of C components, each of
which is described by its own model. The goal of mixture models is to infer
which component an observation stems from and at the same time model
that component.
The OverlappingMixture of Gaussian Processes (OMGP) model (Lázaro-
Gredilla et al., 2012) assumes there are C different underlying latent func-
tions producing the N observed cells. This model was originally developed
for the application of missile tracking, and in that setting an observation is
e.g. a radar based location at a given real time point. As such, the main focus
of the definition of the model is the case of C completely independent com-
ponents. The approach presented here is based on the realisation that the
model would also be able to handle the case of branching trajectories. There
would simply be a time interval where it does not matter which mixture
trajectory data is sampled from. In our setting, an observation is a single
cell and the analog to real time is pseudotime (Figure. 4.7). As an additional
extension, we phrase a version of the OMGPmodel which is non-parametric
in the number of trajectories.
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Original OMGP application Bifurcating OMGP application
Fig. 4.7 Comparison of OMGP use cases. Comparison of the original OMGP use case
(left) and our use case (right), in both cases where the number of trends C = 2. In
the original use case trends are expected to be independent throughout time, albeit
with some ambiguity in some locations. In our application, we interpret ambiguous cell
assignment to be in a common precursor state.
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In the original regression case described in equation 3.1, data is assumed
to be generated by a single smooth unknown function. When modeling our
gene expression data with the Overlapping Mixture of Gaussian Processes,
data is considered to be generated by
X = fc(t) + ε.
However, we are lacking information about which latent function fc gener-
ated any given observation (tn, Xn) of pseudotime and gene expression for
theN observed cells. HereX corresponds to some representation of the tran-
scriptional state of the cells. It could be the expression of all genes (X = Y ),
a single gene (X = yg), or an M -dimensional inferred representation as
discussed above.
This is viewed as a mixture modelling problem, where each cell has
a latent variable zi specifying to which component fc the cell should be
allocated to. Write F for the collection of all latent functions. The covariance
functions kc for each fc can be different from each other, though for the ap-
plications we discuss here, we take them as squared exponential covariance
functions with different hyperparameter values.
In the OMGP formulation, the likelihood is
p(X|F, T, Z) =
N∏
n=1
C∏
c=1
N (xi|fc(tn), σ2)znc .
We specify a multinomial prior on the latent variables Z, namely
p(Z) =
N∏
n=1
C∏
c=1
Π
zn,c
n,c ,
C∑
c=1
Πn,c = 1.
Additionally, each of the latent functions fc has an independent Gaussian
process prior:
p(F |T ) =
C∏
c=1
N (fc|0,Kct ).
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The covariance matricesK1t , . . . ,KCt for the latent functions f1, . . . , fC are
generated from a covariance functions k1(tn1 , tn2), . . . , kC(tn1 , tn2) like in
equation 3.3.
Now we rephrase this as a Dirichlet Process Gaussian Process mixture
model (Hensman et al., 2012). Let every latent function fc have an associated
stick-breaking length vc, based on the stick-breaking formulation of the
Dirichlet Process. Here V = [v1, · · · , v∞] is the collection of stick-breaking
lengths for constructing the Dirichlet process for the assignment. The joint
distribution of the OMGP model is
p(X,Z, V, F ) = p(F |T )p(X|F,Z)p(Z|V )p(V |α).
The value α is a parameter of the model which controls the expected
concentrations of mixtures (which we in practice take as α = 1, a common
default), and
p(V |α) =
∞∏
c=1
Beta(vc|1, α),
where Beta(·, ·) is the beta distribution. The prior distribution over the
collection of Gaussian Processes is
p(F |T ) =
∞∏
c=1
N (fc|0,Kc).
Following the stick-breaking formulation,
p(Z|V ) =
N∏
i=1
∞∏
c=1
πc(V )
zi,c ,
where πc(V ) = vc
∏c−1
j=1(1− vj).
The assignments between observations X and the latent functions F
is given by a binary N × C matrix Z. The assignments to latent functions
are considered as additional variational parameters. Let ϕ be an N × C
matrix where ϕnc is the approximate posterior probability of assigning the
nth observation to the cth latent function. The ϕ parameters are inferred
by collapsed variational inference as described in (Hensman et al., 2012).
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Overall, the likelihood of the model is
p(X|F,Z) =
N∏
n=1
∞∏
c=1
N (xn|fc,Kc)zn,c .
(It should be noted that everything described generalises to the case
where the latent functions fc are vector valued, as long as all output di-
mensions of such a function share the same covariance function. In this
case, probabilities factorise over output dimensions, but beyond that all
calculations are the same.)
4.13.2 Parameter inference In (Lázaro-Gredilla et al., 2012) the latent vari-
ablesZ in the parametric version ofOMGPwere inferred using an expectation-
maximization scheme. Here we describe how we perform variational infer-
ence for the ϕ-parameters in the non-parametric version of the model.
To make the inference problem tractable, the variational distribution
q(Z) is introduced with variational parameters ϕ, at a given truncation level
C such that
q(Z) =
N∏
n=1
C∏
c=1
ϕ
zn,c
n,c .
with the objective of approximating p(Z|F,X, T ).
The lower bound of the log-likelihood of the OMGP model, which we
write as LKL, when approximating p(Z) by q(Z) can be split up in three
terms as
LKL = LM + LMP + LH.
Here LM =∑Cc=1 LMc is the log-likelihood of the latent functions as repre-
sented by Gaussian processes. For the cth latent function, the variational
distribution of fc which maximises the lower bound was derived in (Lázaro-
Gredilla et al., 2012) to be
q(fc) = N (fc|µc,Σc)
whereΣc = (K−1c +Bc)−1, and µc = ΣcBcyc. HereBc is a diagonal matrix
with entries [Bc]i,i = ϕi,cσ2 . Thus the log-likelihood for a particular latent
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function fc, assuming we have optimal assignments ϕ, is
LMc = −
1
2
yTΣ−1c y −
1
2
ln |Σk| − N
2
ln 2π.
The second and third parts ofLKL were derived in (Hensman et al., 2015)
as
LMP = ln
∫
exp{Eq(Z) [ln p(Z|V )]}p(V )dV
= ln
C∏
c=1
(
Γ(ϕˆc + 1)Γ(ϕ˜c + α)α
Γ(ϕˆc + ϕ˜c + α+ 1)
)
and
LH = −Eq(Z) [ln q(Z)] .
For optimising variational mixture assignment parameters we follow
(Hensman et al., 2012), and use natural gradient descent. For hyperparameters
of the kernels, as well as the variance parameter σ2 of the model, we perform
gradient descent.
If we know ∂LKL∂ϕ we can calculate the natural gradient by equation (22)
in (Hensman et al., 2015). The gradients ∂LMP∂ϕ and
∂LH
∂ϕ were derived in
(Hensman et al., 2015), the only unknown part is ∂LM∂ϕ .
We then use the identity ∂L
M
k
∂ϕn,i
= 12Tr
(
∂LMc
∂B−1c
· ∂B−1c∂ϕn,i
)
. Here ∂L
M
c
∂B−1c
= ααT−
(Kc +B
−1
c )
−1, and the matrix ∂B
−1
c
∂ϕn,i
will be zero everywhere, except in the
diagonal element (n, n)where it will be −σ2
ϕ2n,i
.
Using the chain rule, we can calculate log-likelihood gradients of the
model hyperparameters for any covariance function, since we know ∂Kc∂θ ,
resulting in a very general and modular framework. We only need ∂LKL∂Kc =
∂LMc
∂B−1c
= αcα
T
c − (Kc +B−1c )−1. In the case of the model variance σ2 we have
∂LM
∂σ2
=
∑
k
1
2Tr
(
∂LMc
∂B−1c
· ∂B−1c
∂σ2
)
where ∂B
−1
c
∂σ2
will be a diagonal matrix with
1
ϕi,c
on element (i, i) for all i.
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4.14 Downstream analysis of GPfates results
After using our modeling strategy to learn key parameters, several analysis
tasks can be solved. Here we list some some tasks we have investigated
using the results.
4.14.1 Ranking genes by bifurcation Once the OMGP model has been fit-
ted, it can be used to investigate individual genes in terms of their bifurcating
trajectory.
The log-likelihood of the OMGP model depends on the covariance ma-
trices Kt = {Kct , c = 1, . . . , C}, the variational mixture parameter matrix
ϕ, and the N observations (t,X). Let us assume that we have mixture pa-
rameters ϕb which have been found to distinguish a bifurcating trend based
on some X response variables. We can now keep the fitted parameters
and evaluate the marginal likelihood of a model where the response vari-
ables X are replaced by gene expression values yg. We call this new model
Hbifurcating. We wish to find genes which fit this bifurcating model better
than a model where there is no bifurcation. To this end, we make a third
modelHnot bifurcating identical to the previous one, except we replace ϕb with
ambiguous assignments ϕa (where probability is 1C for every data point).
To asses whether a given gene g is better described by the bifurcating or the
not bifurcating model, we evaluate the Bayes factor:
BFg = log p(yg|Hbifurcating)− log p(yg|Hnot bifurcating).
We refer to this ratio as the bifurcation statistic.
To estimate p-values, we used a permutation approachwherewe perform
the same analysis for every gene g, except with permuted t values to estimate
a null distribution.
As a proxy for effect size of bifurcation, we consider how well the ex-
pression values of a gene correlate with the trend assignments to a latent
function. Strong positive correlation will mean the gene is particularly up-
regulated in the cells unambiguously belonging to the trend. Conversely,
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a strong negative correlation indicates the gene is down-regulated in the
strongly assigned cells compared to all cells.
4.14.2 Inferring the bifurcation time point It is possible to qualitatively
appreciate from theGP assignment probability (ϕc ) for each trajectory (fc(t))
of theOMGPmodel, which cells are ambiguous andwhich cells are exclusive to
individual GP’s. In the case of two trends, ambiguous cells have assignment
probability (ϕ) close to 12 . A model where the data can be described by two
trends, but not by one, will have a higher likelihood. Similarly, if only a region
of the ϕ parameters over time are replaced by ambiguous cell assignment
values, the new model will have a lower likelihood.
For the sake of clarity, we make the assumption that the OMGP will
begin as ambiguous, and then become less ambiguous over time, splitting
into two trends, in this special case. To investigate these cases, we pick a
time-point tb in an OMGP, then replace all ϕ values prior to tb with 0.5. We
define this new ϕ as ϕ>tb :
[ϕ>tb ]i,c = 0.5 ti < tb
[ϕ>tb ]i,c = ϕi,k ti ≥ tb.
Now we can evaluate the model likelihood for this particular tb and define
Ltb = LKL(ϕ>tb ,Kt, σ2|X,T ).
This procedure is repeated for multiple t’s over the predictor variable of
the OMGP model. In our implementation, we consider 30 evenly spaced
bins by default, which has given enough resolution for the data investigated
(though the number of bins can easily be changed).
The likelihood has to decrease by definition. However, after the true
bifurcation the decrease is much more pronounced. We use a break-point
heuristic to detect this elbow, which is indicative of the bifurcation time.
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Fig. 4.8 Inferring bifurcation point. The plot illustrates how different points along the
pseudotime are sampled. Ambiguous assignment probabilities replace trained assignment
probabilities in the observations earlier than the sampled points. The breakpoint model
identies the points where a decrease in likelihood differences becomes more extreme.
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To identify the region at which the likelihood decreases more rapidly,
we fit a piece-wise linear curve to the log-likelihoods, defined by
Ltb = k1 · t+ c1 t < tb
Ltb = k2 · t+ (k1 − k2) · p+ c1 t ≥ tb
This curve consists of two linear pieces, broken up at the point p. When the
curve is fitted, we consider the break-point p to be the point after which we
can be confident that a bifurcation has occurred, see Fig 4.8.
4.15 Limitations of the GPfates model
The models we have described here are implemented with the aim of de-
scribing a cellular trajectory and decomposing parallel trends. Using the
Gaussian Process framework we can ask any given question while at the
same time considering known information about our experimental data,
such as collection time.
We have found this strategy to be powerful but it is not perfect and there
are many avenues for potential future improvement.
A more biologically appropriate view of the problem of cellular bifurca-
tion would potentially be a tree-based model, with an explicit branch time
encoded in the model. The computational gain from the mixture model
used here should not be underestimated; an explicit branch point would
require either sampling or global optimisation strategies for inference, which
is much slower than gradient based optimisation.
Throughout we have used regular Gaussian likelihoods for our mod-
els, despite empirically knowing that this is not entirely appropriate. On
the count level the data appears negative binomial distributed, with mean-
variance coupling and many zero-counts. Here we have used log scaled
relative expression values, log (TPM+ 1), and it is not clear how the un-
derlying count distribution affects this. Potential future work could extend
these methods in scalable ways to non-Gaussian likelihoods.
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The likelihood is also limited in that we assume expression values in the
log TPM unit have Gaussian noise in the absence of dropouts. While this
seems to hold true empirically, perhaps a count based likelihood such as
Poisson would be more appropriate for scRNA-seq data.
With regards to the full method, we should point out that here we are
doing two steps of inference. First we infer pseudotime, with uncertainty.
Then we treat the pseudotime as known truth in the mixture model. This
could be improved by either propagating the uncertainty in pseudotime into
the mixture model, or by setting up a joint model which learns pseudotime
and mixture simultaneously. (An “Overlapping Mixture of GPLVMs” if you
will).
When performing pseudotime inference, in this work we are using priors
on the variational parameters rather than the latent parameters the varia-
tional distributions are estimating. A way to improve the model would be to
implement the priors on the latent variables, and then learn the variational
posterior given these priors.
4.16 Implementation and combination with existing workflows
4.16.1 Integration of alternative methods We have presented the use of
the GPfatesmethod when pseudotime or low-dimensional representations
have been based on the GPLVM. This is because the OMGP follows from
this framework, and the statistical assumptions are consistent between the
models.
In practice, other methods for inferring pseudotime or low-dimensional
representations could also be considered. Here we briefly outline possible
strategies for applications of GPfates downstream of popular single-cell
analysis methods.
Recall that to perform the GPfates inference, we need pseudotime t and
some representation of transcriptomic state X . These variables can be set as
the output from other methods.
In Monocle (Trapnell et al., 2014), the low-dimensional representationX
is found by independent component analysis, and the pseudotime t for each
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Fig. 4.9 OMGP is compatible with e.g. Wanderlust and Monocle, as demonstrated with a
toy data set.
cell is defined by the path distance to a starting cell through a minimum
spanning tree in the coordinates of X .
In Wanderlust (Bendall et al., 2014), a heuristic is used to build a stable k
Nearest Neighbor (kNN) graph of the data in the high-dimensional space
of protein measurements. The pseudotime t for a cell is then defined as the
average shortest path from a known starting cell through the kNN graph.
For CyTOF data, which Wanderlust is designed for, only up to 40 analytes
can be measured at once, so it could be feasible to take X to be the original
expression matrix (Y in our notation).
Another dimensionality reduction technique which has been used for
single cell RNA seq data is Diffusion Maps (Haghverdi et al., 2015). Here
X is a spectral embedding of the data manifold, based on the Laplace op-
erator. It has been pointed out that these embeddings preserve branching
structure in the data. Taking the pseudotime t as the Diffusion Pseudotime
(Haghverdi et al., 2016), which is a surprisingly effective approximation
of geodesic distance over the data manifold (from a known starting cell),
GPfates modelling could be used downstream to quantify the branching
structure of the data. We list alternative compatible pseudotime methods in
table 4.1.
As a demonstration, we generated a toy data set with three branches
and extracted the pseudotime using both the Monocle method and the
Wanderlust method. We then fitted an OMGP model with C = 3 on the
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output. The results can be seen in Fig 4.9, which illustrates the correct
identification of the branching processes for either input.
4.17 Assessment of GPfates on simulated and real data
4.17.1 Sample-size robustness analysis Our full analysis consists of sev-
eral independent consecutive steps: in the GPfatesmethod we are i) finding
a low-dimensional representation, ii) smoothing the data over a pseudotime,
and iii) finding a trend mixture model. After this we perform downstream
analysis where we are iv) identifying the end states and bifurcation.
Howmuch data dowe need to accurately reconstruct trends from all four
of the above steps, and how much data is needed for individual steps? We
investigated both how stable the full procedure is, as well as the individual
steps, by re-running it on sub-sampled datasets with fewer cells than the
entire dataset.
To measure the stability of the methods, we consider absolute Pearson
correlation of the parameters inferred for sub-sampled data relative to the
results obtained from performing the analysis on the full data set.
We found that recovering a low-dimensional representation is extremely
stable with respect to the number of cells (Figure. 4.10), with almost perfect
correlations between analysis of the sub-sampled data and the original
GPLVM values. (For example, the lowest absolute Pearson correlation for a
run with 50 cells was 0.96). Similarly, the pseudotime inference is also very
stable to sub-sampling.
Finding the entire OMGP mixture model over pseudotime requires a
larger number of cells. We do not see any higher degrees of consistency until
we reach 150 sub-sampled cells, with correlations around 0.5. It is rare to
see single cell studies with so few cells, and in the study accompanying this
text we had many more cells (N = 408). Identifying only the end states is
rather robust (but in many cases might be best analysed as a cluster problem
rather than a continuous value problem), where we start seeing a correlation
of 0.9 at 150 cells.
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Fig. 4.10 Robustness of analysis steps by subsampling. Parameters inferred from a
subsample of the data are compared to parameters inferred using the full data. The top
panel indicates this analysis for independent steps assuming the previous step is known.
The lower panel shows the result when running the workflow from start to end.
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Fig. 4.11 Analysis with left out data. Complete reanalysis of our T-cell data excluding
cells cellected at day 4. The bifurcation point is identified as being between Day 3 and
Day 7, and is not forced into either of the days.
The individual steps were in general very stable to sub-sampling, relative
to the “gold standard” of using the full data set. When running the entire
procedure, we see that smaller errors early on in the analysis will propagate
and affect later steps.
4.17.2 Predicted bifurcation time is not biased by col lection times We
consider the risk that the identified bifurcation point in the CD4+ T cell
data potentially just reflects the time points at which we have collected
data. We test the robustness of the prediction of the bifurcation as having
happened at Day 4 by re-running the analysis after removing cells collected
at Day 4. In this analysis we find that the bifurcation happens at some point
between Day 3 and Day 7 where we do not have any observed cells. The
alternate hypothesis would have been that the bifurcation would be found
in either Day 3 or Day 7. This provides confidence both in the bifurcation
point identification and, more generally, in the meaningfulness of the low-
dimensional GPLVM representation of the data (Fig. 4.11).
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Fig. 4.12 Detecting the number of branches. Attempts detecting number of trends
with OMGP. Simulated data with expected numbers of trends (1 to 4 from top to second
from bmottom) were fitted with OMGP, where the C cutoff was set to a range of values
(rightmost column). Point clouds were drawn by hand and randomized. Malaria time
course data added in final row for reference.
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4.17.3 Assessment of the abi l ity to select the number of trends in
OMGP In principle, the marginal log likelihood of the OMGPmodel should
let us select the C number of trends which optimally explain the data. We
investigated this by generating four synthetic data sets with between one and
four underlying trends. For each of the data sets, we fitted OMGP models
with the number of trends C varying from 1 to 9 (three times per C value).
We found that the marginal likelihood of the models corresponded to the
correct number of trends in the cases of 3 and 4 ground truth trends, but
not for the 1-trend and 2-trend synthetic data. For 1 trend, the likelihood
was lowest for a larger number of trends, and for 2 trends, the likelihood
was very similar for 2 and 3 trends. This suggests that the OMGP may
have a tendency to overestimate the number of trends if there is a single
progression (Fig. 4.12).
For our CD4+ T cell data, we found that the marginal likelihood contin-
uously increased with the number C. We elected to keep the model simple
and made the assumption that we could sufficiently explain the data with
C = 2.
It is possible that the optimal likelihood forC is notwell definedwhenwe
have trends branching off from a common trend. In the original application
of the OMGP model, the assumption is that the trends will be completely
independent of each other. As we are already to some extent failing to fit
two models in the ambiguous case, this might cause the likelihood to reflect
a poor fit. For quantitatively determining the number of trends in the data,
further work is needed, probably with a model which explicitly considers
branching from a common original trend. The marginal likelihood of the
model is an indication, but the choice of C should also reflect the biological
system under consideration.
4.17.4 Comparison of pseudotime inference with and without priors
For the 1-dimensional Bayesian GPLVM, which we use to find the pseudo-
time of the data, we put priors on the cells based on their known time points.
This is not strictly necessary, but helps to enhance interpretability as there
is intrinsic invariance to the inferred values. If we do not use priors, quali-
4.17 99
Fig. 4.13 Comparison of pseudotime with and without per-cell priors. The upper
left shows the fit of the pseudotime predicted into the 2D GPLVM with and without
priors. Below are the corresponding inferred covariance matrices. The right plot shows
the relations between the two versions of pseudotime, clearly indicating that they have
an approximate one-to-one mapping.
tatively, the same trajectory is identified. Additionally, comparing the two
versions of pseudotime against each other, we see that they correspond to a
circular shift relative to each other. The covariance matrices inferred using
either strategy have a very similar block structure (also by low Frobenius
norm of difference) indicating that neighbor relations are consistent (Figure.
4.13).
4.17.5 Assessment of pseudotime uncertainty As pointed out in (Camp-
bell and Yau, 2015), we can use the posterior distribution of pseudotime
from the Bayesian GPLVM to assess how meaningful the ordering is. By
investigating the confidence intervals of the pseudotime for each cell com-
pared to neighboring cells, we see that the ordering is quite meaningful (few
cells overlap in confidence interval). (Figure. 4.14)
We also investigated how the confidence of the pseudotime depends on
the number of cells observed. As the number of observed cells increases,
the distribution of variance per cell decreases towards zero. (Figure. 4.14)
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Fig. 4.14 Investigation of uncertainty of inferred pseudotimes. Left panel, since the
Bayesian GPLVM fits the variance of the pseudotime for each cell, we can compare the
assignments with each other. The bars correspond to 95% confidence intervals. On the
right panel we see how the lengths of the confidence intervals globally decrease as the
number of cells used increases.
4.17.6 Stabi l ity of the circular shape of the GPLVM representation We
wanted to rule out the possibility that the latent variable representations
of data which appear circular might be artifacts due to random noise, as
suggested by (Diaconis et al., 2008). To make sure this was not the case for
our CD4+ T cell data, we removed two ‘slices’ of cells from the circular 2D
GPLVM pattern. Following this, we fitted a new GPLVM with this reduced
data set. After optimizing the GPLVM, a representation was found which
was again missing the same slices, Figure. 4.15A. This control experiment
strongly suggests that the GPLVM learns the actual topology of the data.
4.17.7 Assessing the accuracy of imputing virtual cel ls Unlike many
other dimensionality reduction techniques, the GPLVM creates a model
which maps into the high dimensional observed space. It is, however, not
clear how meaningful this representation is. We assessed this by taking the
“slice-less” model described above, and in the empty areas corresponding
to the removed cells, predicting “virtual cells” (Figure 4.15A). Using an
independent clustering technique, t-SNE (Van derMaaten andHinton, 2008),
on both the left out slices of cells and the predicted virtual cells, we find that
single cell transcriptomes predicted from a given slice coincide with the real
cells from the corresponding slice (Figure. 4.15). This indicates that GPLVM
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Fig. 4.15 Stability of GPLVM representation, and prediction through GPLVM. Top row:
Predicting cells from regions of higher similarity with left out real cells from corresponding
regions than non-corresponding regions. Bottom row: Predicting cells from unobserved
regions potentially identifies antagonizing gene combinations.
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prediction into high-dimensional spaces is not simply producing overfitted
results.
Following on from this, we investigated the “hole” in our CD4+ T cell
data. We create a number of virtual cells from the hole region and investigate
which genes would be expressed in these cells compared to genes expressed
in all cells (Figure. 4.15C). The underlying reasons for data being non-linear
is that particular combinations of gene expression patterns do not occur
together. If we find genes which are highly expressed in the virtual cells but
are not observed at the same time in actual cells, this might indicate that
they are incompatible with each other. This might be a good complementary
tool for generating hypotheses about regulation. For instance, we identified
the genes Hspe1 and Gm29216 which would be co-expressed in the hole,
but are generally not co-expressed in observed cells (Figure. 4.15D).
4.18 Validating the BGPLVM and OMGP approach by application to other
data sets
In order to further corroborate our analysis approach, we considered two
recently published single cell data sets produced to investigate progression
of single cells in two developmental contexts: murine fetal lung and human
fetal primordial germ cells. In addition to that, we analyzed a third RNA-seq
study that examines the development of frog embryos in a high temporal
resolution.
4.18.1 Analysis of lung development data We downloaded the data from
(Treutlein et al., 2014) and quantified the expression using Salmon. To
smooth the data over pseudotime, we found genes that vary over the a
priori known time points by a likelihood ratio test of an ANOVA model
of the time points. The expression values for the top varying genes were
run on a GPLVM. One of the factors of the optimized GPLVM was used as
pseudotime, and the top two factors of the GPLVM were used to represent
the entire data set. An OMGP was then optimized on this low-dimensional
representation to identify the two trends corresponding to the AT1 and AT2
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Fig. 4.16 Summary of GPfates result of Treutlein et al. (2014) developing lung data.
lung cell lineages without prior annotation. The bifurcation statistic for all
expressed genes in these cells reconstituted many of the genes identified in
a largely manual manner by (Treutlein et al., 2014).
4.18.2 Analysis of human primordial germ cel l data The data from (Guo
et al., 2015) was downloaded and quantified with Salmon as with the other
data, but with an index based on the human transcriptome: Ensembl 78
annotationa of GRCh38, together with ERCC sequences and human specific
repeats from RepBase. To smooth the time course data, we used a likelihood
ratio test to find the top genes which were described linearly along the time
points in the data. The expression of these genes were then used to fit a
GPLVM. This low-dimensional representation of the data was then used to
fit an OMGP, taking one of the latent factors as pseudotime.
In this data set, the ground truth about the sex of the cells is known,
and thus we could have used a supervised approach such as GPTwoSample
(Stegle et al., 2010) or DETime (Yang et al., 2016). Interestingly, the OMGP
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model identifies the split between male and female cells in an unsupervised
fashion.
We applied the bifurcation statistic test to identify genes that follow the
male and female development differently.
Unlike in the case of the lung development data, the majority of the
genes we identify are not discussed in the original study. In the original
study, the authors focused on genes specific to given conditions (e.g. Male
PGC’s fromweek 11 compared to all other cells). In our analysis, we consider
the dynamics of gene expression over development. We find that in the
male branch, the GAGE family is highly upregulated over development.
Additionally we find the Y-linked gene ENSG00000279950. Also among the
top male hits is RHOXF2, a gene linked to male reproduction (Niu et al.,
2011). Interestingly, further down the list we also find PIWIL4, a gene with
function in development and maintenance of germline stem cells (Sasaki
et al., 2003). On the female side, the top hit is MDK, a gene involved in fetal
adrenal gland development (by similariry: UniProtKB P21741). Other top
hits include MEIOB, a meiosis related gene, and the satellite repeat GSATII.
Surprisingly, we also see upregulation of SPATA22, a gene associated with
spermatogenesis. In conclusion, many of the identified genes are plausible
candidates for sex-specific genes.
4.18.3 Analysis of frog development data As a form of negative control,
we subjected the data from (Owens et al., 2016) to our bifurcating analysis.
This is data from a high resolution time course of developing frog embryos.
RNA-sequencing is done using material from the entire embryo, so no
biological bifurcation should occur during the development. It should be
noted that frog embryos have much more RNA than single cells, so the data
is less noisy than single-cell RNA-seq samples.
Expression was quantified with Salmon, and the expression table was
read in with ERCC’s removed. All expressed genes were used to find a
low-dimensional representation and a pseudotime was found using 8,000
genes which were linearly differentially expressed over the time course.
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Fig. 4.17 Summary of GPfates result of Guo et al. (2015) developing primordial germ cell
data.
The pseudotime corresponded extremely well with the real time point
ordering. And in this data set, almost all expression variability can be
explained by the time course. Still we trained the OMGP model on the 2D
Bayesian GPLVM representation of the data.
No strong bifurcation is detected, and thus we skipped gene bifurcation
analysis. The single-trend model explains the data well. Some heterogeneity
can be seen in the early part of the time course. This might suggest that
expression is somewhat noisy in extremely early embryos, but not in a way
that indicates discrete cell populations.
4.19 Comparison to other pseudotime and bifurcation methods
We compared GPfateswith various methods inferring pseudotime and bi-
furcation events: Wishbone (Setty et al., 2016), Monocle22, Diffusion Pseu-
dotime (Haghverdi et al., 2016), SCUBA (Marco et al., 2014) and Mpath
2http://cole-trapnell-lab.github.io/monocle-release/articles/v2.0.0/
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Fig. 4.18 Summary of GPfates result of Owens et al. (2016) developing frog embryo data.
(Chen et al., 2016). We applied the methods to our data and different public
developmental data sets mentioned earlier. Note that the developmental
embryonic frog data was treated as a negative control to investigate if meth-
ods are able to detect false positives, i.e. identifying branches when they do
not exist.
The results are summarized in Fig. 4.19 through 4.22. In order to vali-
date the approaches, we counted the number of bifurcation events for each
method in each data set and compared it to the expected number of bifurca-
tions (Table 4.2).
Furthermore, we assessed the accuracy of a method by calculating Spear-
man’s rank correlation between the inferred pseudotime and the real time
in a given data set (Figure 4.23). For this analysis only Wishbone, Monocle2
and DPT could be considered as the SCUBA and Mpath tools do not report
an inferred pseudotime which can be parsed.
Monocle2 andGPLVMperform similarlywith a high accuracy (> abs(0.80)
Spearman’s correlation) on public data. However, Monocle2 as well as Wish-
bone and DPT failed to assign the correct temporal order with regard to the
malaria infection data. Overall, when applying Wishbone and DPT to the
data sets we achieved poor to moderate accuracy, except for Wishbone per-
forming well on the frog data, and DPT performing well on developmental
lung data.
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Fig. 4.19 Output of bifurcation methods applied to malaria data. (A) Wishbone
results showing the branching structure colored by time points (left) and inferred branches
(right). (B) Minimum spanning tree on cells generated by Monocle2. Cells are colored
by time points (left) and inferred cell states (right). (C) Visualisation of diffusion maps
in DPT colored by time points (left) and inferred branches (right). (D) Lineage tree by
SCUBA reports no bifurcation. Sizes of bubbles are according to number of cells. (E)
MPath’s minimum spanning tree: First number corresponds to the collection time, second
number corresponds to the landmark cluster. (F) GPfates trajectory, colored by time
points.
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Fig. 4.20 Output of bifurcation methods applied to lung data. AT2 and E18.5 cells
are expected to occur in one branch. (A) Wishbone’s branching structure. Cells are
colored by time points (left) and inferred branches (right). (B) Minimum spanning tree
generated by Monocle2. Cells are colored by time points (left) and inferred cell states
(right). (C) Visualization of diffusion maps in DPT colored by time points (left) and inferred
branches (right). (D) Lineage tree by SCUBA: Sizes of bubbles are according to number
of cells. (E) MPath’s minimum spanning tree: First number corresponds to the collection
time, second number corresponds to the landmark cluster. (F) GPfates trajectory, colored
by time points.
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Fig. 4.21 Output of bifurcation methods applied to primordial germ cell data. Bifur-
cation event is expected to split female and male cells. (A) Wishbone results colored by
time points (left), sex (middle) and inferred branches (right). (B) Monocle2 results colored
by time points (left), sex (middle) and inferred cell states (right). (C) DPT results colored
by time points (left), sex (middle) and inferred branches (right). (D) SCUBA result: Sizes
of bubbles are according to number of cells. (E) MPath result: First number corresponds
to the collection time, second number corresponds to the landmark cluster. (F) GPfates
trajectory, colored by time points. Squares corresponds to male, triangles to female cells.
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Fig. 4.22 Output of bifurcation methods applied to developing frog data. Treated
as a negative control, no branching events should be reported. Please note, Mpath
failed to model on developmental frog data. (A) Wishbone results colored by time points
(left) and inferred branches (right). (B) Monocle2 results colored by time points (left)
and inferred cell states (right). (C) DPT results colored by time points (left) and inferred
branches (right). (D) SCUBA result: Sizes of bubbles are according to number of cells. (E)
GPfates trajectory, colored by time points.
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Lung (Treutlein et. al., 2016)
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PGC (Guo et. al, 2015)
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Fig. 4.23 Accuracy of bifurcation methods. Spearman’s rank correlation was calculated
by comparing the real time and the inferred pseudotime.
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Concerning the bifurcation event in developing lung data, most of the
methods cluster AT2 and E18.5 cells into one branch which has been con-
firmed in a previous study (Treutlein et al., 2014). However, in primordial
germ cell data none of the published methods were able to detect branching
events between male and female cells. With regard to the frog embryonic
development study, only SCUBA reflects the non-branching structure of the
data. All other public methods report a branching point.
4.20 Discussion
We have demonstrated the applicability of our GPfatesmethod, where we
use latent variable modeling to infer temporal expression dynamics, and
Gaussian process mixture modeling for identifying diverging global trends.
The method has been investigated in terms of robustness and applied to
several simulated and real data sets showing good results.
Of course there is no single silver bullet that is able to deal with these
sorts of problems, and it would not be surprising if other methods than the
ones we have tested work better for some biological systems. Nevertheless,
we have illustrated that the main component, the Gaussian process mixture
modeling, is compatible with other methods in these cases.
A benefit from the methods we use is that diagnostics such as marginal
likelihood can be used to aid the user in choosing models. Still, the user will
need to keep the biological system in mind and be critical of results.
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Chapter5
Detecting spatially dependent genes in spatial expression
assays
Technological advances have enabled low-input RNA-sequencing, paving
the way for assaying transcriptome variation in spatial contexts, including
in tissue systems. While the generation of spatially resolved transcriptome
maps is increasingly feasible, computational methods for analysing the
resulting data are not established. Existing analysis strategies either ignore
the spatial component of gene expression variation, or require discretization.
To address this, we have developed SpatialDE, a computational framework
for identifying and characterizing spatially variable genes. Our method gen-
eralises variable gene selection, as used in population- and single-cell studies,
to spatial expression profiles. We apply SpatialDE to Spatial Transcriptomics
and to data from single cells expression profiles using multiplexed In Situ
Hybridisation (SeqFISH and MERFISH), demonstrating its general use. Spa-
tialDE identifies genes with expression patterns that are associated with
histology in breast cancer tissue, several of which have known disease im-
plications and are not detected by variable gene selection. Additionally, our
model can be used to classify genes with distinct spatial patterns, including
periodic expression profiles, linear trends and general spatial variation.
This chapter takes the concepts introduced in Chapter 3 and reworks
them in a spatial context, rather than a temporal. Here we also formalize
the statistics of the significance test, and provide computational speedups.
The analysis in Chapters 3 and 4 had to be run on hundreds of compute
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nodes to finish within reasonable time frames. In the work presented in this
chapter the analyses were reproduced in just a few minutes, on a standard
desktop computer.
First we present the motivation and results of our analysis of public data
using our method. Following this, we present the model in detail.
5.1 Results
Technological advances have helped tominiaturize and parallelize genomics,
thereby enabling high-throughput transcriptome profiling from low quanti-
ties of starting material, including in single cells. Increased experimental
throughput has also led to new experimental designs, where the spatial
context of gene expression variation can now be assayed directly. This is
critical for decoding complex tissues from multicellular organisms. The
spatial context of gene expression is crucial in determining the functions
and phenotypes of cells (Ledford, 2017; Lee, 2017). In many cases a gene’s
expression is determined by cellular communication and in other cases cells
migrate to specific locations in tissue to perform their functions.
Several experimental methods tomeasure gene expression levels in a spa-
tial context have been established, which differ in resolution, accuracy and
throughput. These include the computational assignment of transcriptome-
profiles from dissociated cells to a spatial reference (Achim et al., 2015; Satija
et al., 2015), parallel profiling of mRNA using barcodes on a grid of known
spatial locations (Chen et al., 2017; Junker et al., 2014; Ståhl et al., 2016), and
methods based on multiplexed in situ hybridization (Moffitt et al., 2016;
Shah et al., 2016) or sequencing (Ke et al., 2013; Lee et al., 2015, 2014).
A first critical step in the analysis of the resulting datasets is to identify
the genes that exhibit spatial variation across the tissue. However, existing
approaches designed to identify highly variable genes (Brennecke et al.,
2013; Vallejos et al., 2015), in e.g. single-cell RNA-sequencing (scRNA-seq)
studies, ignore the spatial location and do not measure spatial variability.
Alternatively, researchers have applied ANOVA to test for differential expres-
sion between groups of cells, either derived using a priori defined (discrete)
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cell annotations or based on clustering (Achim et al., 2015; Ke et al., 2013;
Satija et al., 2015; Shah et al., 2016; Ståhl et al., 2016), with some clustering
strategies incorporating spatial information (Pettit et al., 2014). Importantly,
such strategies are unable to detect variation that is not well captured by
discrete groups, including linear and nonlinear trends, periodic expression
patterns and other complex patterns of expression variation.
To address this, we propose a computational approach termed SpatialDE
for identifying and characterizing spatially variable genes (SV genes). Our
method builds on Gaussian Process Regression, a class of models that is
widely used in geostatistics, also known as Kriging (Williams and Ras-
mussen, 2006). For each gene, our model decomposes the expression vari-
ability into a spatial and non-spatial component (Figure 5.1A). Significant
SV genes can then be identified by comparing this full model to a model
that assumes no spatial dependency of expression variation (Figure 5.1B,
Methods).
In addition to identifying spatially variable genes, SpatialDE also allows
to classify the spatial patterns of individual genes, differentiating between
linear trends, periodic expression profiles or general spatial dependencies
(Figure 5.1B). By interpreting the fitted model parameters it is possible to
identify the length scale (the expected number of changes directional in a
unit interval (Williams and Rasmussen, 2006)) or the period length of spatial
patterns for individual genes (Figure 5.1B). Finally, SpatialDE achieves un-
precedented computational efficiency by leveraging computational tricks for
efficient inference in linear mixed models (Lippert et al., 2011) and precom-
puting operations where possible (Figure 5.1C). Taken together, SpatialDE
is a widely applicable tool for the initial analysis of spatial transcriptomics
datasets.
First, we applied our method to Spatial Transcriptomics (ST) data from
breast cancer tissue (Ståhl et al., 2016). Briefly, ST gene expression levels are
derived from thin tissue sections of frozen material, placed on an array with
poly(dT) probes and spatially resolved DNA barcodes in a grid of “spots”.
Following permeabilization, the mRNA is captured by the probes, and the
spatial location can be recovered from sequenced barcodes. The resulting
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Fig. 5.1 Overview of SpatialDE for the identification of spatially variable genes
(A) In spatial gene expression studies, expression levels vary in ways that depend on
spatial coordinates. SpatialDE defines spatial dependence for a given gene using a
non-parametric approach, testing whether gene expression levels at different locations
covary in a manner that depends on their relative location. (B) SpatialDE partitions the
expression variation into a spatial component (using functional dependencies f((x1, x2))),
characterized by alternative spatial covariances, and observation noise (Ψ). Alternative
spatial covariance models considered by SpatialDE: no spatial effect (null model), general
spatial, periodic spatial patterns and linear trends. Example expression patterns with
the covariances plotted below corresponding matrix. (C) Computational efficiency of
SpatialDE compared to a Stan implementation of the same model. Caching operations
and linear algebra speedups are used where possible, enabling genome-wide analyses
with thousands of samples. Benchmarks performed on a late 2013 iMac with 3.2 GHz
Intel Core i5 processor.
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gene expression profiles can be analysed in the context of hematoxylin and
eosin (HE) stained microscopic images of the tissue (Figure 5.2A).
SpatialDE identified 115 SV genes (FDR < 0.05). Notably, seven highly
ranking genes were also included in a set of 14 genes with known roles in
the disease that were highlighted in the primary analysis of the data (Figure
5.2C, red text). Significantly SV genes were enriched for collagens, which
distinguish tissue substructure (Seewaldt, 2012) (Reactome term “Collagen
formation”, P < 5 * 10-14 using gProfiler (Reimand et al., 2016)). Additionally,
we identified the autophagy related gene, TP53INP2, surrounding the fatty
tissue (q-value = 0.022, Figure 5.2B, extended examples Figure D.1). Interest-
ingly, the set of SV genes also included the cytokines CXCL9 (q-value = 5.4 *
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Fig. 5.2 Applications of SpatialDE to Spatial Transcriptomics and data generated
using SeqFISH. (A) Correlated image of breast cancer tissue from Spatial Transcriptomics
(Ståhl et al., 2016). (B) Visualization of nine selected spatially variable genes (out of
115, FDR < 0.05). The black scale bar corresponds to 1 mm. For genes identified with
periodic dependencies, the orange bar shows the fitted period length on the same scale.
Analogously, the blue bar shows the fitted length scale for genes with general spatial
trends. 2D plots show the relative expression level for genes across the tissue section
coded in color. Stars next to gene names denote significance levels (* q-value < 0.05
, ** q-value < 0.01, *** q-value < 0.001) of spatial variation. Insets in lower left show
the posterior probability of these three function classes for each gene. (C) Proportion
of variance (x-axis) explained by spatial variation (FSV) versus adj. P-value (y-axis, FDR
adjusted) for 12,856 genes. Dashed line corresponds to the FDR = 0.05 significance
level (N = 115 genes). Genes classified as periodically variable are shown in orange (N
= 22), genes with a general spatial dependency in blue (N = 93). Disease-implicated
genes annotated based on prior knowledge (Ståhl et al., 2016) are indicated with red
labels, and are significantly enriched in SpatialDE results (P = 10−11, Fisher exact test).
Other representative genes selected by stratifying over function periods / length scales
are annotated with black labels. Size of of points indicate certainty in the estimate of
Fraction Spatial Variance (FSV), larger points have smaller standard deviation. The X
symbol show the result of running SpatialDE on the estimated total RNA content per
spot. (D) SeqFISH data from a region of mouse hippocampus from Shah et al (Shah et al.,
2016). Black scale bar correspond to 50 µm, Voronoi tessellation representative of tissue
structure. (E) Expression patterns of six selected SV genes analogous to panel B (out
of 32, FDR < 0.05). Shown are genes with linear (htr3a ), periodic (foxj1 ), and generally
spatial models. Black arrows indicate distinct region of low expression of Mog , Myl14
and Ndnf. (F) Proportion of variance (x-axis) versus adj. P-value (y-axis, FDR adjusted)
for 249 genes, as in (C). Genes with a linear dependency are highlighted in green.
10-4) and CXCL13 (q-value = 1.3 * 10-4), both of which are expressed in a
visually distinct region (Figure 5.2A, black arrow), together with the IL12
receptor subunit gene IL12RB1 (q-value = 2.8 * 10-4), indicating a potential
tumour related immune response in the tissue. Notably, neither of these
genes (and N=29 others), were identified as differentially expressed when
applying clustering in conjunction with an ANOVA test between the iden-
tified groups of cells (Figure D.2). Nor did they have highly ranked based
on conventional Highly Variable Genes measures (such as the mean-CV2
relation (Brennecke et al., 2013) or mean-dropout rate relation (Andrews and
Hemberg, 2016)); measures that do not take the spatial context into account
(Figure D.3). Generally, we observed that SpatialDE is complementary to
existing methods, and is able to find SV genes with localized expression pat-
terns, as indicated by small fitted length scales, or periodic patterns, that are
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not detected by methods that ignore spatial contexts (Figure D.2E). Finally,
we confirmed the statistical calibration and the robustness of SpatialDE using
randomization experiments (Figure D.4).
As a second application, we considered a study of mouse olfactory bulb
(Ståhl et al., 2016), profiled using the same ST protocol. Again, SpatialDE iden-
tified SV genes with clear spatial sub-structure, consistent with the matched
HE stained image (Figure D.5A-B). These included canonical marker genes
highlighted in Stahl et al, such as PENK,DOC2G, andKCTD12, but also addi-
tional genes that define the granule cell layer (GCL) of the bulb. Genes in the
latter set were classified as periodically variable with period lengths corre-
sponding to the distance between the centers of the hemispheres (including
KCNH3, NRGN, or MBP with 1.8 mm period length, Figure D.5). Other
genes with periodic patterns, such as the vesicular glutamate transporter
SLC17A7, were identified with shorter periods (1.1 mm), and inspection
revealed regularly dispersed regions, potentially identifying a pattern with
regions of higher neuron density (Jahn et al., 2000). This suggests that
periodic expression patterns in tissue contexts are a biological feature of
interest.
Taken together, these results demonstrate that SpatialDE can be used
to characterize clinically relevant features in spatial tissue samples in the
absence of a priori histological annotation.
SpatialDE is not limited to sequencing technologies, and can be applied
to any expression datatype with spatial and/or temporal resolution. To
explore this, we applied the method to data generated using multiplexed
single molecule FISH (smFISH), a recent technological development that
allows for quantifying gene expression with subcellular resolution for large
numbers of target genes in parallel. Briefly, probes are hybridized to RNA
while carrying barcodes of fluorophores, which allows for quantifying gene
expression using several thousand probes (Chen et al., 2015) by high-content
imaging.
We applied SpatialDE toMultiplexed smFISHdata frommouse hippocam-
pus, generated using SeqFISH (Shah et al., 2016). This study considered 249
genes that were chosen to investigate the cell type composition along dorsal
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and ventral axes of the hippocampus (Figure 5.2D). SpatialDE identified 32
SV genes (FDR < 0.05), with the three highest ranking genes, MOG (q-value
= 10−14), MYL14, (q-value = 10−14) and NDNF (q-value = 2 · 10−12) display-
ing a distinct region of lower expression (Figure 5.2E, black arrows). Again,
SpatialDE identified genes with different types of spatial variation, including
linear trends (N=5) and periodic patterns (N = 8, Figure 5.2F, extended
examples in Figure D.6).
SpatialDE can also be used to test for spatial expression variation in cell
culture systems, where spatial variation may not be expected a priori. We
explored this, and considered data from another recent multiplexed sm-
FISH dataset generated using MERFISH with 140 probes from a human
osteosarcoma cell culture (Moffitt et al., 2016) (Figure D.7A-B). Interestingly,
the model revealed that a substantial proportion of the genes assayed were
spatially variable (N=92, 65%, FDR < 0.05). This reconstitutes results from
the primary analysis, where the authors noted spatially restricted popula-
tions of cells with higher proliferation rates. Indeed, six of the seven genes
highlighted as differentially expressed between proliferation subpopula-
tions were identified as SV genes (e.g. THBS1 and CENPF1, Figure D.7C).
This result is also consistent with previous studies which observed that
high confluence in cell culture, promoting cell-to-cell communication and
causing crowding, leads to spatial dependency in gene expression (Battich
et al., 2015). We also considered negative control probes in the data, which
were not detected as spatially variable, thereby confirming the statistical
calibration of SpatialDE (Figure D.7D).
5.2 Discussion
Herein, we have presented a method for identifying spatially variable genes.
The commoditization of high-throughput experiments, including spatially
resolved RNA-seq, means that there will be a growing need for methods that
account for this new dimension of expression variation, such as SpatialDE.
We applied our model to data from multiple different protocols, from
Spatial Transcriptomics to multiplexed single-molecule FISH, considering
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both tissue systems and cell lines. The extent of spatial variationwe observed
in cell lines may be surprising, a result that is consistent with recent studies
that have reported coordinated expression changes across neighbouring
cells (Battich et al., 2015). The method is also applicable to temporal data
from time-course experiments (Figure D.8), and it can be applied without
modification to 3-dimensional data from e.g. in situ sequencing when such
technologies mature (Lee et al., 2015, 2014).
SpatialDE generalizes previous approaches for the detection of highly
variable genes, most notably methods designed for conventional scRNA-
seq (Brennecke et al., 2013). Our model separates spatial variation from
non-spatial effects, which may include biological and technical variability.
Underlying this approach is the assumption that technical noise is indepen-
dent across sampling positions, which circumvents the need to explicitly
model technical sources of variation, which enables applications to virtually
any protocol.
Future extension of SpatialDE could be tailored towards specific plat-
forms, for example to make use of spike-in standards or unique molecular
identifiers, thereby explicitly estimating technical variation. Another area
of future work are extensions for incorporating information about the tissue
makeup or local differences in cell density. Our framework also opens up
the possibility for future work to define spatial patterns that are common
to groups of genes, using clustering combined with the spatial Gaussian
Process framework (Hensman et al., 2015).
5.3 The SpatialDE model
SpatialDE builds on the Gaussian process framework which we introduced
in Section 3.12, thereby assessing the evidence that the gene expression
patterns of individual genes are explained by functions with different spatio-
temporal dependencies.
In the following we assume that y = (y1, . . . , yN ) corresponds to a vector
of expression values at N spatial locations X = (x1, . . . ,xN ) for a given
gene. The coordinates of the spatial locations are typically two-dimensional,
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i.e. xi = (xi1 , xi2), however the model is general and can also be applied
to any dimensionality such as three-dimensional or uni-dimensional (e.g.
time-series) data.
5.3.1 Gaussian Processes regression A Gaussian Process (GP) is a proba-
bility distribution over functions y = f(x),
f ∼ GP(k (x,x′ |θ)). (5.1)
AGaussian processmodelHGP is defined by the covariance function k(x,x′ |θ),
which parameterizes the dependency between any pair of function values
based on their inputs x and x′; and θ denotes a vector of additional hyper-
parameters of the covariance (see below).
Any finite representation of a GP for an observed dataset can be obtained
by marginalizing over all unobserved function values, resulting in a finite
realisation of joint Gaussian distribution:
p(y |HGP) = N
(
y
∣∣∣µ1, σ2s · (Σk(x,x′ |θ) + δ · I)) . (5.2)
Here, µ1 account for mean effects (bias term) and the scaling parameter σ2s
determines the proportion of variance explained by the spatial covariance.
The term σ2sδI explains iid observation noise, i.e. variation in the data that
does not follow the spatial pattern.
The covariance matrix is derived by evaluating the covariance function
for all pairs of observed datumsΣk(x,x′ |θ)i,j = k(xi,xj |θ), for which the pa-
rameters θ can be determined using maximum likelihood (see Secion 5.3.4).
θˆ =argmax
θ
LL(HGP,θ) (5.3)
=argmax
θ
log p(y |HGP,θ),
where LL(HGP,θ) denotes the log marginal likelihood.
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5.3.2 Covariance functions To test and compare between alternative hy-
pothesis of spatial variation of expression patterns, we assess GP models
with different covariance functions.
• Null model
knull(x,x
′) ∝ 0
• General spatial pattern (known as the RBF or Gaussian kernel)
kspatial(x,x
′ |θ) ∝ e− 12L2 |x−x′|2
• Linear trend
klin(x,x
′ |θ) ∝ xx′T
• Periodic pattern (known as the cosine kernel)
kperiodic(x,x
′ |θ) ∝ cos(1p |x− x′|)
Interpretation of model parameters
As the scale is parameterized using σ2s in Eq. 5.2, the proportionality factors
do not change the marginal likelihood. However, in order to be able to
interpret the parameter σ2s as the proportion of variance explained we use
Gower’s transformation to correct the σ2s parameter for the structure in the
covariance matrix Σ (Kostem and Eskin, 2013):
g =
Tr(PΣP )
n− 1 ,
where
P = I − 1
n
11T.
This allows for defining the Fraction of Spatial Variance, FSV = σ
2
s ·g
σ2s ·g+σ2s ·δ ,
which corresponds to the proportion of varaince explained by the spatial
variance component compared to the total variance.
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5.3.3 Statist ical s ignif icance and classi f ication of spatial ly variable
genes
P-values from hypothesis testing
Significant spatial variance component are tested via mode comparison:
p(y |H1) = N
(
y
∣∣∣µ1, σ2s · (Σk(x,x′ |θ) + δ · I)) ,
p(y |H0) = N
(
y
∣∣µ1, σ2s · I) .
Here,H1 denotes the alternative model that includes both a spatial and
non-spatial component and H0 denotes the null model, lacking a spatial
variance component.
The parameters of bothmodels are optimised usingmaximum likelihood
(see Section 5.3.4). Significance of the spatial variance component is then
assessed using a likelihood ratio test (LRT) between the alternative and the
null model. P-values can be estimated in closed form, assuming that the log
likelihood ratios (LLRs) under the null model are χ2 distributed with one
degree of freedom.
To correct for multiple testing, we use the FDR based strategy by (Storey
and Tibshirani, 2003) yielding q-values. Unless stated otherwise, we report
genes at q-Value < 0.05 as significant SV genes.
Calibration of the P-values was investigated through negative control
probes in the MERFISH experiment. The fraction of significant negative
control probes behave as expected with regards to the family-wise error rate
(Figure D.7).
Classification of spatial patterns using model comparison
In order to identify interpretable spatial trends, we can compare the spatial
model to alternative models that make stronger assumptions about the
spatial dependency. Specifically, for significant spatially variable genes (e.g.
q-value < 0.05), we compare GP models with alternative prior covariances:
the general spatial model using an RBF kernel, a GP prior with periodic
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covariance function, using the cosine kernel (See Section 5.3.2), and a GP
prior with linear covariance function.
As these models differ in their number of parameters, we employ the
Bayesian Information Criterion (BIC), which has been shown to be effective
for model comparisons of alternative GPmodels (Lloyd et al., 2014). The BIC
penalises themaximum log-likelihood by the number of effective parameters
in the model, thereby accounting for differences in model complexity:
BIC = log(n) ·M − 2 · LˆL.
Here, LˆL denotes the log marginal likelihood (Eq. 5.3),M corresponds to
the number of observations and n denotes the number of hyperparameters
of a given model. Each gene is then classified into different spatial trends by
selecting the GP model that minimises the BIC.
We also use theBIC to estimate posterior probabilities of specificmodels.
Briefly, the BIC is an estimate of− log p(x,y|Hi), which allows for deriving
an approximate form of the marginal likelihood of the modelHi,
p(Hi|X,y) = 1
Z
· p(X,y|Hi) · p(Hi) = 1
Z
·
∫
θ
p(X,y|Hi, θ)dθ ≈ − 1
Z
·BICi,
where
Z =
∑
i
p(X,y|Hi) · p(Hi) ≈
∑
i
−BICi.
We consider the models {Hspatial,Hlinear,Hperiodic} described above (Sec-
tion 5.3.2), deriving posterior probabilities of these models given the data.
5.3.4 Parameter inference Maximum likelihood inference (Eq. 5.3) requires
determining µ, σ2s , δ and, depending on the model, additional hyperpa-
rameters of the selected covariance function (e.g. the length-scale l, see
Section 5.3.2). The log likelihood is
LL(y,X, θ) = −1
2
(n log(2π) + log(|σ2s · (Σℓ + δ · I)|)+
(y − µ)T (σ2s · (Σℓ + δ · I))−1(y − µ)
)
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Evaluation of the likelihood requires inverting the covariance matrix Σℓ
which depends on the parameter ℓ, this makes gradient based optimisation
of ℓ a key bottleneck in inference. We comment on this later, but for now,
assume ℓ is known. To circumvent inverting the entire matrix σ2s · (Σℓ +
δ · I), we follow (Lippert et al., 2011) and factor the matrix Σℓ by spectral
decomposition, USUT = Σ, and noting that UUT = I :
σ2s · (Σℓ + δ · I) = σ2s · (USUT + δ · I) = σ2s · U(S + δ · I)UT
Now if we write the log likelihood as a function of δ, σ2s and µ, we obtain
LL(δ, σ2s , µ) =
= −1
2
(n log(2πσ2s) + log(|Σℓ + δ · I|) +
1
σ2s
(y − µ)T (Σℓ + δ · I)−1(y − µ))
= −1
2
(n log(2πσ2s) + log(|U(S + δI)UT |)
1
σ2s
(y − µ)T (U(S + δ · I)UT )−1(y − µ))
= −1
2
(n log(2πσ2s) + log(|U ||S + δ · I||UT |) +
1
σ2s
(y − µ)TU(S + δI)−1UT (y − µ))
= −1
2
(n log(2πσ2s) + log(|S + δ · I|) +
1
σ2s
((UTy)− (UT 1)µ)T (S + δ · I)−1((UTy)− (UT 1)µ))
= −1
2
(n log(2πσ2s) +
n∑
i=1
log(Si,i + δ) +
1
σ2s
n∑
i=1
([UTy]i − [UT 1]iµ)2
Si,i + δ
)
The key features used is that |U | = |UT | = 1, and S + δ · I is diagonal, so
both the determinant and inverse are trivial to compute. The expression UT 1
only depends on the coordinates X and can be precomputed for every gene.
The expression UTy will need to be re-computed for each gene, however, it
can be re-used for inference evaluations.
We make use of the constraint that for the optimal µ = µˆwe must have
∂LL(δ, σ2s , µ)
∂µ
= 0,
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and so
1
σ2s
((UT 1)T (S + δ · I)−1(UTy)− (UT 1)T (S + δ · I)−1(UT 1)µˆ) = 0
⇒
(UT 1)T (S + δ · I)−1(UT 1)µˆ = (UT 1)T (S + δ · I)−1(UTy)
⇒
µˆ = ((UT 1)T (S + δ · I)−1(UT 1))−1(UT 1)T (S + δ · I)−1(UTy)
=
(
n∑
i=1
1
Si,i + δ
[UT 1]Ti [U
Ty]i
)
/
(
n∑
i=1
1
Si,i + δ
[UT 1]Ti [U
T 1]i
)
.
When data is given, this expression only depends on δ and we write this as
µˆ(δ).
The same procedure for σ2s gives us
σˆ2s(δ) =
1
n
n∑
i=1
([UTy]i − [UT 1]iµˆ(δ))2
Si,i + δ
,
which also depend only on δ. So the entire expression for the log likelihood
can be written as
LL(δ) = −1
2
(n log(2π) + S1(δ) + n+ n log(
1
n
S2(δ))),
S1(δ) =
n∑
i=1
log(Si,i + δ),
S2(δ) =
n∑
i=1
([UTy]i − [UT 1]iµˆ)2
Si,i + δ
.
To optimise LL(δ) with respect to δ we use gradient based optimisation
with l-bfgs-b and numerically approximated gradient. Empirically, we ob-
served that an analytically calculated gradient would require more floating
point operations per iteration step with no gain in performance.
To avoid gradient based optimization of the length scale ℓ, we precal-
culate a grid of covariance matrices Σℓ and factorise them. The number of
grid points can be specified by the user, but our default settings put 10 grid
points logratihmically spaced between half shortest and twice the longest
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distance observed in the data. We have found to give sufficient sensitivity.
After factoring the Σℓ’s, the U and S matrices can be reused for each gene.
We only need to do as many O(n3)matrix inversions as we have grid points.
Each gene under investigation will have a O(n2) step for each grid point to
calculate the UTy factor. All other calculations, including each optimisation
iteration, will be O(n). Since our aim is to investigate data where G >> 10,
this greatly reduces the computational burden, as illustrated in Figure 5.1C.
Estimation of standard errors
The only optimised parameter in our model is δ, the uncertainty of the maxi-
mum likelihood estimate of this parameter is the inverse of ∂
2LL(δ)
∂δ2
evaluated
at δˆ. We use rules of uncertainty propagation to estimate uncertainty of FSV
since this can be expressed as a function of δ,
FSV(δ) = σˆ
2
s(δ) · g
σˆ2s(δ) · g + δ · σˆ2s(δ)
,
where g is the Gower factor for covariance matrix Σℓ for a given grid point.
So, the standard error of FSV is
s2FSV =
(
∂FSV(δ)
∂δ
∣∣∣
δ=δˆ
)2
· s2δ ,
where
s2δ = 1/
(
∂2LL(δ)
∂δ2
∣∣∣
δ=δˆ
)2
.
To evaluate the two derivatives, we use finite difference approximation
on the LL and FSV functions.
5.4 Data normalisation
The presented Gaussian process model is based on the assumption of nor-
mally distributed residual noise and independent observations across cells.
To meet these requirements, we have identified two necessary normalisation
steps.
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A B
Fig. 5.3 Variance stabilization of negative binomial counts. (A) Mean vs variance
relation of genes in the different spatial technologies. Compared to Poisson noise,
variance is higher than expected, and is consistent with negative binomial noise with
a fixed overdispersion parameter per dataset. (B) The same figure after applying the
approximate Anscombe transform for negative binomial data. At moderate to high
counts variance no longer depend on the mean. Note that (A) is on a log-log scale while
(B) is not.
First, both spatial transcriptomics and in-situ hybridisation data pro-
duces counts of transcripts. Spatial Transcriptomics uses Unique Molecular
Identifiers (UMI’s) to count amplified transcript tags from next generation
sequencing reads, while smFISH counts fluorescent probes inside cell bound-
aries. By investigating the mean-variance relation for all genes in multiple
data sets from all spatial technologies we note that the data empirically
correspond to negative binomial (NB) noise (Figure 5.3A).
To stabilise the variance, we use the approximate Anscombe’s transform
for NB data on the observed counts yˆg, yg = log(yˆg + 1ϕ), where ϕ is the
overdispersion parameter, so that Var(y) = E(y) + ϕ · E(y)2, and ϕ is esti-
mated by curve fitting across all genes in a study (Anscombe, 1948) (Figure
5.3B).
Second, we note that in all the data we investigated, every gene’s expres-
sion correlates with the total count in the cells. In particular, for MERFISH
data the area of cells is provided, and we note that the total count correlates
strongly with the cytoplasmic area. This relation has previously been de-
scribed by Padovan-Merhar et al. (2015), who showed that cells compensate
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mRNA content in response to the cytoplasmic volume of a cell. The total
count thus corresponds to the size of cells.
While there are many cases where cells grow for biologically interesting
reasons, cell size assays are easier than gene expression assays, and here we
focus on regulation of gene expression. In particular, if the distribution of
relative cell sizes show spatial dependencies, every gene will be considered
spatially variable.
Consequently, we consider expression levels that are adjusted for vari-
ation in cell size, using linear regression to account for this dependence,
regressing out the log total count from the Anscombe transformed expres-
sion values before fitting the spatial models.
For context, we also perform the spatial variation test on the total count
in each data set. In all data sets the variation is significant, with between 30%
and 80% FSV (results marked as X’s in figures). In the frog development
data, proxies for cell size (ERCC expression and number of genes detected)
are over 95% spatially variable.
Chapter6
Concluding remarks
In this thesis we introduced the history of single cell RNA-sequencing (Chap-
ter 1), technically evaluated the methods (Chapter 2), and investigated how
to use these technologies to study cellular development and differentiation
(Chapters 3-5).
The field of single cell RNA sequencing is starting to mature. In the
beginning it was unclear how representative the measurements were and
it was not known how technical noise affects the measurements. The most
striking result of our initial assessment of the scRNA-seq protocols was
that the measurements are quantitative, and can reflect different levels of
expression are captured with high precision (Chapter 2).
As a consequence, we were comfortable studying systems of continuous
and changing expression levels in cells. Time course analyses are demanding
experiments and would in many cases require artificial in vitro systems. To
avoid this, we have shown how snapshots that capture different stages of a
time series in a single experiment can be very informative. We have looked at
ex vivo data both in the context of blood development and immune responses.
Since the conceptual introduction of the notion of pseudotime to single
cell transcriptomics studies (Trapnell et al., 2014), attempts to learn under-
lying trajectories from single snapshots have become extremely popular.
Pseudotime snapshots can be compared to the introduction of shotgun DNA
sequencing, where small fragments of DNA are sequenced, then recon-
structed computationally to whole chromosomes. One way to think about
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this approach is as a “shotgun time course”. Given the prior expectation that
gene expression follows smooth functions during cellular development, we
used Gaussian process models to study these data. We have used Gaussian
process latent variable models for ordering cells and classifying them with
mixture models, and to analyse individual genes, variations on Gaussian
process regression were employed.
With this strategy, we discovered the underlying patterns of gene expres-
sion as hematopoietic progenitor cells specialize to thrombocytes. Whereas
this system has classically been studied in terms of discrete cell populations,
we found a continuum of differentiation. Intermediate cell types between
progenitors and thrombocytes identifid by our analysis were verified phe-
notypically and by replication experiments. The differentiation continuum
correlated with decreases in general transcription and translation programs
and a steady increase in the expression of functionally important thrombo-
cyte genes (Chapter 3).
We were able to study cellular decision making in the immune system
in the same way. Our analysis strategy allowed us to establish a timeline
of events during the CD4+ T-cell immune response to malaria: Cells 1)
get activated, 2) clonally expand, 3) enter a highly proliferative state, 4)
specialize towards sub-cell type, 5) stop proliferating and undergo terminal
differentiation. These events could be related to real time (days of infection),
and the models we used allowed us to identify genes related to these events
(Chapter 4), in particular relating cell proliferation status to cell fate choice.
The focus of this thesis is the development of methods to allow the
analysis of gene expression over a continuous timeline, reflecting cell dif-
ferentiation or development. Prior work on continuous trends of RNA
expression during cell development or differentiation was limited, which
led us to consider non-parametric regression methods. This has enabled us
to find very general temporal patterns of gene expression.
While we can identify genes which we deem “interesting" these general
models do, however, come with a downside. Followup questions, such
as “when is it activated?", “how quickly does it go down?", “when does
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it peak?", etc, are not possible to answer in other ways than by heuristic
downstream analysis of individual genes.
Questions such as the ones listed above could provide insight into the
expected behavior of temporal expression functions, but only for individual
genes. Recent studies have proposed sigmoidal functions (Campbell and
Yau, 2016) or impulse functions (Sander et al., 2016) as definitive of biolog-
ically meaningful behavior. Our results (chapter 3 and Eckersley-Maslin
et al. (2016) are consistent with the idea of sigmoidal functions. However, in
Chapter 4 a substantial fraction of interesting and important genes follow
transient expression, related to the proliferative status of the cells, consistent
with impulse-like functions.
In our studies however, time was learned from the data using the latent
variable model. This might bias the resolution and uncertainty of the pseu-
dotime for the cells, since the GPLVM only considers a single length scale
for all genes. In our re-analysis of a high resolution whole-transcriptome
time course, the most interesting genes follow functions which are extremely
hard to model in a parametric form. Although the functions were complex,
curves were very reproducible with little observation noise (Figure D.8B,
e.g. cog2, gsn, or hunk). Results from clustering time courses as in Chapter 3
or from inspection of significantly time dependent genes might allow us to
identify parametric forms for the general temporal trends.
When applying the latent variable model to the frog development data,
the learned pseudotime and real time are highly rank correlated. But we can
appreciate variable speed of pseudotime compared to real time, reflecting
more fast-acting transcriptional changes in the early part of development
(Figure 4.23). In ancient greek there are two words for time: “chronos” for
quantitaive time and “kairos” for qualitative time. From the perspective of
the biological system in the frog embryos, real time (chronos) passes faster in
the later part of the time course. “Shotgun time course” experiments might
miss important events on short time scales due to the difficulty of sampling
enough cells to notice a signal for these.
The value of a large number of knownmeasurement to performGaussian
process analysis on was further demonstrated by our analysis of spatial
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expression patterns in Chapter 5. We find clearer signals in this spatial
setting than in pseudotime settings. A fantastic technological development
would be the ability to parallelize time course experiments to match the
data density we see in spatial experiments. Even in an in vitro setting, this
could be valuable for verifying interesting expression patterns that were
discovered from snapshots.
Beyond the ability to answer questions about the properties of trends,
another reason to move to parametric models is the growth of data. Most
of the work discussed in this thesis is based on experiments using older
technologies with medium throughput. Newer methods are able to generate
data with orders of magnitude larger scale (Chapter 1). While we show in
Chapter 5 that we can design highly efficient scalable methods in this mod-
elling framework, some underlying concepts for Gaussian process models
might not be appropriate for massive data, especially with pseudotime time
as missing data.
Gaussian process models are highly data efficient and perform well with
relatively few observations. With larger data, simpler models could poten-
tially be used. It unlikely to be feasilble to use latent variable models as the
data grows substantially. In latent variable models each observation has one
or more parameters associated with them, which need to be fitted. Learning
latent functions which summarize the data instead of latent variables for
each data point will be more powerful. Such functions should be able to
take the transcriptome of a cell, and predict what part of the trajectory it
came from. Lacking a ground truth reference for time, this could be done
with autoencoding strategies: train a model which predicts time from tran-
scriptome (encoder), jointly with a model which predict the transcriptome
from time (decoder).
Gaussian process regression is suitible for the latter part, allowing ex-
tremely flexible non-linear functions from time to expression. It is however
known that Gaussian processes perform poorly with large numbers of pre-
dictors, and so the encodingmodel would need a different strategy. In image
analysis deep neural networks are a popular choice for these problems, but
it might be the case that simpler parametric functions suffice.
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In conclusion, we have harnessed Gaussian processes to design analysi
techniques that have given novel biological insights from complex data sets
and will be applicable in many other setting.
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AppendixA
Additional Material for Chapter 2
A.1 Experimental methods
The wet-lab experiments for this study was performed by Kedar Natarajan,
experimental details are provided above in full for completelness.
A.1.1 Mouse embryonic-stem-cel l culture Wild-type E14 mouse ES cells
(kindly provided by P. Liu, Wellcome Trust Sanger Institute) were cul-
tured on gelatin-coated dishes with Knockout DMEM (10829; Gibco),
15% fetal calf serum (FB-1001/500; batch tested from Labtech), 1× peni-
cillin–streptomycin–glutamine (10378-016; Gibco), 1×MEMNEAA (11140-
035; Gibco), 2-mercaptoethanol (31350-010; Gibco), and 1,000 U leukemia
inhibitory factor (LIF; ESG1107). mESCs tested free of mycoplasma contami-
nation were passaged every 2 or 3 d.
A.1.2 SMARTer, Smart-seq2 and STRT-seq on C1 E14 mESCs were
trypsinized to obtain a single-cell suspension and were passed through
a 30-µm filter (CellTrics; 04-0042-2316). Cells were processed with a C1 Sin-
gle Cell Auto Prep System (Fluidigm; 100-7000 and 100-6209), according to
the manufacturer’s protocol (100-5950 B1). Briefly, we performed SMARTer,
Smart-seq2, and STRT-seq each across three small C1 Open App IFCs (5–10
µm; 100-5759). The specific sample-preparation steps for the three protocols
(SMARTer3,15–18, Smart-seq219, and STRT-aeq9,11,20,21) were downloaded
from the Fluidigm Script Hub. Dissociated single cells were loaded and
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captured on C1 Open App IFCs, and this was followed bymanual inspection
to demarcate empty wells, doublets or debris-containing wells. Two dif-
ferent spike-in RNA control sets were used for batch-matched comparison
of different protocols: 92 ERCC spike-ins (4456740; lot 1411014; Ambion)
and 69 SIRV spike-ins (SKU025.03; E2 Spike-in RNA Variant Control Mixes;
Lexogen) were mixed (0.5 µl 1:500-diluted ERCCs + 0.6 µl 1:500-diluted
SIRVs) and added to respective lysis buffer master mixes for SMARTer (20
µl), Smart-seq2 (27 µl), and STRT-seq (20 µl). 9 µl of the respective lysis
master mix was added to each Open App C1 IFC. The subsequent steps
(cell lysis, cDNA synthesis by reverse transcription, and PCR reaction) were
performed as described in the Fluidigm Script Hub.
A.1.3 SMARTer and Smart-seq2 on C1 E14 mESCs were trypsinized to
obtain a single-cell suspension and were passed through a 30-µm filter
(CellTrics; 04-0042-2316). The single-cell suspension was processed with
SMARTer and Smart-seq2 in parallel across two C1 Single Cell Auto Prep
Systems (Fluidigm; 100-7000 and 100-6209), according to the manufacturer’s
protocol (100-5950 B1). The Smart-seq2 protocol was downloaded from the
Fluidigm Script Hub. The cells were loaded, captured on C1 Open App
IFCs, and manually inspected. Both ERCC and SIRV spike-ins were mixed
(0.5 µl 1:500-diluted ERCCs + 0.6 µl 1:500-diluted SIRVs) and added to the
respective lysis-buffer master mixes for SMARTer (20 µl) and Smart-seq2 (27
µl). The subsequent steps (cell lysis, cDNA synthesis by reverse transcription,
and PCR reaction) were performed as described in the Fluidigm Script Hub.
A.1.4 Spike-in degradation experiment using Smart-seq2 on plates We
used a new tube of spike-ins, ERCC (4456740; lot 1412014; Ambion) and SIRV
(E2 mix; SKU025.03; lot 216651530; Lexogen), for this experiment. Briefly,
1:100 dilutions of ERCCs and SIRVs were mixed together to produce a spike-
in master mix (1:200 final dilution; termed ‘×2 freeze-thaw’). The spike-in
master mix was divided among three tubes: one incubated overnight at 37
°C (condition 1), one incubated overnight at room temperature (condition
2), and one incubated overnight at -80 °C. The following
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A.1.5 Library preparation and sequencing Representative cDNA from
single cells across threeC1 runs and Smart-seq2 (on plates)was assessedwith
High Sensitivity DNA chips for the Agilent Bioanalyzer (5067-4626 and 5067-
4627; Agilent Technologies). Single-cell cDNA from SMARTer3,15–18 and
Smart-seq2 C1 IFCs and Smart-seq2 (on plates) was tagmented and pooled to
generate libraries by using an Illumina Nextera XT DNA sample-preparation
kit (Illumina; FC-131-1096) with 96 dual-barcoded indices (Illumina; FC-131-
1002). The library cleanup and sample pooling was performedwith AMPure
XP beads (Agencourt Biosciences; A63880). All protocols were as described
in the Fluidigm protocol (100-5950), Fluidigm Script Hub, and Smart-seq2
protocol19. The STRT-seq libraries were generated and sequenced at the
Karolinska Institutet as previously described9,20. The single-cell libraries
from SMARTer and Smart-seq2 C1 IFCs and Smart-seq2 (on plates) were
sequenced across 1 lane of a HiSeq V4 (Illumina) by using 75-bp/125-bp
paired-end sequencing.
A.1.6 10× Genomics Chromium experiment A Single Cell Gel Bead kit
(120217), Single cell chip kit (120219) and Single cell library kit (120218)
were used along with a 10× GemCode Single Cell Instrument, per the man-
ufacturer’s specifications and manuals (document CG00011; revision B).
Equal volumes of control brain RNA (3 µl; FirstChoice Human Brain Total
RNA; AM7962) and ERCC spikes (3 µl 1:4 dilution; 4456653) were mixed to
produce a ‘2× control RNA + ERCC’ master mix. We further diluted this
mixture to ‘1× control RNA + ERCC’ with PCR-grade water. We generated
two single-cell master-mix preparations with 3 µl of 2× control RNA + ERCC
and 1× control RNA + ERCC instead of single-cell suspension (adjusted
with 34.4 µl nuclease-free water). The remaining protocol was performed
according to the manufacturer’s manual (document CG00011; revision B).
Each 10× library was sequenced across a HiSeq2500 (2× lanes; rapid run),
per Wellcome Trust Sanger Institute sequencing guidelines.
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A.2 Computational methods
A.2.1 Data sources Raw read data from published studies were down-
loaded from either ENA or SRA, as listed in Supplementary Table 1. These
included Gene Expression Omnibus accession codes GSE53334 (ref. 22),
GSE65785 (ref. 23), GSE67833 (ref. 24), GSE53386 (ref. 25), GSE71318 (ref.
26), GSE46980 (ref. 9), GSE60361 (ref. 20), GSE60768 (ref. 27), GSE54695 (ref.
11), GSE78779 (ref. 28), GSE54006 (ref. 21), GSE72857 (ref. 29), GSE63473
(ref. 30), and GSE65525 (ref. 31); European Genome-phenome Archive
accession code EGAS00001001204 (ref. 32); European Nucleotide Archive
accession codes ERP010108 (ref. 32), ERP005640 (ref. 15), ERP006670 (ref.
16), ERP010952 (ref. 33), and ERP013160 (ref. 32); Sequence Read Archive
accession codes SRP030617 (ref. 3), SRP041736 (ref. 17), SRP033209 (ref. 18),
SRP055153 (ref. 34), SRP045422 (ref. 35), SRP047290 (ref. 36), SRP025171
(ref. 37), SRP050499 (ref. 38), and SRP073767 (ref. 39); and ArrayExpress
accession codes E-MTAB-3346 (ref. 40) and E-MTAB-3624 (ref. 40).
Information regarding the concentration and volume of the ERCC mix
in each sample was gathered from the original publications (also indicated
in Supplementary Table 1) or through direct communication with authors
in ambiguous cases.
The expression table for mESC-STRT had nonstandard names annotating
the ERCC spike-ins, and through personal communication with the authors,
we received a table for converting these to the names provided by Life
Technologies. Additionally we were informed by the authors that the final
spike-in dilution noted as 1:50,000 in Islam et al (Islam et al., 2014) had
actually been 1:20,000.
The concentrations of the ERCC solution in the dendritic-MARS table
was ambiguous, because there were two different values in the GEO table
and in the text of the paper. Communication with the authors clarified that
these referred to different volumes. The volume and dilution described in
the GEO table were used. Thirty samples were excluded because they were
annotated as not having had ERCC spike-ins added to them.
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For the K562-SMART data, it was unclear which data sets had used spike-
ins, and personal communication with the authors provided the names of
the two batches which had spike-ins added.
A.2.2 RNA-seq data processing of coverage-based protocols For
coverage-based data, relative abundances were quantified with Salmon (Pa-
tro et al., 2017) 0.6.0, with library type parameter –l IU and the optional
flag –biasCorrect. The Salmon transcriptome indices were built by the ad-
dition of ERCC sequences to cDNA sequences from Ensembl. For samples
with a mouse background, this was the Ensembl 83 cDNA annotation of
GRCm38.p4. For samples with a human background, this was the cDNA
annotation from Ensembl 78 of GRCh38, and for samples with a zebrafish
background, this was the Ensembl 77 annotation of Zv9. Finally, for samples
with a frog background, this was the Ensembl 84 annotation of JGI4.2.
All coverage-based data sets were sequenced with Illumina paired-end
sequencing with read lengths between 75 and 150 bp.
A.2.3 Cellular RNA content bootstraps Confidence intervals with regard
to accuracy and sensitivity for nonempty and empty wells were estimated
by bootstrapping. Therefore, studies SRP055153, ERP010952 and SRP070989
were pooled, separating nonempty and empty wells. For each group, sample
sizes of 20 were randomly picked with replacement, and the median of the
bootstrapped samples was determined. This process was repeated with
1,000 iterations. Having sorted the bootstrapped estimates, we determined
the median and the 2.5th and 97.5th percentiles of the distributions for
nonempty and empty wells. All data necessary for our analysis are provided
as Supplementary Table 2.
A.3 Additional figures
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Fig. A.1 Comparison and overview of spike-in sets. ERCC spike-ins consist of 92
very distinct sequences based on bacterial genes logarithmically distributed across 22
abundance levels (in Mix 1), with poly-A tails ranging from 20 to 26 base pairs. SIRV
spike-ins are 69 sequences, modeled after sequences and splicing patterns in 7 human
genes. In Mix 2, which we used, the SIRV molecules are present at 4 abundance levels,
with virtual alternative isoforms from each gene present at each abundance level. All
SIRV molecules have 30 base pair long poly-A tails.
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Fig. A.2 UMI efficiency as an alternative metric of sensitivity. (A) Assuming that
UMI counts correspond to a count of the fraction of molecules successfully captured by
the RNA-sequencing process, in log-log space the efficiency corresponds to the offset
from perfect correspondence between input molecules and counted UMIs. (B) With the
exception of data from the MARS-Seq protocol, spike-in detection limits correspond well
with UMI efficiency measures. The spike-in detection limit can however also be used
for coverage based data quantified by TPM. (C) The assumption with UMI counting as a
quantitative measurement is that efficiency is the only factor determining differences
between real counts and observed counts. However, fitting a model with a non-one
exponent on the number of input molecules shows this is almost in all cases < 1. This
means UMI counts underestimate expression of highly expressed genes. (D) The saturation
of UMI counts can be partially explained by short UMIs. If an experiment uses too short
UMIs, eventually the number of possible observable UMIs plateau. However, even for
very long UMIs, such as 10 base pairs, the mean molecule exponent is 0.8, indicating
some additional unexplained factor is causing a saturation of UMI counts. (E) Averaged
efficiency comparison of endogenous genes and ERCC spike-ins. The data by Grun et
al had smFISH measurements for 9 genes in the same experimental conditions as the
single-cell RNA-seq data. Assuming 100% capture rate for smFISH, we can compare
average smFISH counts with average UMI counts. Round markers correspond to median
value across cells, and bars correspond to 95% confidence interval across cells. The
smFISH counts suggest UMI counts for endogenous transcripts are on the order of 5-10%
on average, while ERCC spike-in UMI counts correspond to 0.5-1% efficiency on average.
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Fig. A.3 Trace plots from Bayesian models of degradation. The posterior samples
from the model parameters in Stan (Carpenter et al., 2016) for both the ERCC and
SIRV analysis show very narrow confidence intervals and good correspondence between
the different sampling chains. The SIRV based model is slightly noisier, which can be
expected, as isoform-level expression when multiple isoforms are present is a harder
quantification problem than quantifying expression of the unique ERCC sequences. For
the ERCC model, the mode of the degradation rate parameter p is 19%, and for the SIRV
model it is 18.5%.
AppendixB
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B.1 Experimental methods
The wet-lab experiments for this study were performed by Charlotte La-
ballette and Iain Macaulay. The experimental details are listed below for
completeness.
B.1.1 Zebraf ish strains and maintenance The maintenance of wild-type
(Tubingen Long Fin) and transgenic zebrafish Tg(cd41:GFP) lines were per-
formed in accordance with EU regulations on laboratory animals, as previ-
ously described (Bielczyk-Maczyńska et al., 2014).
B.1.2 Single-cel l sort ing and whole transcriptome ampli f ication A sin-
gle kidney from heterozygote Tg(cd41:EGFP) or wild-type fish was dissected
and carefully passed through a strainer using the plunger of a 1 ml syringe.
In the follow-up experiment, circulating GFP-positive cells were collected
from the dissected heart of the same fish. Cells were collected in cold 13
PBS/5% fetal bovine serum. The kidney of a non-transgenic line was used
to set up the gating and exclude autofluorescent cells. Dead cells were ex-
cluded based on PI staining. Individual cells were sorted using a Becton
Dickinson Influx sorter with 488- and 561-nm lasers (Schulte et al., 2015) and
collected in a single well of a 96-well plate containing 2.3 ml of 0.2% Triton
X-100 supplemented with 1 U/ml SUPERase In RNase inhibitor (Ambion).
At the same time, information about cell size and granularity and the level
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of the fluorescence were recorded. Whole transcriptome amplification and
library preparation was performed using the Smart-seq2 protocol (Picelli
et al., 2013, 2014b), with ERCC spike-in controls added at the same time as
the oligo-dT and dNTP mixture. Twenty-five PCR cycles were performed
during the amplification.
B.1.3 Cell cycle analysis GFP-positive cells from Tg(cd41:EGFP) kidney
suspension were sorted using a Mo-Flo XDP (Beckman Coulter) with 488-,
561-, and 640-nm lasers. Cells were centrifuged at 1,200 rpm for 10 min at 4
C, resuspended in 100 ml 13 PBS and fixed by adding 300 ml ethanol. Cells
were fixed overnight at 4 C, washed twice in 13 PBS, and re-suspended in
500 ml PI solution (25 mg/ml PI, 0.1% Triton X-100, 0.1% sodium citrate).
Cells were incubated for 3 hr with RNase A (Sigma) and analyzed by BD LSR
Fortessa (Becton Dickinson). Data were analysed using FlowJo software.
B.1.4 Cytology Sorted EGFP-positive cells were concentrated by cytocentrifu-
gation at 350 rpm for 5 min onto SuperFrostPlus slides using a Shandon Cy-
tospin 3 cytocentrifuge. Slides were fixed for 3 min in methanol and stained
withMay-Gru€nwaldGiemsa (Sigma) as described elsewhere (Stachura et al.,
2009). Images were captured as described elsewhere (Bielczyk-Maczyńska
et al., 2014).
B.1.5 Verif ication of RNA-Seq data with qPCR GFP-positive cells from
Tg(cd41:EGFP) and Tg(fli1:EGFP) kidney suspensions were sorted using
a Mo-Flo XDP (Beckman Coulter), along with an equal number of viable
cells from the whole kidney, into 75 ml RLT buffer (QIAGEN) containing 1%
b-mercaptoethanol. mRNA was extracted using Oligo (dT)25 Dyna-beads
(Ambion) and cDNA was prepared using SuperScript VILO (Invitrogen), ac-
cording to the manufacturers’ instructions. qPCR reactions were performed
using the 7900HTReal Time system (Life Technologies) with primers for vWf
(F: CGGCAGCACATACACACATT and R: CGTTCCATCCACAGAGAGGT)
and two housekeeping genes (eif1a F: GAGAAGTTCGAGAAGGAAGC and
R: CGTAGTATTTGCTGGTCTCG, and b-actin F: CGAGCAGGAGATGGG
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AACC and R: CAACGGAAACGCTCATTGC). The DDCt method was used
for data analysis.
B.1.6 Single-Cel l RNA-Seq data processing Reads from RNA-seq were
aligned to the zebrafish genome (Zv9.77) combined with sequences for eGFP
and ERCC spike-ins as artificial chromosomes, using STAR (version 2.3;
(Dobin et al., 2013). The Ensembl Genes annotation track from UCSC was
used with the read_distribution.py tool from the RSeQC tool suite (Wang
et al., 2012) to generate quality control information. Gene expression was
quantified using Salmon (Patro et al., 2017) with parameter -l IU using Zv9
cDNA sequences from Ensembl version 77 as transcript sequences, together
with ERCC spike-in and eGFP sequences as artificial transcripts. Based on
comparison with empty control wells, samples with less than 50,000 paired
reads and 1,000 expressed genes were considered unfit and were excluded
from further analysis (Figure S2).
For the follow-up experiment, expression was quantified the same way.
We used a different stock and concentration of ERCC spike-ins, which
changed the scales of the QC values. For these samples, we excluded cells
with less than 200,000 paired reads and less than 150 expressed genes (Figure
S6).
Downstreamanalysiswas performedusing Transcripts permillion (TPM)
values reported by Salmon. The TPMunit is ameasure of relative abundance
of a gene, which is stable across samples (Li and Dewey, 2011; Wagner et al.,
2012). Before analysis expression for endogenous spike-ins were filtered out
for each cell, and the TPM for each cell was rescaled to sum to a million.
This gives us the interpretation that TPM of a gene will correspond to the
concentration of mRNAs from a gene in a given cell.
Unless stated otherwise, for all analyses, we filtered out genes expressed
at a level higher than 1 TPM in only less than three cells, which leaves 20,556
genes.
B.1.7 Identi fying processes and ordering cel ls by hidden factors We
used ICA (Hyvärinen and Oja, 2000) to identify four latent factors (hidden
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variables modeling the data), as implemented in scikit-learn (with parameter
random_state = 3,984 for the sake of reproducibility). The choice of four
components was based on testing between one and ten components, and
seeing diminishing returns on the Frobenius norm reconstruction error
past four components. One latent factor explains a progression among
EGFPlow cells; another factor explains a switch from EGFPlow cells toward
the population of EGFPhigh cells. A third factor explains progression among
EGFPhigh cells. The fourth factor identifies three outlier cells. We used
the fluorescence levels of GFP to flip the orientation of the latent factors
so that a higher factor value always corresponded to a higher GFP value.
Because these factors are orthogonal, they are statistically independent. In
other words, there are three distinct processes happening sequentially. We
performed hierarchical Ward clustering (Ward, 1963) of the cells in the four-
dimensional ICA space, and assigned the cells to six clusters. Based on
which cluster the cells belonged to, and which factor explains the variability
of the cells of that cluster, we ordered cells along this three-stage progression.
This ranking of cells through the entire process was treated as pseudotime.
As an alternative way to estimate a pseudotime, we applied a Bayesian
Gaussian process latent variable model with a one-dimensional latent vari-
able (Titsias and Lawrence, 2010). Briefly, the Bayesian GPLVM will infer a
nonlinear function from an unobserved latent space to an observed high-
dimensional space, using inducing inputs that are variationally inferred,
which helps smooth the data and speed up computation. In our case, the
latent space is the one-dimensional pseudotime, and the non-linear function
will be a mapping from pseudotime to gene expression values. We used
the BayesianGPLVM implementation in the GPy package using a Radial
Basis Function (RBF) kernel on the log-transformed TPM values, all other pa-
rameters default. Without any information about the EGFP expression, the
BayesianGPLVM recovers our original ordering, up to orientation (Spearman
correlation 0.97; Figure B.3B).
To depict the structure of the data in a friendly way, we performed t-
distributed stochastic neighbor embedding (t-SNE) (Van der Maaten and
Hinton, 2008) of the four latent factors into two dimensions. The goal of the
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t-SNE algorithm is to attempt to preserve both global and local structures
of higher dimensional data in two dimensions. It additionally tries to not
crowd areas with too many points, making them hard to see. We set the
perplexity parameter to 75 and used a fixed random seed to make sure the
t-SNE plot would be reproducible (parameter random_state = 254 in the
scikit-learn implementation of t-SNE).
We can depict the inferred pseudotime by regressing it into the two-
dimensional tSNE space (Figure B.3A) and can see howwell the twomethods
of constructing pseudotime agrees.
B.1.8 Transparant analysis All analysis scripts are provided as IPython
notebooks in the supplemental information together with a table of detailed
information of each sample in a Github repository at https://github.com/
Teichlab/spectrum-of-differentiation-supplements.
B.2 Additional figures
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Fig. B.1 The gating strategy for sorting cd41-EGFP cells by flow cytometry. First,
debris was excluded by forward and side-scatter (A, D). Next, singlets were selected (B,
E) and dead, PI positive cells, were excluded (C, F). Finally, autofluorescent cells were
excluded from the analysis (G, H). The GFP positive population was split into GFPlow and
GFPhigh based on the level of GFP fluorescence (I).
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A	 B	
Fig. B.2 Quality control assessment. Quality control was assessed by analysing the
number of detected genes compared to the number of input reads (A) or ERCC content
(B). In each plate we sorted 94 cells, leaving two wells per plate without cells. Blue dots
represent wells with cells and orange dots show wells without cells. Following sequencing
and quality control, 13 cells were removed from further analysis. We excluded data points
(cells) with few reads (less than 50,000) and few genes or with high ERCC content. As
expected, wells without cells (orange) have ERCC content equivalent to 100%.
A	 B	
Fig. B.3 Pairwise plots of the four independent components used to represent
the data. A) The initial names of the components (“difference_component”, “out-
lier_component”, “within_large_component”, “within_small_component”) were given
based on visual features. The dots, representing cells, are colored white for EGFPlow
sorted cells and green for EGFPhigh sorted cells. B) Ward clustering of the cells in ICA
space. The clusters (here colored) were used to associate cells to progression along a
component where the cluster varies the most.
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F g. B.4 The gating strategy for sorting cells from clusters 1a/1b/2, 3 and 4 by flow
cytometry. A-B) Plots of viable, single cells based on their GF and PERCP fluorescence
fr m either a non transgenic (A) or Tg(cd41:EGFP) (B) kidney single c ll suspension. The
GFPlow cells (C) can be further split into two groups based on SSC values: GFPlowSSChigh
o GFPlowSSClow (D). GFP fluorescence (E) and light sc tter (F) properti s of e c
cell coloured based on the cluster it belongs to. G) Stacked column graph sho ing the
p oportion of cells from each of the clusters in three different gates named here: GFPhigh,
GFPlowSSClow and GFPlowSSChigh.
GFPlowSSChigh	
Clusters	1a/1b/2	enriched	
GFPlowSSClow	
Cluster	3	enriched	
GFPhigh	
Cluster	4	
Fig. B.5 May-Grunwald Giemsa staining of cells from clusters 1a/1b/2, 3 and
4. Cd41:EGFP cells were sorted based on GFP and SSC values to GFPlowSS-
Chigh,GFPlowSSClow and GFPhigh. Cytospin slides were prepared from sorted cells
and stained with May-Grunwald Giemsa. The GFPlowSSChigh cells are enriched for cells
from clusters 1a/1b/2, GFPlowSSClow and GFPhigh cells are enriched for cells from cluster
3 and 4 respectively.
B.2 175
EarlyEnriched
EGFP
EGFP
EGFP
EGFP
A	 B	
Fig. B.6 Follow-up experiment. A) Quality control of cells from the follow-up experiment.
Out of 288 single cells, 19 were removed from further analysis due to having less than
200,000 sequenced reads, less than 150 detected genes or more than 99.5% ERCC
spike-in content in the well. Thresholds were guided by control wells which were either
empty or contained 50 cells. B) The data follow a similar pattern as in the original
experiment (for comparison please see Figure B.3A-B). Pairwise plots of three independent
components representing the data from the follow-up experiment. The EarlyEnriched
population is confined to the early progression along component 0 (corresponding to
within_small_component in Figure B.3B) before the switch in component 2 (corresponding
to difference_component in Figure B.3B). This corresponds to cluster 1a/1b/2 in the original
data as expected. GFPhigh cells from both the kidney and circulation completely overlap,
indicating no further differentiation happens after the cells leave the kidney, and vary
over component 1 (corresponding to within_large_component in Figure B.3B).
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Fig. B.7 The total mRNA content and number of expressed genes per cell are
correlated with its differentiation state, not technical properties of the cells. Light
scatter properties FSC and SSC, total mRNA content, number of reads and the number
of expressed genes in pseudotime. The dots, representing cells, are coloured based on
the cluster the cells belong to.
AppendixC
Additional Material for Chapter 4
C.1 Experimental methods
The wet-lab experiments for this study were perfmed by Tapio Lonnberg
and Kylie James. All details about the experiments are listed below for
completeness.
C.1.1 Experimental mice, adoptive transfer and infections C57BL/6,
rag1-/-, and congenic PTprca mice were purchased from Australian Re-
source Center (Canning Vale) or bred in-house. PbTII, C57BL/6, rag1-/-,
congenic PTprca (CD45.1), nzEGFP, lgals1-/- (Jackson Laboratory: Stock No:
006337), LysMCre (Jackson Laboratory Stock No: 004781), ROSA26iDTR
(iDTR) (Jackson Laboratory Stock No: 007900) mice, and all crosses were
maintained under specific pathogen-free conditions within animal facilities
at the Wellcome Trust Genome Campus Research Support Facility (Cam-
bridge, UK), registered with the UK Home Office, or at QIMR Berghofer
Medical Research Institute (Brisbane, Australia). All mice were female and
used at 8-12 weeks of age. All animal procedures were in accordance with
the Animals (Scientific Procedures) Act 1986 and approved by the Animal
Welfare and Ethical Review Body of the Wellcome Trust Genome Campus,
or in accordance with Australian National Health and Medical Research
Council guidelines and approved by the QIMR Berghofer Medical Research
Institute Animal Ethics Committee (approval no. A02-633M).
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Spleens from PbTII donor mice were aseptically removed and homoge-
nized through a 100 µm strainer before erythrocytes lysis using RBC lysis
buffer (eBioscience). CD4+ T cells were enriched using CD4 microbeads
(Miltenyi Biotech) and stained with CellTrace™ Violet (Invitrogen). Cells
were injected (106/200µl RPMI) via a lateral tail vein.
PcAS parasites were used after one in vivo passage in WT C57BL/6
mice. Mice were infected with 105 pRBCs i.v. and blood parasitemia was
monitored by Giemsa-stained thin blood smears obtained from tail bleeds.
C.1.2 Flow Cytometry Single-cell suspensions were prepared by homoge-
nizing spleens through 100 µm strainers and lysing erythrocytes using RBC
lysis buffer (eBioscience). Prior to staining, Fc receptors were blocked using
anti-CD16/32 antibody (BD Pharmingen or in-house). Intracellular staining
was performed by first incubating cells in brefeldin-A (10 mg/ml) at 37oC
for 3 hours. For IL-10/IFNγ staining, cells were also incubated with Iono-
mycin (500 ng/ml) and PMA (25 ng/ml). Staining was performed using the
eBioscience FoxP3 intracellular kit. For DNA/RNA staining, Hoechst33342
(10µg/ml; Sigma) was added at 1/500 v/v to cell preparation 15 minutes
prior to acquisition using a BD LSRFortessa IV (BD Bioscience). Cells were
sorted using a MoFlo XDP (Beckman Coulter), a FACSAria II (Becton Dickin-
son) or an Influx (Becton Dickinson) instrument. Activated PbTII cells were
sorted as CD4+TCRβ+ and CD69+ and/or divided at least once as mea-
sured using the CellTraceTM Violet proliferation dye. Dendritic cells were
sorted as CD11chiMHCIIhiTCRβ-B220-. Naive dendritic cells were further
sorted as CD8α+CD11b- or CD8α-CD11b+, and inflammatory monocytes
as CD11bhiLy6ChiLy6GloTCRβ-B220-.
C.1.3 Single-cel l capture and processing Single cell processing with the
Fluidigm C1 system was performed using small–sized capture chips (for
5-10 µm cells). 1 βl of a 1:4000 dilution of External RNA Control Consortium
(ERCC) spikeins (Ambion, Life Technologies) was included in the lysis buffer.
For processing with the Smartseq2 protocol, the cells were sorted into 96-
well plates containing lysis buffer. The lysis buffer consisted of Triton-X,
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RNase inhibitor, dNTPs, dT30 primer and ERCC spike-ins (Ambion, Life
Technologies, final dilution 1:100 million). 24 cycles of cDNA amplification
were performed. Libraries were prepared using Nextera XT DNA Sample
Preparation Kit (Illumina), pooling up to 96 single cells. Pooled libraries
were purified using AMPure XP beads (Beckman Coulter) and sequenced
on an Illumina HiSeq 2500 instrument, using paired-end 100 or 125-base
pair reads.
C.1.4 Processing and QC of scRNA-Seq data Gene expressionwas quanti-
fied using Salmon, version 0.4.0. The parameter libType=IU, and a transcrip-
tome index built on Ensembl version 78 mouse cDNA sequences. Sequences
from the ERCC RNA spike-ins were included in the index, as well as 313
mouse-specific repeat sequences fromRepBase. As quality control measures,
we assessed the number of input read pairs, and the amount of mitochon-
drial gene content, considering cells with less than 100,000 reads or more
than 35% mitochondrial gene content as failed. For T cells, we additionally
considered cells where number of genes was less than 100 + 0.008 * (mito-
chondrial gene content) as failed. For the data generated using a 96-well
plate-based Smart-seq2 protocol, which does not permit visual inspection
of the captured cells, we additionally excluded low-quality cells from which
fewer than 2000 genes were detected, motivated by negative control wells.
To verify that that the cells sorted in the wells were PbTII cells, we only
selected cells from which both the transgenic TCR alpha and beta chains
were detected (Supplementary Tables 2 and 3). For expression values, the
Transcripts Per Millions (TPM’s) estimated by Salmon included ERCC spike-
ins. Thus, to obtain values representing only the endogenous RNAs, we
removed ERCC’s from the expression table and scaled the TPM’s so they
again summed to a million. We also globally removed genes from analysis
where less than three cells expressed the gene at minimum 1 TPM, unless
stated otherwise.
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C.1.5 Determining T cel l receptor expression T cell receptor sequences
were reconstructed from scRNAseq data using the TraCeR software as pre-
viously described (Stubbington et al., 2016).
C.1.6 Annotation of cel l-surface receptors, cytokines and tran-
script ion factors Genes likely to encode transcription factors, cell-
surface receptors or cytokines were found by combining information
from KEGG (http://www.genome.jp/kegg/), the Gene Ontology Consor-
tium (http://geneontology.org/, PANTHER (http://www.pantherdb.org/)
along with the more specific databases detailed below.
Transcription factors were found by searching the Gene Ontology
Consortium database using the following ontology term: GO:0003700
(sequence-specific DNA binding transcription factor activity); KEGG for
ko03000 (Transcription Factors); PANTHER for PC00009 (DNA binding)
AND PC00218 (Transcription Factors). The presence of genes in the
following databases was also used as evidence for transcription factor
activity: AnimalTFDB (http://www.bioguo.org/AnimalTFDB/index.php),
DBD (http://www.transcriptionfactor.org), TFCat (http://www.tfcat.ca),
TFClass (http://tfclass.bioinf.med.uni-goettingen.de/tfclass), UniProbe
(http://the_brain.bwh.harvard.edu/uniprobe) and TFcheckpoint
(http://www.tfcheckpoint.org).
Cell-surface receptors were found by searching the Gene Ontology Con-
sortium database using the following ontology terms GO:0004888 (trans-
membrane signaling receptor activity) OR GO:0008305 (integrin complex))
AND NOT (GO:0004984 (olfactory receptor activity) OR GO:0008527 (taste
receptor activity); KEGG for ko04030 (G-Protein Coupled Receptors) OR 64
ko04050 (Cytokine Receptors) OR ko01020 (Enzyme-linked Receptors); PAN-
THER for PC00021 (G-Protein Coupled Receptors) OR PC00084 (Cytokine
Receptors) OR PC00194 (Enzyme-linked Receptors). Annotation of genes
as receptors in the ImmPort (https://immport.niaid.nih.gov/), GPCRDB
(http://gpcrdb.org/) or IUPHAR (http://www.guidetopharmacology.org/)
databases was also used as evidence for receptor functionality.
C.1 181
Cytokines were found by searching the Gene Ontology Consortium
database using the following ontology terms GO:0005125 (cytokine activ-
ity); KEGG for ko04052 (Cytokines); PANTHER for PC00083 (Cytokines).
Annotation of genes as cytokines in ImmPort was also used in this case.
Genes were scored according to the number of databases and search results
in which they occurred. Scores were weighted according to the strength
of evidence provided by each database such that functional annotations
supported bymanually reviewed experimental evidence were given a higher
score than those that were solely computationally generated (Table)
Genes were assigned as likely cell-surface receptors or cytokines if they
had a cumulative score greater than or equal to 5 in that category. Genes
were assigned as likely transcription factors if they had a cumulative score
greater than or equal to 6 in that category.
C.1.7 In vivo depletion Cellular depletion in LysMCre x iDTR mice was
performed by intraperitoneal injection of 10ng/g DT (Sigma-Aldrich) in
200µl 0.9% saline (Baxter) at day 3 post-infection. Control mice were given
0.9% saline only. For B cell depletion, anti-CD20 (Genentech) or isotype
control antibody was administered in a single 0.25mg dose via i.p. injection
in 200µl 0.9% NaCl (Baxter), 7 days prior to infection.
C.1.8 Confocal microscopy Confocal microscopy was performed on 10–20
µm frozen spleen sections. Briefly, splenic tissues were snap frozen in
embedding optimal cutting temperature (OCT) medium (Sakura) and stored
at -80oC until use. Sections were fixed in ice-cold acetone for 10 minutes
prior to labeling with antibodies. DAPI was used to aid visualization of
white pulp areas. Samples were imaged on a Zeiss 780-NLO laser-scanning
confocal microscope (Carl Zeiss Microimaging) and data analyzed using
Imaris image analysis software, version 8.1.2 (Bitplane). Cells were identified
using the spots function in Imaris, with thresholds <10mM and intensities
<150. All objects were manually inspected for accuracy before data were
plotted and analyzed in GraphPad prism (version 6).
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C.2 Computational methods
C.2.1 Software avai labi l i ty We have made a software package for using the
GPfatesmethod, which is available at https://github.com/Teichlab/GPfates.
It provides guidance and sensible defaults for the kind of analysis we have
described here. It makes extensive use of the GPy1 package, and the GPclust2
package, where we implemented the non-parametric OMGP model.
C.2.2 Practical use of GPfates The basis principle of GPfates is the combi-
nation of pseudotime and mixture modelling.
Input to theGPLVM is an expression table consisting of log scaled relative
abundance values Transcripts Per Million, TPM, with a value of 1 added
to handle cases where expression is 0. As relative abundance follow a log-
normal distribution, the Gaussian likelihood used for Gaussian Process
regression should be appropriate.
In practice, the pseudotime should represent the biological process of
interest. If this process is clear, the expression data should be usable without
pre-processing. In single cell time course experiments where the process
of interest is less immediate, a strategy highlighted in (Trapnell et al., 2014)
is to select the gene set used could be to rank the genes by an ANOVA test
over the time points, and select a larger number of significant genes.
Similarly, the low-dimensional representation of the transcriptomic cell
state should represent the biological response of interest. It can be beneficial
to select the parts of the representation which correspond to this. For exam-
ple, in the analysis of CD4+ T cell time course, we use the second GPLVM
latent variable as a representation of T cell response, and model this factor
by the OMGP.
While pseudotime can be inferred directly from the expression matrix
Y , in many cases it helps interpretation to perform an intermediate step of
dimensionality reduction. This process could also be beneficial if the data
has a very complex structure.
1https://github.com/SheffieldML/GPy
2https://github.com/SheffieldML/GPclust
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Another practical consideration is that single cell expression values can
be quite noisy. This limits the time-scale at which we can expect to measure
proper functional differences in expression levels. Due to this, we tend to
put lower limits on the lengthscale lSE of the squared exponential covariance
function.
C.2.3 Preprocessing publ ic RNA-seq data We removed ERCCs from our
expression data table and re-scaled the expression values to TPM. Further-
more, we eliminate cells containing NA’s in the frog data.
Some of the used methods require a start or root cell. Therefore, we ran-
domly picked a cell from an early collection time point: 1771-026-187-E6
(malaria), SRP033209_E14.5_rep_1_cell_24 (lung), 2013600 (pgc) and 1795679
(frog).
C.2.4 Wishbone The analysis with Wishbone version 0.4.1 was performed
according to the tutorial using default or suggested parameters (Setty et al.,
2016). We ran t-SNE with n_components = 5 and perplexity = 30. To run
wishbone the start cells were chosen as stated above with k=15 or k=50 for
frog data, components_list=[1,2] and num_waypoints = 150.
C.2.5 Monocle The Monocle analysis was performed with version 2.1.0 of
the Monocle package, following the steps outlined in the original vignette
(Trapnell et al., 2014). In brief, the analysis was performed using the size
normalized data (TPM) including all genes expressed in ≥ 50 cells with
default parameters. The genes used for the ordering of cells were defined
by carrying out a differential expression analysis of the time points using
the differentialGeneTest in the Monocle package. Following the original
vignette, genes with q-value < 0.01 were selected. To reduce the dimension
the max_components option was set to 2 and the DDRTreemethods was used.
C.2.6 Diffusion Pseudotime (DPT) DPT analysis was done using the R
package version 0.6.0 and an additional package called destiny (version
1.3.4) (21). In order to calculate the transition matrix DPT uses a Gaussian
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kernel with parameter sigma. The optimal sigmawas chosen by using the
function find.sigmas() of the destiny package. Given the transitionmatrix
and root cell dpt()was executed with branching=TRUE.
C.2.7 SCUBA In order to run SCUBA we used the python package PySCUBA
version 0.1.13 which provides a graphical user interface (Marco et al., 2014).
Selecting the RNA-seq data set including temporal information we ran
SCUBA with cluster_mode = PCA2 and pseudotime_mode = 0.
C.2.8 Mpath We performed analyses with Mpath using the package version
1.0 (Chen et al., 2016). Prior to the analysis, a quality check includes a
removal of genes having TPM values < 1 in more than 95 percent of cells in
each group. In order to find the number of optimal clusters the parameters
diversity_cut and size_cut were set as suggested to 0.6 and 0.05, respec-
tively, when calling the function landmark_designation(). Inspecting the
resulting plots, the number of optimal clusters were chosen as 10 (malaria),
19 (lung) and 24 (pgc). Mpath failed to run on the frog data set. Using the
landmark clusters we constructed the weighted neighborhood graph and
trimmed it using the minimal spanning tree method.
C.3 Additional figures
3https://github.com/GGiecold/PySCUBA
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Fig. C.1 Enrichment of PbTII cells for adoptive transfer. (A) CD4+ T cells were
enriched using positive selection (MACS microbeads) from the spleen of a naive, PbTII x
CD45.1 mouse. FACS plots show purity, expression of Vα2 and Vβ12 transgenes, and
CellTrace™ Violet (CTV) staining of enriched PbTII cells compared to corresponding
flowthrough from the enrichment process.
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Fig. C.2 Sorting strategy for PbTII cells. (A) PbTII cells (CD4+ TCRβ+ CD45.1+) were
adoptively transferred into WT congenic (CD45.2+) recipient mice At indicated days,
early activated (CD69+) and/or proliferated (CTVlo) PbTII cells were cell-sorted from
spleens of PcAS-infected mice, and naive PbTII cells (CD69loCTVhi) were cell-sorted
from the spleens of naive mice at day 7 post-transfer.
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Fig. C.3 Flow cytometric assessment of TH1/TFH responses during PcAS infection.
(A) Flow cytometic gating strategy employed to analyze splenic PbTII responses throughout
this manuscript. (B) Isotype controls for direct ex vivo intracellular staining of IFNγ, T-bet
and Bcl6, and fluorescence minus one (FMO) control for staining of CXCR5 expression by
splenic PbTII cells from day 7-infected mice. (C) Remaining FACS plots from data in Fig.
1B-C, showing expression of T-bet and Bcl6 by IFNγ+ or CXCR5+ splenic PbTII cells at
day 7 post-infection with PcAS. Each plot represents an individual mouse.
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Fig. C.4 Expression of subset-specific marker genes in PbTII cells. (A) Representative
FACS plot (gated on CD4+ TCRβ+ live singlets) and proportion of FOXP3+ (Treg) splenic
PbTII (104 transferred) (CD45.1+; red dashed box) or polyclonal CD4+ T (CD45.1-; black
dashed box) cells from mice (n=6) at day 7 post-infection. (B-C) FACS plots (gated
on CD45.1+ CD4+ TCRβ+ live singlets) of (B) IL-4+GATA3+ (Th2) and (C) IL-17+RORγt+
(Th17) splenic PbTII cells in naive (receiving 106 cells) or PcAS-infected mice (receiving
104 cells) at day 7 post-infection. (A-C) Data are representative of two independent
experiments. Statistics: Mann-Whitney U test; *p<0.05. (D) The mRNA expression of
selected subset-specific cytokines and the Treg hallmark transcription factor Foxp3 in
PbTII cells. The red dots and line indicate the fraction of cells in each time point where
the particular mRNA was detected.
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Fig. C.5 Heterogeneity of activated PbTII cells and variability associated with cell
size and differentiation. (A) PCA of single PbTII cells at 2, 3, 4 and 7 days post-
infection with PcAS. The PCA was based on all genes expressed at ≥ 100 TPM in at
least 2 cells. The arrows represent the Pearson correlation with PC1 and PC2. Cell size
refers to the number of detected genes. “Th1 signature” and “Tfh signature” refer to
cumulative expression of top 30 signature genes associated with Th1 and Tfh phenotypes
(15). The numbers in parenthesis show proportional contribution of respective PC. (B)
The relationship of detected cell number with the fraction or reads mapping to ERCC
spikein RNA (top) and with cumulative expression of proliferation markers Mki67, Mybl2,
Bub1, Plk1, Ccne1, Ccnd1 and Ccnb1 (31) (Figure 4B and S9). (C) Ranked loading scores for
PC1-PC6 of the Th1 and Tfh signature genes in the PCA shown in (A). The numbers in
parenthesis show proportional contribution of respective PC.
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Fig. C.6 Heterogeneity of TH1/TFH signature gene expression in activated PbTII
cells. (A) Principal component analyses of day 4 (left) and day 7 (right) PbTII cells were
performed using established Th1/Tfh signature genes (15) detected at the level ≥ 100
TPM in at least 2 cells. The numbers in parenthesis show proportional contribution
of respective PC. (B) The PC1 and PC2 loadings of individual Th1 (red) and Tfh (blue)
signature genes in PCA of day 4 and day 7 PbTII cells (A). (C) The correlation of PC1 from
the analysis with the signature genes alone and PC2 of the genome-wide analysis (Figure
1E).
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Fig. C.7 Heterogeneity of the entire PbTII time series and the contribution of
TH1 and TFH genes to the overall variability. (A) The first five components of the
Principal Component Analysis of the entire time series. The numbers in parenthesis
show proportional contribution of respective PC. (B) The rankings of the Th1 and Tfh
signature genes among the loadings of Principal Components 1-7.
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B A
Fig. C.8 The relationship of pseudotime with time points and with the TH1 assign-
ment probability.
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Fig. C.9 Correlation of GPfates trends with TH1 and TFH signature genes. (A) The
effect of the probability threshold on the cumulative expression of TH1 and TFH signature
genes (15). The p-values were calculated using Wilcoxon rank sum test. (B) Correlation of
expression of TH1 and TH1 assignment probability. (C) Relation between genes expression
correlation with mixture assignment probability, and the bifurcation statistic, for each
gene. The threshold of bifurcation statistic = 49 has some stronger effect sizes. This is
analogous to a volcano plot in classical differential expression testing.
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Fig. C.11 Expression of endogenous TCRs does not influence PbTII cell TH1/TFH
differentiation. (A) Representative FACS plots (gated on CD45.1+ (WT) or CD45.2+
(Rag1-/-), CD4+ TCRβ+ Vβ12+ live singlets) showing expression of T-bet or Bcl6 by splenic
WT or Rag1-/- PbTII cells (104 transferred into congenic recipient mice) at day 7 p.i. with
PcAS (n=4). (B) Summary graphs of proportions of WT or Rag1-/- PbTII cells exhibiting
T-bethi and Bcl6hi phenotypes from (A). (C) Representative histograms of CXCR5 and
IFNγ expression by T-bethi or Bcl6hi WT and Rag1-/- PbTII cells from (A) & (B). Statistics:
Mann-Whitney U test; NS, not significant.
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Fig. C.12 Robustness of top bifurcating genes across experiments. (A) Experimental
design for the replicate PcAS infection. Single cells were sorted into 96-well plates and
cDNA was amplified using the Smart-seq2 protocol. (B) Bayesian Gaussian Process Latent
Variable model of the combination of original and replicate data. The BGPLVM was
fitted using the residuals from an ordinary least squares model of expression from the
categorical variable of experiment, equivalent to limma::removeBatchEffect. Replicate
data groups with corresponding data from the original experiment, illustrating that
both experiments capture the same transcriptional landscape. (C) The emergence of
subset-specific gene patterns at day 7 of infection. For the top bifurcating genes (Fig
S5C) pairwise gene-to-gene Spearman correlations were calculated. The rowside colours
represent the association of the gene with either Th1 fate (red) or Tfh fate (blue). (D) The
expression of top 20 Th1 and Tfh associated genes identified using GPfates in single PbTII
cells at days 4 and 7. The genes were annotated as Th1- or Tfh-associated based on
public datasets (15, 37, 4 , ). *Cdk2ap2 appears twice because two alternative genomic 4
47 annotations exist.
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Fig. C.13 Flow cytometric validation of CXCR6 expression in PbTII cells prior to
and after bifurcation. (A) Representative FACS plots showing kinetics of CellTraceTM
Violet (CTV) dilution and CXCR6 expression, with summary graphs showing proportion
of PbTII cells expressing this (after 106 PbTII cells transferred) in un-infected (Day 0)
and PcAS-infected mice at indicated days postinfection (n=4 mice/time point, with
individual mouse data shown in summary graphs; solid line in summary graphs indicates
results from third order polynominal regression analysis.) Data are representative of two
independent experiments. (B) Representative FACS plots showing CXCR6 expression in
Tbethi (red gate) and Bcl6hi (blue gate) PbTII cells, compared to naive PbTIIs (gray) at 7
days post-infection. Summary graph shows mean & standard deviations for geometric
mean fluorescence intensity of CXCR6 expression in gated PbTII populations (n=4 mice)
Statistics: Mann-Whitney U test *p<0.05.
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Fig. C.14 T cell-intrinsic Galectin-1 supports T 1 fate commitment. (A) Expression of
Lgals1 in the GPfates model across pseudotime. Curves represent Th1 (red) and Tfh (blue)
trends when weighing the information from data points according to trend assignment.
(B) Histograms of Galectin-1 expression by splenic PbTII cells (n=3-6 mice per group,
all data shown overlaid within each groups) and proportions expressing Galectin-1 in
naive mice (106 transferred; gray), and by T 1 (T-bethi IFNγ+; blue) and T H (Bcl6 h
iCXCR5 +; green) cells (10 4 transferred) in PcAS-infected mice at day 7 post-infection.
Statistics: Mann-Whitney U Test; ** p<0.01. Data are representative of two independent
experiments. (C) Schematic showing co-transfer of WT (GFP+ CD45.2+) and Lgals1-/-
(CD45.2+) PbTII cells (104 of each transferred) into WT congenic CD45.1+ recipient mice
(n=10), and gating strategy for assessment of splenic PbTII cells at 7 days post-infection.
(D) Representative FACS plots (gated on GFP+ or GFP-, CD45.2+ CD4+ TCRβ+ Vβ12+
live singlets) and paired analysis of proportions of splenic WT and Lgals1-/- PbTII cells
exhibiting Tbethi IFNγ+ (T 1) and Bcl6hi CXCR5+ (T Wilcoxon signed-rank Pairwise T-test;
**p<0.01; NS, not significant.
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Fig. C.15 IL-10- and IFNγ-coproducing Tr1 cells derive from T 1 cells.(A) The expression
kinetics of Ifng (left) and Il10 (right) according to the GPfates model. Curves represent the
expression patterns associated with the T 1 (red) and the T (B) Co-expression of Ifng and
Il10 in single cells. The colors of the data points represent time points and the shapes
represent cells from two replicate experiments. Tr1 cells were defined as cells expressing
both Ifng and Il10 at ≥ 10 TPM. T 1 cells were defined as cells expressing Ifng but not
Il10 at ≥ 10 TPM. (C) Representative FACS plots (gated on CD45.1+ CD4+ TCRβ+ live
singlets), proportions and mean fluorescence intensities of IFNγ (T 1) and IL-10+ IFNγ+
(Tr1) PbTII cells (104 transferred) with or without ex vivo PMA/ionomycin restimulation at
day 7 post-infection with PcAS. Statistics: Mann-Whitney U test; *p<0.05. Geom Mean
FL; Geometric Mean Fluorescence Level. (D) Differential expression genes between day 7
T 1 cells and Tr1 cells, as defined in (B). All genes expressed in at least 20% of the single
cells were included in the analysis. P-values were calculated using Wilcoxon Rank Sum
test, and adjusted for multiple testing using Benjamini & Hochberg correction. The top
hit Il10 is not shown. (E) Analysis of expression frequency for all genes in the day 7 T 1
cells and Tr1 cells, as defined in (B). Expression frequency was defined as the number of
cells where the transcript was detected, HFH (blue) trends. divided by total number of
cells. Genes with at least 0.3 difference in expression frequency between T 1 and Tr1
cells are highlighted in red.
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Fig. C.16 Proliferative burst of activated PbTII cells. (A) Fluorescence minus one (FMO)
control for expression of Ki67 by splenic PbTII cells from a day 7-infected mouse. (B) The
expression of established proliferation genes (31) along pseudotime. (C) ModFit plots and
proportions of PbTII cells in G0/G1, G2/M and S-phase of cell cycle as determined by
Hoechst staining.
200 Additional Material for Chapter 4
Ackr1 Ackr2 Ackr4 Ccr1
Ccr2 Ccr3 Ccr4 Ccr5 Ccr6
Ccr7 Ccr8 Ccr9 Cx3cr1 Cxcr2
Cxcr3 Cxcr4 Cxcr5 Cxcr6 Xcr1
Pseudotime
Not detected: Ackr3, Ccr10, Cxcr1 
Ex
pr
es
sio
n 
(lo
g1
0(
TP
M
+1
))
Th1 assignment 
probability
1.0 00.5
Th1
Tfh
Bifurcation
Fig. C.17 Kinetics of chemokine receptor expression during PcAS infection accord-
ing to the GPfates model. Curves represent the expression patterns associated with
the T 1 (red) and the T (blue) trends.
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Fig. C.18 Coexpression of chemokine receptors at single-cell level during PcAS
infection. (A) The expression of chemokine receptors in single cells at day 4 post
infection. (B) The expression of chemokine receptors in single cells at day 7 post infection.
(C) Representative FACS plots and proportions of splenic PbTII cells co-expressing CXCR5
and CXCR3 in naive (gray; n=3) or infected mice (green; n=6) at 4 days post-infection
with PcAS. Results are representative of two independent experiments. Statistics: Mann-
Whitney U test *p<0.05.
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Fig. C.19 B cells are essential for T responses in PbTII cells during PcAS infection.
Representative FACS plots (gated on CD4+ TCRβ+ CD45.1+ live singlets) of splenic PbTII
cells, showing proportions exhibiting T H (Bcl6+ CXCR5+) and T γ+) phenotypes in WT
mice (receiving 104 PbTII cells), treated with anti-CD20 monoclonal antibodies (0.25mg)
to deplete B-cells, or control IgG, and infected for 7 days with PcAS. Individual mice data
(n=5) shown in summary graph. Mann-Whitney U test *p<0.05; **p<0.01. Results are
representative of two independent experiments.
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204 Additional Material for Chapter 4
Naïve CD8 + 
Naïve CD8 -   
PcAS mixed 
PC1 
(4.21%) 
PC2 
(2.05%) 
PC3 
(1.72%) 
PC4 
(1.39%) 
PC5 
(1.33%) 
P
C
2 
(2
.0
5%
) 
P
C
3 
(1
.7
2%
) 
P
C
4 
(1
.3
9%
) 
P
C
5 
(1
.3
3%
) 
P
C
6 
(1
.2
4%
) 
40 20 0 20 40
30
20
10
0
10
20
30
30
20
10
0
10
20
30
40 20 0 20 40
20
10
0
10
20
30
40
20
10
0
10
20
30
40
40 20 0 20 40
0
20
40
60
0
20
40
60
40 20 0 20 40
30
20
10
0
10
20
30
20
10
0
10
20
40 20 0 20 40
20
10
0
10
20
20
10
0
10
20
30 20 10 0 10 20 30
20
10
0
10
20
30
40
20
10
0
10
20
30
40
30 20 10 0 10 20 30
0
20
40
60
0
20
40
60
30 20 10 0 10 20 30
30
20
10
0
10
20
30
20
10
0
10
20
30 20 10 0 10 20 30
20
10
0
10
20
20
10
0
10
20
20 10 0 10 20 30 40
0
20
40
60
0
20
40
60
20 10 0 10 20 30 40
30
20
10
0
10
20
30
20
10
0
10
20
20 10 0 10 20 30 40
20
10
0
10
20
20
10
0
10
20
0 20 40 60
30
20
10
0
10
20
30
20
10
0
10
20
0 20 40 60
20
10
0
10
20
20
10
0
10
20
30 20 10 0 10 20
20
10
0
10
20
20
10
0
10
20
Fig. C.21 PCA of cDCs from naive and infected mice. Results of Principal Component
(PC) Analysis on scRNA-seq mRNA reads (filtered by minimum expression of 100 TPM in
at least 2 cells) from 131 single splenic naive CD8α+ and CD8α- and mixed day 3 PcAS-
infected cDC. PC1-PC6 shown. Axis labels show proportional contribution of respective
PC.
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Fig. C.22 Differential gene expression between single splenic CD8α+ and CD8α-
cDCs. (A) Results of differential gene expression analysis between naive splenic CD8α+
and CD8α- cDCs, for all genes expressed in greater than 2 cells. (B) Complete list of
differentially-expressed genes between naive CD8α+ and CD8α- cDCs, which were
expressed in >10 cells of either subset with a qval <0.2 as determined in (A). (C) Heatmap
of naive cDCs ordered by PC2 (Fig. 6A) and expression of genes from (B) ordered by PC2
loading in (Fig 6A). (D) Heatmap examining hierarchical clustering of mixed CD8α+ and
CD8α- CD11b+ day 3- infected cDCs (cell-sorted and mixed at a ratio of 50:50 prior to
scRNA-seq) using differentially expressed genes from (B) ordered by PC2 loading shown
in (Fig 6A).
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Gene Log2 (Fold change) qval 
Tgtp1 4.36E+00 4.84E-11 
Tgtp2 2.78E+00 1.68E-10 
Ifi47 3.56E+00 4.23E-10 
Kdm6b 4.25E+00 1.22E-09 
Actb 1.62E+00 1.01E-07 
Igtp 4.00E+00 1.43E-07 
AC124762.1 3.06E+00 3.69E-07 
Gm15427 -9.78E-01 1.51E-06 
Stat1 2.49E+00 1.92E-06 
U6 -3.31E+00 8.27E-06 
Snora31 9.27E-01 9.92E-06 
Nlrc5 2.09E+00 1.43E-05 
Gm12250 5.43E+00 1.61E-05 
Zbp1 4.87E+00 5.59E-05 
Gbp4 3.41E+00 1.82E-04 
R3hdm4 2.19E+00 2.52E-04 
Slc39a1 3.20E+00 7.09E-04 
Gm10800 6.42E-01 8.35E-04 
Cxcl10 3.43E+00 1.81E-03 
Alkbh5 3.20E+00 1.98E-03 
Cxcl9 2.42E+00 2.38E-03 
Dtx3l 1.74E+00 4.69E-03 
Wtap 2.85E+00 4.87E-03 
AC131780.3 1.11E+00 5.07E-03 
Gbp3 1.40E+00 5.89E-03 
Wac 2.87E+00 8.31E-03 
Pml 2.96E+00 1.35E-02 
Arf4 1.89E+00 1.56E-02 
Irf1 1.44E+00 2.27E-02 
Gbp2 2.12E+00 4.55E-02 
Fig. C.23 Differentially expressed genes between single naive and day 3 PcAS-
infected cDCs. List of differentially expressed genes, expressed in >10 cells (qval<0.05)
between naive and day 3- infected cDCs. Mean TPM fold-change in gene expression
relative to naive levels.
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Figure S19 
Fig. C.24 PCA of Ly6Chi monocytes from naive and infected mice. Results of
Principal Component (PC) Analysis using scRNA-seq mRNA reads (filtered by minimum
expression of 100 TPM in at least 2 cells) of 154 single splenic Ly6Chi monocytes from
naive and infected mice. PC1-PC6 shown. Axis labels show proportional contribution of
respective PC.
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Fig. C.25 Myeloid cell depletion in LysMCre x iDTR mice. LysMCre x iDTR mice were
infected with PcAS, and treated 3 days later with DT (10ng/g intraperitoneal injection)
or control saline (n=6 per group). 24 hours later spleens were harvested for cellular
compositional analysis: (A) Representative FACS plots enumerating splenic inflamma-
tory monocytes (Ly6Chi CD11bhi Ly6G- B220- TCRβ-). (B) Representative fluorescence
micrographs showing spleen tissue sections co-stained for B cells (B220 in red) and
macrophages (CD68 (top panel) or SIGN-R1 (bottom panel) in green) and summary graphs
of average cell number in three fields of view covering the total cross section of a spleen.
(C) Flow cytometric enumeration of splenic cDC (CD11chi MHCIIhi B220- TCRβ-).

AppendixD
Additional Material for Chapter 5
D.1 Data sets and specific processing steps
The analysis presented in this study is based on a number of publicly avail-
able datasets. Some of these data were however not available in typical data
repositories owing to their novel nature.
D.1.1 Spatial Transcriptomics data The count tables from Stahl et al were
downloaded from the website http://www.spatialtranscriptomicsresearch.
org/datasets/doi-10-1126science-aaf2403, linked from the publication. For
the breast cancer data, we used the file annotated as “Layer 2" with the
corresponding HE image. For the mouse olfactory bulb, we used the file
named “Replicate 11" with corresponding HE image. Images included in
figures were cropped, down-scaled and converted to grey scale to conserve
file sizes.
D.1.2 SeqFISH data We downloaded the expression table from the supple-
mentary material of Shah et al, and extracted cell counts from the region
annotated with number 43 in the 249 gene experiment (Table S8 in the orig-
inal publication). The shape of the data suggested this corresponded to a
region in the lower left part of the corresponding supplementary figure,
informing our sketch in Fig. 2D (this was only relevant for illustration, and
not used for analysis or results).
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D.1.3 MERFISH data From the website http://zhuang.harvard.edu/merfish
we downloaded the file “data_for_release.zip" which contain data from
Moffitt et al. We used the files in the folder called “Replicate 6", as these had
the larges number of cells and highest confluency. Jeffrey Moffitt helped us
understand the data format through personal communication.
D.1.4 Frog development RNA-seq data We downloaded the TPM expres-
sion table for Clutch A from GEO accession GSE65785.
D.2 Computational Performance Benchmark
Data for 10,000 genes were simulated according to the SpatialDEmodel with
various effect magnitudes for multiple sample sizes. For SpatialDE, the test
was run on these data and timed according to wall clock. For the Stan
implementation, 100 random genes were sampled for each sample size, and
timing was extrapolated by multplying the time by 100. The Stan model was
fitted using L-BFGS-B optimization. It should be noted that this problems is
trivially parallelizable over the genes, and neither of the implementations
make use of this fact. The benchmarks were performed on a Late 2013 iMac
with a 3.2 GHz Intel Core i5 processor and 32 GB of DDR3 RAM, a typical
consumer level PC.
D.3 Software availability
The primary implementation of SpatialDE is a Python 3 package, which can
be installed from PyPI using pip. Development is public on Github1. A
Stan implementation is also provided in the same repository, as well as all
analysis presented in this paper, and additional tutorials and notebooks
illustrating how to use the package. All data used in our analysis is also
available in preprocessed form the Github repository using git-lfs.
D.4 Additional Figures
1https://github.com/Teichlab/SpatialDE
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Fig. D.1 Expanded example of Breast Cancer tissue genes. Spatial expression pattern
for 37 additional SV genes (out of 115), selected to represent patterns from different
function periods and length scales to illustrate different spatial patterns.
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Fig. D.2 Comparison to differential expression analysis using clustering. (A) Principal
Component Analysis of individual “spots”, color coded by cluster membership for N=4
clusters (identified by Bayesian Gaussian Mixture Modelling). (B) Bayesian Gaussian
Mixture Model cluster probabilities, the 250 spatial breast cancer “spots” can be clustered
into four groups when ignoring spatial structure. (C) Visualization of cluster membership
in the original tissue context. (D) Comparison of P-values from an ANOVA test between
clusters (x-axis) with significance from SpatialDE (y-axis). 83 genes are identified as
significantly variable by both approaches; 32 genes are significant only in the SpatialDE
test, among them immune genes. (E) Histogram of the fitted length scales for SV genes
detected by both approaches (blue) and SV genes detected only by SpatialDE (orange).
Genes detected only by SpatialDE have smaller length scales, indicating more localized
expression patterns.
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Genes Adj. P-value < 0.05
Fig. D.3 Comparison of SpatialDE to other measures of expression heterogeneity.
(A) Comparison of P-values from SpatialDE to other commonly used summary statistics
- Upper left: Mean, Upper right: Variance, Lower left: CV2 (squared coefficient of
variation), Lower right: Dropout rate (fraction of samples a gene is not detected in).
Random selection of significant SV genes highlighted in red for context. (B) Comparison
with common strategies to define highly variable genes, which are based on regression
models between summary statistics: Relation with CV2 (Upper) or Variance (Middle),
or with dropout fraction (Bottom). Model residuals are compared with the SpatialDE
significance to the right of the relation. Polynomial regression for CV2 and Variance,
logistic regression for dropout rate. Significant SV genes as identified by SpatialDE are
shown in grey. Other, non-significant genes are shown in solid black.
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Fig. D.4 Statistical calibration of SpatialDE. (A) QQ-plot of expected P-values (Chi2
distribution with 1 degree of freedom) compared to observed P-values derived using the
log likelihood ratio test in SpatialDE. (B) To simulate data from an empirical null, without
spatial structure, expression values were shuffled among the sampled coordinates. Shown
is COL3A1 expression as an example. (C) Adj. P-values for genes on shuffled data, which
are generally below the FDR = 0.05 threshold. (D) Analogous QQ-plot as in A on shuffled
expression values. P-values follows the null distribution, indicating that the model is
calibrated.
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Fig. D.5 Application to Mouse Olfactory Bulb tissue. (A) The corresponding image for
mouse olfactory bulb data from Stahl et al. (B) SpatialDE identified 67 spatially variable
genes (SV genes, FDR < 0.05). Of these, 19 were assigned to periodic functions. Genes
highlighted in Stahl et al are displayed in red, representative examples of SV genes are
annotated with black text (Colors and sizes as in Figure 2). (C) Representative examples
of SV gene with different periods and length scales (indicated in orange and blue bars,
respectively, relative to scale bar). Black scale bar correspond to 1 mm. Colors and
significance levels as described in Figure 2.
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Fig. D.6 Expanded examples of significant spatially variable genes for the mouse
hippocampus dataset. Visualization of 24 SV genes with from the mouse hippocam-
pus SeqFISH data, showing selected genes with periodic, linear, and general spatial
dependencies with different estimated length scales. Black scale bar correspond to 50
µm.
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Fig. D.7 Application to MERFISH data. (A) In MERFISH study of an osteosarcoma cell
culture from Moffitt et al9 the majority of genes are found spatially variable. 21 of 92
significant SV genes were assigned to a periodic function by the model, and 9 genes had
linear functions. Negative control probes are indicated with red labels. Genes indicated
as enriched in proliferating cells in the original study marked in green, and depleted genes
in blue. (B) Visualization of the MERFISH data by plotting general RNA probes in pink
and MALAT1 probes in blue on two 512 x 512 virtual pixel grids at different scales. The
original imaged region was 5.2 mm wide and 8.2 mm high totalling 38,594 cells (upper).
We analysed a region of 1 mm x 1 mm in the middle of the cell culture with 1,056 cells
(lower). (C) Expression levels in the cell culture region visualised for selected SV genes
with various fitted periods and length scales (Significance levels and colors as in Figure 2).
Black scale bar correspond to 200 µm. (D) Fraction of gene probes and control probes
detected as significant SV genes as a function of the family-wise error rate (FWER). The
number of significant control probes was in line with the FWER.
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Fig. D.8 Application to expression time-course data. (A ) When applying SpatialDE
to developmental time 27 course data from Owens et al , the majority of genes were
found differentially expressed (21,009 out of 22,256 genes, FDR < 0.05). Of these, 241
were assigned to periodic patterns, and 269 were detected with linear trends. Colors and
point sizes as in Figure 2. The X marks indicates result of running test on ERCC content
and number of detected genes. (B) Examples of temporally DE genes of various periods
and length scales. Black scale bar corresponds to 12 hours in the time-course, periods
and length scales of functions are indicated relative to this. Collection time in units of
hours post fertilization (hpf) (C) The expression patterns of the top 400 significantly SV
genes are visualised, ordered by the time they reach their highest expression value.
Example genes from B are annotated.
